<SEC-DOCUMENT>0001193125-26-001087.txt : 20260102
<SEC-HEADER>0001193125-26-001087.hdr.sgml : 20260102
<ACCEPTANCE-DATETIME>20260102171814
ACCESSION NUMBER:		0001193125-26-001087
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		20
CONFORMED PERIOD OF REPORT:	20251224
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20260102
DATE AS OF CHANGE:		20260102

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			American Well Corp
		CENTRAL INDEX KEY:			0001393584
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-BUSINESS SERVICES, NEC [7389]
		ORGANIZATION NAME:           	07 Trade & Services
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39515
		FILM NUMBER:		26503178

	BUSINESS ADDRESS:	
		STREET 1:		75 STATE STREET
		STREET 2:		26TH FLOOR
		CITY:			Boston
		STATE:			MA
		ZIP:			02109
		BUSINESS PHONE:		617-205-3500

	MAIL ADDRESS:	
		STREET 1:		75 STATE STREET
		STREET 2:		26TH FLOOR
		CITY:			Boston
		STATE:			MA
		ZIP:			02109
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>amwl-20251224.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2026-01-02T17:14:59.4142+00:00 -->
<!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:amwl="http://business.amwell.com/20251224" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16">
 <head>
  <title>8-K</title>
  <meta http-equiv="Content-Type" content="text/html"/>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;-webkit-text-size-adjust:100%;position:relative;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_8f326e7c-a74c-4211-9351-37ca84db312d" name="dei:EntityCentralIndexKey" contextRef="C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658">0001393584</ix:nonNumeric><ix:nonNumeric id="F_f5e02698-a278-42c3-a64a-75d7aa9c6295" name="dei:AmendmentFlag" contextRef="C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="amwl-20251224.xsd"/></ix:references><ix:resources><xbrli:context id="C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001393584</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-12-24</xbrli:startDate><xbrli:endDate>2025-12-24</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
  <div style="z-index:2;min-height:0.5in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="border-top:2.25pt double #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:5.75pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">UNITED STATES<br/>SECURITIES AND EXCHANGE COMMISSION<br/></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">WASHINGTON, D.C. 20549</span></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><h2 style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FORM </span><span style="font-size:18pt;font-family:Times New Roman;"><ix:nonNumeric id="F_62bf9aa3-d82f-4ee0-9113-066293c4457c" contextRef="C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658" name="dei:DocumentType"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8-K</span></ix:nonNumeric></span></h2><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CURRENT REPORT</span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:100%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.398%;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Date of Report (Date of earliest event reported): </span><span><ix:nonNumeric id="F_dfa433db-1595-4366-bcb5-6184b09c8d4c" contextRef="C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 24, 2025</span></ix:nonNumeric></span></p></td>
    </tr>
   </table><p style="margin-left:40%;font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:24pt;font-family:Times New Roman;"><ix:nonNumeric id="F_40c8a37a-2588-4d60-b970-d0cd9b6efeac" contextRef="C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658" name="dei:EntityRegistrantName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:24pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">American Well Corporation</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Exact name of Registrant as Specified in Its Charter)</span></p><p style="margin-left:40%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:20%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:20%;box-sizing:content-box;"/>
     <td style="width:18%;box-sizing:content-box;"/>
     <td style="width:41%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_f3d1998b-da92-45a5-bd26-2c83a0578925" contextRef="C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_e4288165-f1d2-4705-8ef4-1b2dd8d20cd7" contextRef="C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658" name="dei:EntityFileNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">001-39515</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_e4ddeece-befa-4963-aadc-c12ca58ed113" contextRef="C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658" name="dei:EntityTaxIdentificationNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">20-5009396</span></ix:nonNumeric></span></p></td>
    </tr>
    <tr style="height:7pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(State or Other Jurisdiction<br/>of Incorporation)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Commission File Number)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(IRS Employer<br/>Identification No.)</span></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_cc742520-5292-436a-8d47-ca0f7cabd245" contextRef="C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658" name="dei:EntityAddressAddressLine1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">75 State Street</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_7600ce43-cd3d-4740-a4b8-e267c071aae0" contextRef="C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658" name="dei:EntityAddressAddressLine2"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">26th Floor</span></ix:nonNumeric></span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_dffd31a5-f1fb-46aa-9ac8-9b703d50471e" contextRef="C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658" name="dei:EntityAddressCityOrTown"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">	 Boston</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">, </span><span><ix:nonNumeric id="F_f1ac7087-fe16-4072-afca-3daf97a7057b" contextRef="C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Massachusetts</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_272a0fe7-42f5-4268-898f-5838f5ea5817" contextRef="C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658" name="dei:EntityAddressPostalZipCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">02109</span></ix:nonNumeric></span></p></td>
    </tr>
    <tr style="height:7pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Address of Principal Executive Offices)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Zip Code)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:100%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.125in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.398%;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Registrant&#8217;s Telephone Number, Including Area Code:</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span><span><ix:nonNumeric id="F_76cd6f8a-2737-4944-80b3-fbeeed973f87" contextRef="C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658" name="dei:CityAreaCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">617</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span><span><ix:nonNumeric id="F_920a4465-4212-4fb2-b198-5b2b605b3bc1" contextRef="C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658" name="dei:LocalPhoneNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">204-3500</span></ix:nonNumeric></span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:100%;box-sizing:content-box;"/>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.125in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Former Name or Former Address, if Changed Since Last Report)</span></p><p style="margin-left:40%;font-size:10pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:3pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_33ef86bd-2c19-4174-82cb-2263a5f04306" contextRef="C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7f65d22b-904c-4769-b62a-e729c1fa63db" contextRef="C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_35184c92-0639-4b08-a848-5d4be7475d63" contextRef="C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e683ec61-d1d3-4d2e-9859-3c9d27a4e5da" contextRef="C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:9pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:38%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:15%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:45%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><br/>Title of each class</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Trading<br/>Symbol(s)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><br/>Name of each exchange on which registered</span></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_e9e073c0-53f1-4ef2-a2fd-f61625a3439f" contextRef="C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658" name="dei:Security12bTitle"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">	 Class A Common Stock, $0.01 Par Value</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_9d3615b3-def2-4882-909b-beb59e2a6e2e" contextRef="C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658" name="dei:TradingSymbol"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">AMWL</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_9bc56296-f098-44a7-9d8a-806f0205e249" contextRef="C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">New York Stock Exchange</span></ix:nonNumeric></span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#8239;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#8239;240.12b-2 of this chapter).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Emerging growth company </span><span style="font-size:10pt;"><ix:nonNumeric id="F_67c7ac61-1378-4fc7-af6e-a8f5b19ab237" contextRef="C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:2.25pt double #000000;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="z-index:2;min-height:0.5in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><h2 style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 1.01 Entry into a Material Definitive Agreement.</span></h2><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On December 24, 2025, American Well Corporation (the &#8220;Company&#8221;) entered into an amendment to extend its Master Services Agreement dated January 1, 2023 (the &#8220;MSA&#8221;) with Elevance Health, Inc. f/n/a/ Anthem Inc. (&#8220;Elevance Health&#8221;); and on December 25, 2025 entered into a related Statement of Work updating the Company&#8217;s Healthy Impact service offerings (the &#8220;Healthy Impact SOW&#8221;), effective as of January 1, 2026. The Statement of Work dated January 1, 2023 (together with the Healthy Impact SOW and the MSA, the &#8220;Agreements&#8221;) automatically renewed January 1, 2026 for an additional annual term, which extend the parties&#8217; partnership. Pursuant to the Agreements, we operate a white-labelled digital care delivery platform on behalf of Elevance Health under the brand name LiveHealth Online</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Elevance Health is obligated to pay us annual subscription fees and may engage us for certain mutually agreed upon professional services, development, innovation and engagement marketing services.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Each of the MSA and the Healthy Impact SOW has a term of 3 years, commencing on January 1, 2026 and ending on January 1, 2029, and thereafter automatically renews for successive one-year terms unless terminated by either party. Each party may terminate each of Agreements after the lapse of a cure period for material breaches of the applicable Agreement by the other party, upon the bankruptcy or insolvency of the other party, and in the case of Elevance Health, upon a breach by the Company of certain security or confidentiality provisions, the occurrence of certain change-of-control transactions, or at its convenience upon 365 days&#8217; advance written notice to Company.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, on December 24, 2025, Online Care Group, PC (&#8220;OCG&#8221;), the Company&#8217;s clinical partner, entered into amendments to two provider agreements (collectively, the &#8220;Provider Agreement Amendments&#8221;) with Elevance Health related entities, which extend the parties&#8217; partnership.  Pursuant to the Provider Agreement Amendments, OCG will continue to provide prioritized access to a 50-state network of clinical professionals who will provide digital care consultations to Elevance Health members via the LiveHealth Online platform in consideration for access and per consultation fees.  The terms of the Provider Agreements were extended for a period of 3 years, commencing on January 1, 2026 and ending on January 1, 2029, and thereafter automatically renew for successive one-year terms unless terminated by either party.  Either party may terminate the Provider Agreements for convenience upon 365 days' prior written notice to the other party.  In addition, either party may terminate the Provider Agreements upon the termination of the MSA or the applicable SOW, the other party&#8217;s bankruptcy, or occurrence of other specified events.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The foregoing description of the MSA, Healthy Impact SOW, and Provider Agreement Amendments do not purport to be complete and is qualified in its entirety by reference to the full text of the Agreements and the Provider Agreement Amendments, which are attached as Exhibits 10.1, 10.2, 10.3 and 10.4 hereto.</span></p><h2 style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9.01 Financial Statements and Exhibits.</span></h2><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(d) </span><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibits</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  The following exhibits are being filed herewith:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:4.98%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:94.02%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1*&#134;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="amwl-ex10_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Amendment to Master Services Agreement, dated as of December 24, 2025, by and between American Well Corporation and Elevance Health, Inc.</span></a></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.2*</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="amwl-ex10_2.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Statement of Work, dated as of December 25, 2025, by and between American Well Corporation and Elevance Health, Inc.</span></a></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.3*</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="amwl-ex10_3.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Amendment to Provider Agreement, dated as of December 24, 2025, by and between Blue Cross of California doing business as Anthem Blue Cross and Online Care Group, P.C</span></a></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.4*</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="amwl-ex10_4.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Amendment to Provider Agreement, dated as of December 24, 2025, by and between Rocky Mountain Hospital and Medical Service, Inc., doing business as Anthem Blue Cross and Blue Shield and HMO Colorado, Inc. doing business as HMO Colorado, Anthem Health Plans, Inc. doing business as Anthem Blue Cross and Blue Shield, Anthem Insurance Companies, Inc. and Blue Cross Blue Shield Healthcare Plan of Georgia, Inc. d/b/a Anthem Blue Cross and Blue Shield, Anthem Insurance Companies, Inc. doing business as Anthem Blue Cross and Blue Shield, Anthem Health Plans of Kentucky, Inc. d/b/a Anthem Blue Cross and Blue Shield, Anthem Health Plans of Maine, Inc. doing business as Anthem Blue Cross and Blue Shield, RightCHOICE Managed Care, Inc., Anthem Health Plans of New Hampshire, Inc. doing business as Anthem Blue Cross and Blue Shield and Matthew Thornton Health Plan, Inc., Rocky Mountain Hospital and Medical Service, Inc. doing business as Anthem Blue Cross and Blue Shield and HMO Colorado, Inc. doing business as HMO Nevada, Empire Health Choice HMO, Inc. (d/b/a Empire BlueCross BlueShield HMO or Empire Blue Cross HMO) and Empire Health Choice Assurance, Inc. (d/b/a Empire BlueCross BlueShield or Empire Blue Cross), Community Insurance Company doing business as Anthem Blue Cross and Blue Shield, Anthem Health Plans of Virginia, Inc. doing business as Anthem Blue Cross and Blue Shield, Blue Cross Blue Shield of Wisconsin doing business as Anthem Blue Cross and Blue Shield ("Anthem") and Online Care Group, P.C</span></a></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">104</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">*</span><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Portions of this exhibit have been redacted pursuant to Item 601(b)(10) of Regulation S-K. Such redacted terms are those that the Company customarily and actually treats as private or confidential and are not material.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#134; Exhibits and schedules have been omitted pursuant to Item 601(a)(5) of Regulation S-K and will be provided on a supplemental basis to the Securities and Exchange Commission upon request.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="z-index:2;min-height:0.5in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9.35pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SIGNATURES</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:6%;box-sizing:content-box;"/>
     <td style="width:44%;box-sizing:content-box;"/>
     <td style="width:4%;box-sizing:content-box;"/>
     <td style="width:46%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:4.3pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">AMERICAN WELL CORPORATION</span></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date:</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 2, 2026</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Anna Nesterova</span></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Anna Nesterova<br/>Deputy General Counsel, Head of Legal</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>amwl-ex10_1.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!-- DFIN ActiveDisclosure (SM) HTML Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2026-01-02T17:14:59.4206+00:00 --><!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html>
 <head>
  <title>EX-10.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;-webkit-text-size-adjust:100%;position:relative;">
  <div style="padding-top:0.2in;z-index:2;min-height:1.06in;position:relative;box-sizing:border-box;"><p style="margin-left:3.147%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:19.8pt;text-align:right;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Exhibit 10.1</font></p><p style="margin-left:13.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:11.253%;text-indent:-0.107%;padding-left:0.093%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.2pt;margin-right:1.315%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Fifth Amendment to</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font><font style="color:#0c0c0c;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:11.253%;text-indent:-0.107%;padding-left:0.093%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.2pt;margin-right:1.315%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Master Services Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#0c0c0c;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:11.253%;text-indent:-0.107%;padding-left:0.093%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:14.4pt;margin-right:1.37%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Between Elevance Health and American Well Corporation</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#0c0c0c;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:13.173%;text-indent:-0.128%;padding-left:0.107%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:13.45pt;margin-right:3.444%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Fifth Amendment (&#x201c;Amendment&#x201d;) dated and effective as of January 01, 2026 (&#x201c;Amendment Effective Date&#x201d;) is by and between Elevance Health, Inc., on behalf of itself and its Affiliates (&#x201c;Elevance Health&#x201d;) and American Well Corporation (&#x201c;Supplier&#x201d;) and amends that certain Master Services Agreement between the parties dated January 01, 2023 (the &#x201c;Agreement&#x201d;).</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">   </font><font style="color:#0c0c0c;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:11.253%;text-indent:-0.107%;padding-left:0.093%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12.35pt;margin-right:1.37%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RECITALS</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#0c0c0c;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:13.173%;text-indent:-0.126%;padding-left:0.107%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:13.35pt;margin-right:1.806%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">WHEREAS, the Parties desire to amend the Master Services Agreement to update the Contract Term, Medicaid Exhibits, Required Information Security Controls (RISC) Exhibit, and add a provision pertaining to Artificial Intelligence (AI).</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></p><p style="margin-left:11.253%;text-indent:-0.105%;padding-left:0.093%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12.15pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">AGREEMENT</font><font style="color:#0c0c0c;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:14.6pt;margin-right:1.759%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOW, THEREFORE, in consideration of the mutual promises and undertakings described in this Amendment, the parties, intending to be legally bound, hereby agree to amend the Agreement as follows:</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#0c0c0c;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="margin-left:13.204%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:15.5pt;margin-right:0.935%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.681229549748838%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid #000000;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Conflict of Terms, Definitions</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  In the event of a conflict between the terms of this Amendment and the terms of the Agreement, the terms of this Amendment shall control. Unless otherwise specified in this Amendment, all capitalized terms shall have the meaning given to them in the Agreement. </font><font style="color:#0c0c0c;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div><div class="item-list-element-wrapper" style="margin-left:13.204%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:15.05pt;margin-right:0.935%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.681229549748838%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid #000000;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Term</font><font style="color:#0c0c0c;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Section 7 Term: Termination is deleted in its entirety and replaced with the below Section 7 in </font><font style="color:#0c0c0c;white-space:pre-wrap;text-decoration:underline solid #0c0c0c;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Attachment 1</font><font style="color:#0c0c0c;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> hereto. </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div><div class="item-list-element-wrapper" style="margin-left:13.204%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:14.05pt;margin-right:0.935%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.681229549748838%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid #000000;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Medicaid Exhibits.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  All States Medicaid Exhibits link is updated with Exhibit E in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid #000000;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Attachment 1</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font><font style="color:#0c0c0c;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div><div class="item-list-element-wrapper" style="margin-left:13.204%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:13.65pt;margin-right:0.935%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.681229549748838%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid #000000;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Artificial Intelligence.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  Section</font><font style="color:#0c0c0c;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> 18-Artificial Intelligence provision in </font><font style="color:#0c0c0c;white-space:pre-wrap;text-decoration:underline solid #0c0c0c;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Attachment 1</font><font style="color:#0c0c0c;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> is hereby added to the Agreement.  </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.53in;min-height:2.64in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="margin-left:9.96%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#0c0c0c;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:9.96%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain confidential information contained in this document, marked by [**], has been omitted because American Well Corporation has determined that the information (i) is not material and (ii) is the type that American Well Corporation customarily and actually treats as private or confidential.</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#0c0c0c;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.2in;z-index:2;min-height:1.06in;position:relative;box-sizing:border-box;"><p style="margin-left:13.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:13.204%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0.2pt;margin-right:0.935%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.681229549748838%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.</font><div style="display:inline;"><font style="color:#0c0c0c;white-space:pre-wrap;text-decoration:underline solid #0c0c0c;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RISC Exhibit</font><font style="color:#0c0c0c;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Exhibit A-RISC is deleted in its entirety and replaced with the following Exhibit A-RISC in </font><font style="color:#0c0c0c;white-space:pre-wrap;text-decoration:underline solid #0c0c0c;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Attachment 1</font><font style="color:#0c0c0c;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div><p style="margin-left:19.867%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.2pt;margin-right:0.907%;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><div class="item-list-element-wrapper" style="margin-left:13.204%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0.3pt;margin-right:0.935%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.681229549748838%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">6.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid #000000;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No Other Modifications</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Except as provided herein, the terms and conditions of the Agreement shall remain the same, in full force and effect. </font><font style="color:#0c0c0c;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div><p style="margin-left:13.293%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0c0c0c;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.53in;min-height:2.64in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="margin-left:9.96%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain confidential information contained in this document, marked by [**], has been omitted because American Well Corporation has determined that the information (i) is not material and (ii) is the type that American Well Corporation customarily and actually treats as private or confidential.</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#0c0c0c;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.2in;z-index:2;min-height:1.06in;position:relative;box-sizing:border-box;"><p style="margin-left:13.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:13.133%;text-indent:-0.108%;padding-left:0.093%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.2pt;text-align:justify;"><font style="color:#0c0c0c;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">IN WITNESS WHEREOF, the parties have caused this Amendment to be duly executed as of the Amendment Effective Date indicated above.</font><font style="color:#0c0c0c;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:1.827%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:3.1pt;text-align:left;"><font style="color:#0c0c0c;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> 		</font></p>
   <table style="margin-left:12.565%;border-spacing:0;table-layout:auto;width:85.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:45.28%;box-sizing:content-box;"></td>
     <td style="width:5.78%;box-sizing:content-box;"></td>
     <td style="width:48.94%;box-sizing:content-box;"></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;text-align:right;">
     <td style="padding-top:0in;text-indent:93.75pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="margin-left:0.56%;text-indent:-21.213%;padding-left:16.8%;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:6.2pt;margin-right:3.444%;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;text-indent:93.75pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="margin-left:13.173%;text-indent:-5.286%;padding-left:4.187%;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:6.2pt;margin-right:3.444%;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;text-indent:12pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="margin-left:2.227%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:6.2pt;margin-right:3.444%;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:11pt;white-space:pre-wrap;word-break:break-word;text-align:right;">
     <td style="padding-top:0in;text-indent:93.75pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="margin-left:0.56%;text-indent:-21.213%;padding-left:16.8%;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:6.2pt;margin-right:3.444%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">American Well Corporation</font></p></td>
     <td style="padding-top:0in;text-indent:93.75pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.075in;"><p style="margin-left:13.173%;text-indent:-5.286%;padding-left:4.187%;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:6.2pt;margin-right:3.444%;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;text-indent:12pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="margin-left:2.227%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:6.2pt;margin-right:3.444%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Elevance Health, Inc.</font></p></td>
    </tr>
    <tr style="height:11pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;text-indent:3pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="margin-left:0.56%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:6.2pt;margin-right:3.444%;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;text-indent:93.75pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="margin-left:13.173%;text-indent:-5.286%;padding-left:4.187%;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:6.2pt;margin-right:3.444%;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;text-indent:12pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="margin-left:2.227%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:6.2pt;margin-right:3.444%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Elevance Health</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;text-align:right;">
     <td style="padding-top:0in;text-indent:93.75pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="margin-left:0.56%;text-indent:-21.213%;padding-left:16.8%;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:6.2pt;margin-right:3.444%;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;text-indent:93.75pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="margin-left:13.173%;text-indent:-5.286%;padding-left:4.187%;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:6.2pt;margin-right:3.444%;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;text-indent:12pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="margin-left:2.227%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:6.2pt;margin-right:3.444%;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:11pt;white-space:pre-wrap;word-break:break-word;text-align:right;">
     <td style="padding-top:0in;text-indent:93.75pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="margin-left:0.56%;text-indent:-21.213%;padding-left:16.8%;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:6.2pt;margin-right:3.444%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Anna Nesterova</font></p></td>
     <td style="padding-top:0in;text-indent:93.75pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.075in;"><p style="margin-left:13.173%;text-indent:-5.286%;padding-left:4.187%;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:6.2pt;margin-right:3.444%;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;text-indent:12pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="margin-left:2.227%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:6.2pt;margin-right:3.444%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Chad R Frost</font></p></td>
    </tr>
    <tr style="height:11pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;text-indent:93.75pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="margin-left:0.56%;text-indent:-21.213%;padding-left:16.8%;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:6.2pt;margin-right:3.444%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Signature</font></p></td>
     <td style="padding-top:0in;text-indent:93.75pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="margin-left:13.173%;text-indent:-5.286%;padding-left:4.187%;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:6.2pt;margin-right:3.444%;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;text-indent:12pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="margin-left:2.227%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:6.2pt;margin-right:3.444%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Signature</font></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;text-indent:93.75pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="margin-left:0.56%;text-indent:-21.213%;padding-left:16.8%;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:6.2pt;margin-right:3.444%;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;text-indent:93.75pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="margin-left:13.173%;text-indent:-5.286%;padding-left:4.187%;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:6.2pt;margin-right:3.444%;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;text-indent:12pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="margin-left:2.227%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:6.2pt;margin-right:3.444%;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:11pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:93.75pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="margin-left:0.56%;text-indent:-21.213%;padding-left:16.8%;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:6.2pt;margin-right:3.444%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Anna Nesterova</font></p></td>
     <td style="padding-top:0in;text-indent:93.75pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.075in;text-align:left;"><p style="margin-left:13.173%;text-indent:-5.286%;padding-left:4.187%;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:6.2pt;margin-right:3.444%;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;text-indent:12pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="margin-left:2.227%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:6.2pt;margin-right:3.444%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chad R Frost</font></p></td>
    </tr>
    <tr style="height:11pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;text-indent:93.75pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="margin-left:0.56%;text-indent:-21.213%;padding-left:16.8%;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:6.2pt;margin-right:3.444%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Printed Name</font></p></td>
     <td style="padding-top:0in;text-indent:93.75pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="margin-left:13.173%;text-indent:-5.286%;padding-left:4.187%;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:6.2pt;margin-right:3.444%;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;text-indent:12pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="margin-left:2.227%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:6.2pt;margin-right:3.444%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Printed Name</font></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:93.75pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;text-align:right;"><p style="margin-left:0.56%;text-indent:-21.213%;padding-left:16.8%;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:6.2pt;margin-right:3.444%;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;text-indent:93.75pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;text-align:left;"><p style="margin-left:13.173%;text-indent:-5.286%;padding-left:4.187%;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:6.2pt;margin-right:3.444%;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;text-indent:12pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;text-align:right;"><p style="margin-left:2.227%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:6.2pt;margin-right:3.444%;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:11pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:93.75pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="margin-left:0.56%;text-indent:-21.213%;padding-left:16.8%;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:6.2pt;margin-right:3.444%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deputy General Counsel, Head of Legal</font></p></td>
     <td style="padding-top:0in;text-indent:93.75pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.075in;text-align:left;"><p style="margin-left:13.173%;text-indent:-5.286%;padding-left:4.187%;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:6.2pt;margin-right:3.444%;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;text-indent:12pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="margin-left:2.227%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:6.2pt;margin-right:3.444%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director, Strategic Sourcing</font></p></td>
    </tr>
    <tr style="height:11pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;text-indent:93.75pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="margin-left:0.56%;text-indent:-21.213%;padding-left:16.8%;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:6.2pt;margin-right:3.444%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Title</font></p></td>
     <td style="padding-top:0in;text-indent:93.75pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="margin-left:13.173%;text-indent:-5.286%;padding-left:4.187%;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:6.2pt;margin-right:3.444%;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;text-indent:12pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="margin-left:2.227%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:6.2pt;margin-right:3.444%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Title</font></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;text-indent:93.75pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="margin-left:0.56%;text-indent:-21.213%;padding-left:16.8%;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:6.2pt;margin-right:3.444%;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;text-indent:93.75pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="margin-left:13.173%;text-indent:-5.286%;padding-left:4.187%;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:6.2pt;margin-right:3.444%;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;text-indent:12pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="margin-left:2.227%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:6.2pt;margin-right:3.444%;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:11pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:93.75pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="margin-left:0.56%;text-indent:-21.213%;padding-left:16.8%;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:6.2pt;margin-right:3.444%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12-23-2025</font></p></td>
     <td style="padding-top:0in;text-indent:93.75pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.075in;text-align:left;"><p style="margin-left:13.173%;text-indent:-5.286%;padding-left:4.187%;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:6.2pt;margin-right:3.444%;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;text-indent:12pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="margin-left:2.227%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:6.2pt;margin-right:3.444%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12/24/2025</font></p></td>
    </tr>
    <tr style="height:11pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;text-indent:93.75pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="margin-left:13.173%;text-indent:-5.286%;padding-left:4.187%;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:6.2pt;margin-right:3.444%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date</font></p></td>
     <td style="padding-top:0in;text-indent:93.75pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="margin-left:13.173%;text-indent:-5.286%;padding-left:4.187%;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:6.2pt;margin-right:3.444%;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;text-indent:12pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="margin-left:2.227%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:6.2pt;margin-right:3.444%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date</font></p></td>
    </tr>
   </table><p style="margin-left:1.827%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:3.1pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.6pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.53in;min-height:2.64in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="margin-left:9.96%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain confidential information contained in this document, marked by [**], has been omitted because American Well Corporation has determined that the information (i) is not material and (ii) is the type that American Well Corporation customarily and actually treats as private or confidential.</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#0c0c0c;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.2in;z-index:2;min-height:1.06in;position:relative;box-sizing:border-box;"><p style="margin-left:13.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:11.413%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.15pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ATTACHMENT 1</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:13.027%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12.3pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:11.4pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid #000000;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TERM; TERMINATION</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:13.067%;text-indent:-0.219%;padding-left:0.187%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:13.3pt;margin-right:1.63%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7.1 </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid #000000;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  The term of this Agreement shall begin on January 1, 2026 and shall end January 1, 2029 unless earlier terminated in accordance with this Agreement (the &#x201c;Initial Term&#x201d;). Upon expiration of the Initial Term, this Agreement will automatically renew for successive one (1) year terms (each an &#x201c;Extension Term&#x201d;, and collectively, the &#x201c;Term&#x201d;), unless either party provides the other with notice of its intent to terminate pursuant to Section 7.4, provided however, that upon expiration, any SOW(s) then in effect that have specified a term longer than the Term stated above shall continue to be subject to the terms and conditions contained in this Agreement.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:13.067%;text-indent:-0.219%;padding-left:0.187%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:13.3pt;margin-right:1.63%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7.2 </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid #000000;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Termination for Supplier&#x2019;s Breach</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Elevance Health, in its sole discretion, may suspend or terminate the entire Agreement or any one or all Statements of Work (i) immediately upon a Security Incident, if Supplier is in breach of Sections 9 (Security), 10 (Confidentiality), or (ii) upon thirty (30) days written notice and opportunity to cure in the event of a material breach by Supplier if Supplier has not remedied such breach within thirty (30) days of its receipt of written Notice from Elevance Health of such breach.  Should Supplier again materially breach the Agreement in substantially the same manner as a prior material breach by Supplier within one (1) year of such prior material breach, Elevance Health may terminate any or all Statements of Work or this entire Agreement upon no less than ten (10) business days written notice.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">   </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:13.067%;text-indent:-0.219%;padding-left:0.187%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:15.8pt;margin-right:1.63%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7.3 </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid #000000;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Termination for Elevance Health&#x2019;s Breach</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Subject to the following sentence, Supplier may terminate a SOW upon written notice in the event of a material breach of such SOW by Elevance Health or an Elevance Health Affiliate if Elevance Health or an Elevance Health Affiliate has not remedied such breach within thirty (30) days of its receipt of written notice from Supplier of such breach.  Prior to issuing any notice of termination and within the thirty day cure period, Supplier shall escalate the matter to Elevance Health executives pursuant to the informal dispute resolution procedures set forth in Section 16 (Dispute Resolution).</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">   </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:13.067%;text-indent:-0.219%;padding-left:0.187%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:13.3pt;margin-right:1.63%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7.4 </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid #000000;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Termination for Convenience</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Elevance Health may terminate this Agreement or any one or all Statements of Work issued hereunder, in whole or in part, for any or no reason upon three hundred sixty-five (365) days&#x2019; advance written notice to Supplier.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:13.067%;text-indent:-0.219%;padding-left:0.187%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:13.3pt;margin-right:1.63%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7.5 </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid #000000;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Termination Due to Insolvency</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Either Party may terminate this Agreement or any SOW immediately upon the occurrence of any of the following events with respect to the other Party:  (a) the other Party becomes insolvent, generally unable to pay its debts as they become due, or makes an assignment for the benefit of its creditors or seeks relief under any bankruptcy, insolvency or debtor&#x2019;s relief law; (b) if proceedings are commenced against the other Party under any bankruptcy, insolvency or debtor&#x2019;s relief law, and such proceedings have not been vacated or set aside within sixty (60) days from the date of commencement thereof; (c) a receiver is appointed for the other Party or its material assets; or (d) if the other Party is liquidated, dissolved or ceases operations.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.53in;min-height:2.64in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="margin-left:9.96%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain confidential information contained in this document, marked by [**], has been omitted because American Well Corporation has determined that the information (i) is not material and (ii) is the type that American Well Corporation customarily and actually treats as private or confidential.</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#0c0c0c;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.2in;z-index:2;min-height:1.06in;position:relative;box-sizing:border-box;"><p style="margin-left:13.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:13.067%;text-indent:-0.219%;padding-left:0.187%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:13.3pt;margin-right:1.63%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7.6 </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid #000000;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Termination Upon Change of Control of Supplier Involving Elevance Health Competitor</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  If a change in Control of Supplier occurs, such that Supplier is controlled by an Elevance Health Competitor, then Elevance Health may at its option, terminate this Agreement or any SOW, in whole or in part, by giving Supplier at least thirty (30) days&#x2019; prior written notice and designating a date upon which such termination will be effective.  Any such notice must be given within six (6) months of Supplier&#x2019;s provision of written notice to Elevance Health of such change in Control.  For this purpose, &#x201c;Control&#x201d; and its derivatives means the legal, beneficial or equitable ownership, directly or indirectly, of at least fifty percent (50%) of the aggregate of all voting equity interests in an entity or equity interests having the right to at least fifty percent (50%) of the profits of Supplier or, in the event of dissolution, to at least fifty percent (50%) of the assets of an entity and, if Supplier is a partnership, also includes the holding by an entity of the position of sole general partner in Supplier.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:13.067%;text-indent:-0.219%;padding-left:0.187%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:13.3pt;margin-right:1.63%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7.7 </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid #000000;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Effect of Termination or Expiration</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  In the event that Elevance Health terminates a SOW pursuant to the terms contained in such SOW, Elevance Health may, in its sole discretion, simultaneously terminate other Statements of Work materially and adversely affected by such termination or expiration.  Notwithstanding the foregoing, the termination of a particular SOW, or portion of a SOW, shall not result in the termination of the Agreement unless such termination explicitly provides for termination of the entire Agreement between the Parties.   However, termination of the Agreement shall serve to terminate all Statements of Work unless such notice of termination specifies otherwise. All sections identified as surviving the termination of a SOW, as well as Sections 3.5 (Record Retention), 4 (Services), 8 (Intellectual Property Ownership), 9 (Security), 10 (Confidentiality), 13 (Indemnification), 14 (Limitation of Liability) and 16 (Dispute Resolution) inclusive, shall survive the expiration or termination of the Agreement.  In the event of termination for any reason of any SOW, Elevance Health shall pay Supplier any undisputed Fees and/or expenses owed in accordance with such SOW up to the effective date of termination.  If the Agreement includes Deliverables, Supplier shall promptly deliver such Deliverables, in whatever stage of completion, to Elevance Health.  The return or destruction of Confidential Information upon termination is addressed in Section 10.5 of the original MSA.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:13.067%;text-indent:-0.219%;padding-left:0.187%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:14.75pt;margin-right:1.63%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7.8 </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid #000000;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Continuity of Care.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> If Online Care Group, PC (including its affiliates, &#x201c;Amwell Medical Group&#x201d;) is required either by applicable law or by contract with Elevance Health or its Affiliate(s) to continue delivery of care to Elevance Health members for any period after the date of termination of this Agreement or any applicable SOW (the &#x201c;Continuity of Care Period&#x201d;), then notwithstanding the termination date or anything to the contrary, Elevance Health will be deemed to have invoked Section 4.11 (Transition Assistance) of the Agreement and the terms of such SOW and this Agreement will continue in effect during the Continuity of Care Period. During any such Continuity of Care Period, Supplier shall continue performing the Services under such SOW and the Agreement, as applicable, and Elevance Health shall continue to pay Supplier the fees for the Services at the existing SOW rate until the Continuity of Care Period expires.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:11.56%;text-indent:-0.106%;padding-left:0.093%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9pt;margin-right:0.083%;text-align:center;"><font style="color:#0c0c0c;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EXHIBIT &#x201c;E&#x201d;</font><font style="color:#0c0c0c;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.1pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font><font style="color:#0c0c0c;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">STATE MEDICAID ATTACHMENTS</font><font style="color:#0c0c0c;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:13.133%;text-indent:-0.114%;padding-left:0.093%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.2pt;margin-right:4.824%;text-align:center;"><font style="color:#0c0c0c;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">      [**]</font></p><p style="margin-left:11.467%;text-indent:-0.106%;padding-left:0.093%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.2pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.53in;min-height:2.64in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="margin-left:9.96%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain confidential information contained in this document, marked by [**], has been omitted because American Well Corporation has determined that the information (i) is not material and (ii) is the type that American Well Corporation customarily and actually treats as private or confidential.</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#0c0c0c;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.2in;z-index:2;min-height:1.06in;position:relative;box-sizing:border-box;"><p style="margin-left:13.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:11.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></p><p style="margin-left:11.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.15pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> 	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid #000000;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 18</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">   	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid #000000;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Artificial Intelligence</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">   </font></p><p style="margin-left:11.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.1pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></p><p style="margin-left:15%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:2.1pt;margin-right:3.296%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid #000000;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Artificial Intelligence:</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">   </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Parties agree to work in good faith to negotiate and finalize mutually acceptable terms governing Vendor&#x2019;s use of AI Technologies in delivering the Services and Deliverables under this Agreement. Vendor and Elevance Health will use reasonable efforts to amend this Agreement to include such AI Technology-related provisions within ninety (90) days following the Effective Date, and upon approval of Elevance Health&#x2019;s governance committee process. &#x201c;AI Technologies&#x201d; means a system, application, algorithm, statistical model or other technology that can perform tasks that typically require human intelligence, including understanding natural language, recognizing patterns, solving problems, making predictions, making decisions and interpreting and processing data or that are prompted by inputs it receives to produce outputs, such as predictions, classifications, prescribed actions, content, recommendations or decisions. AI Technologies include: machine learning-based algorithms for health risk estimation; machine learning-based algorithms for claims or clinical request processing; machine learning-based algorithms for optimization of member engagement strategies; applications of neural networks and deep learning, evolutionary and genetic computation, reinforcement learning, and supervised or unsupervised machine learning; computer vision (e.g., object recognition, image understanding); speech and audio processing (e.g., speech recognition and production); natural language processing (e.g., machine translation, language generation); and audio and video manipulation technologies (e.g., voice cloning, deepfakes)</font><font style="color:#000000;white-space:pre-wrap;font-size:13.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:13.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0c0c0c;white-space:pre-wrap;font-size:13.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  	</font><font style="color:#000000;white-space:pre-wrap;font-size:13.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:11.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.2pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:11.56%;text-indent:-0.106%;padding-left:0.093%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.1pt;text-align:center;"><font style="color:#0c0c0c;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EXHIBIT A</font><font style="color:#0c0c0c;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><h1 style="margin-left:34.507%;text-indent:-0.143%;padding-left:0.093%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.2pt;text-align:left;"><font style="color:#0c0c0c;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Required Information Security Controls Exhibit</font><font style="color:#0c0c0c;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></h1><p style="margin-left:13.16%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:13.16%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#0c0c0c;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">[**]</font><font style="color:#0c0c0c;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:16.547%;text-indent:-8.891%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6.2pt;margin-right:1.806%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:14.44%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0c0c0c;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.53in;min-height:2.64in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="margin-left:9.96%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain confidential information contained in this document, marked by [**], has been omitted because American Well Corporation has determined that the information (i) is not material and (ii) is the type that American Well Corporation customarily and actually treats as private or confidential.</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#0c0c0c;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>amwl-ex10_2.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!-- DFIN ActiveDisclosure (SM) HTML Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2026-01-02T17:14:59.4872+00:00 --><!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html>
 <head>
  <title>EX-10.2</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;-webkit-text-size-adjust:100%;position:relative;">
  <div style="padding-top:0.4in;z-index:2;min-height:0.98in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10.7pt;text-align:right;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 10.2</font></p><p style="margin-left:1.267%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:-0.098%;padding-left:0.093%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1.05pt;margin-right:4.398%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">STATEMENT OF WORK</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:-0.098%;padding-left:0.093%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1.05pt;margin-right:4.398%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Healthy Impact</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:2.1pt;margin-right:2.972%;text-align:center;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:1.267%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:3.05pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1.8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SUPPLIER: American Well Corporation   	   	   	   	   	ELEVANCE HEALTH</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1.8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  Contact: Legal Department   	   	   	   	   	               Name: [**]</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:-0.098%;padding-left:0.093%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:3.3pt;margin-right:4.806%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Address: 75 State Street, Boston, MA 02090   	                                             Telephone No.: [**]</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></p><p style="text-indent:-0.098%;padding-left:0.093%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:3.3pt;margin-right:4.806%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Telephone No.: (617)204-3500</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:1.267%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:2.45pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">   	 </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:1.267%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:1.133%;text-indent:-0.1%;padding-left:0.093%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1.55pt;margin-right:5.444%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Statement of Work (&#x201c;SOW&#x201d;) is made pursuant to, and incorporates the terms of, the Master Services Agreement (the &#x201c;Agreement&#x201d;) dated January 1, 2023, by and between Elevance Health, Inc. (&#x201c;Company&#x201d; or &#x201c;Elevance Health&#x201d;), and American Well Corporation (&#x201c;Supplier&#x201d; or &#x201c;Vendor&#x201d;). Capitalized terms used but not defined herein have the meaning ascribed to them in the Agreement.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:1.133%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:2.25pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:1.267%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1.7pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:0.88%;text-indent:-0.094%;padding-left:0.093%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1.55pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Project Name:  LHO &#x2013; Healthy Impact</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:1.267%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:2.1pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:1.267%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:3.2pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1.55pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Project Start (&#x201c;Effective Date&#x201d;) Date: 1/1/2026   	   	   	 Project End Date: 1/1/2029</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:1.267%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:2.25pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:1.267%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:2.85pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:1.55pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:6.729924796850553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">I.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Professional Services. </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div><p style="margin-left:1.293%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1.65pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0.2pt;margin-right:4.796%;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">a.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the period beginning on the Effective Date and ending on the Project End Date (the &#x201c;Term&#x201d;), </font></div></div><p style="margin-left:7.827%;text-indent:-0.109%;padding-left:0.093%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.3pt;margin-right:6.083%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Elevance Health shall pay fees for the Professional Services on a time and materials basis at a blended rate (&#34;Professional Services Rate&#34;) of [**] per hour pursuant to a mutually agreed Statement of Work.</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:1.8pt;margin-right:4.796%;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">b.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Elevance Health shall reimburse Vendor for those Elevance Health approved expenses (e.g., expenses for other printing costs or outsourced marketing services) incurred in connection with such Statement of Work as agreed in advance by the parties in writing.  </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0.2pt;margin-right:4.796%;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">c.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Vendor shall present appropriate receipts or other evidence of payment with its invoices regarding reimbursement of such expenses. </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:1.8pt;margin-right:4.796%;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">d.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Vendor shall not increase the Professional Services Rate prior to December 31, 2028. Thereafter, </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">for any </font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1.1pt;margin-right:7.324%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Professional Services Statement of Work executed after December 31, 2028 and throughout the</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:8.067%;text-indent:-0.107%;padding-left:0.093%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1.8pt;margin-right:4.806%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Term any approved increases may not exceed the percentage increase in the Consumer Price Index-All </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Urban Consumers, U.S. City Average, Not Seasonally Adjusted, Base Period 1982-84=100 published by the United States Department of Labor's Bureau of Labor Statistics (the &#x201c;CPI&#x201d;), over the previous twelve (12) month period. If the CPI is no longer published at the relevant time, the parties shall designate the most closely comparable index. Annual rate increases can only be applied to a SOW executed 6 months or less prior to such increase and such increase shall apply only to work done after the effective date of such annual increase.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12.05pt;margin-right:4.796%;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">e.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Vendor shall provide Elevance Health with sixty (60) days&#x2019; advance written notice of any price increases described in this Section. </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div><p style="margin-left:1.293%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:2.8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:1.55pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:6.729924796850553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">II.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Resale. </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.52in;min-height:0.89in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.95pt;margin-right:4.315%;text-align:center;margin-left:0;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">1</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:1.24%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Certain confidential information contained in this document, marked by [**], has been omitted because American Well Corporation has determined that the information (i) is not material and (ii) is the type that American Well Corporation customarily and actually treats as private or confidential.</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font><font style="color:#0c0c0c;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.4in;z-index:2;min-height:0.98in;position:relative;box-sizing:border-box;"><p style="margin-left:1.267%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:1.293%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1.55pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="margin-left:1.731%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:1.8pt;margin-right:4.796%;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.3917105089092185%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">a.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Amwell hereby appoints Elevance Health as an authorized reseller of the third-party program services set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid #000000;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Schedule 1</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> hereto, and Elevance Health may market and resell such programs to its employer clients (each, a &#x201c;Company Client&#x201d;). </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div><div class="item-list-element-wrapper" style="margin-left:1.731%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:1.8pt;margin-right:4.796%;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.3917105089092185%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">b.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the event that Elevance Health desires to resell the Online Care Service to another health plan or insurer, including the Health Impact programs described herein, the parties will meet and negotiate in good faith the terms and related fees due to Vendor resulting from such a transaction. For clarity, Elevance Health will not be </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">able to consummate such a resale or other transaction with a health plan or insurer without Vendor&#x2019;s written </font></div></div><p style="margin-left:5.16%;text-indent:-0.104%;padding-left:0.093%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1.8pt;margin-right:4.806%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">consent or an amendment to this Agreement.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:5.067%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1.65pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="margin-left:1.731%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:1.8pt;margin-right:4.796%;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.3917105089092185%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">c.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the event that Elevance Health desires to resell employer service offerings developed by Vendor to Company Clients, Elevance Health may purchase such offerings from Vendor at the prices set forth on Schedule 1, attached hereto. In such a case, Vendor will bill Elevance Health in accordance with the terms in the Agreement. </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div><p style="margin-left:1.267%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.75pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="margin-left:1.731%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:4.796%;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.3917105089092185%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">d.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the event of a unique circumstance regarding a potential Elevance Health customer, the parties will meet and negotiate in good faith variations from the terms and related fees due under Schedule 1 hereto related to such a </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div><p style="margin-left:5.067%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1.8pt;margin-right:4.806%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">transaction. For clarity, Elevance Health will not be able to consummate such a unique resale or other transaction without Vendor&#x2019;s written consent or an amendment to this Agreement.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">   </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:7.933%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:13.85pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12.9pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">III.  	</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Payments.</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="margin-left:7.463%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:1.8pt;margin-right:6.537%;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.6018025222343497%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">a.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Except as expressly stated otherwise in Schedule 1 hereto, Elevance Health shall pay Vendor in accordance with the terms set forth in this Section. </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div><p style="margin-left:11.133%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.15pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="margin-left:7.463%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:1.55pt;margin-right:6.537%;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.6018025222343497%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">b.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Upon receipt of a correct and undisputed invoice, Elevance Health shall pay the amounts in accordance with Elevance Health's then current payment policies (e.g. payment via the ACH electronic payment to Vendor's financial institution per instructions in Elevance Health's ACH electronic payment form). </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div><p style="margin-left:20.067%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.3pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="margin-left:7.463%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:1.55pt;margin-right:6.537%;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.6018025222343497%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">c.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Except as otherwise provided in a Statement of Work, all payments are due to Vendor within thirty (30) days of invoice date. All fees and charges are stated in United States Dollars. Any amounts payable pursuant to this Agreement are to be net to Vendor and shall not include taxes or other governmental charges or surcharges, if any.  If any excise, use, property or other taxes, or any other governmental charges or surcharges (including, without limitation, interest, penalties and fines) are due or are assessed on or with respect to any amounts payable by Elevance Health pursuant to this Agreement (other than Vendor's income taxes), they will be the sole responsibility of and payable by Elevance Health. Elevance Health shall not be liable for the payment of taxes imposed upon Vendor or upon Vendor's personnel resources, including state and federal income taxes, franchise taxes, Social Security taxes, welfare taxes, unemployment contributions, disability insurance, training taxes and any prepayments, estimated payments, reports, or withholdings required for such taxes. Except as provided in Section 8 below, past due balances on the amounts due to Vendor pursuant to this Agreement shall be subject to an interest charge equal to (a) the lesser of one percent (1.0%) per month OR (b) the maximum rate not prohibited by applicable law, in each case, computed from the date fifty (50) days after invoice date of each payment.  </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div><p style="margin-left:11.133%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.15pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="margin-left:7.463%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:1.55pt;margin-right:6.537%;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.6018025222343497%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">d.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Invoice  Disputes. Elevance Health may withhold payment of good faith disputed invoiced amounts until no later than ninety (90) days after the date on which such withheld amounts are due if Elevance Health notifies Vendor within the original payment period that such amounts are disputed and are being withheld, along with a written statement specifying the portion of fees or expenses being withheld and </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.52in;min-height:0.89in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.95pt;margin-right:4.315%;text-align:center;margin-left:0;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">2</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:0.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Certain confidential information contained in this document, marked by [**], has been omitted because American Well Corporation has determined that the information (i) is not material and (ii) is the type that American Well Corporation customarily and actually treats as private or confidential.</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font><font style="color:#0c0c0c;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:1.24%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.4in;z-index:2;min-height:0.98in;position:relative;box-sizing:border-box;"><p style="margin-left:1.267%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:7.463%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:1.55pt;margin-right:6.537%;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.6018025222343497%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">providing a reasonably detailed explanation  of the reasons for withholding  such fees or expenses. The parties shall negotiate expeditiously and in good faith to resolve any such dispute, and Elevance Health will pay all outstanding amounts as may be agreed by the parties in writing within thirty (30) days of the conclusion of such dispute resolution process, or within such ninety (90) day period, whichever concludes sooner, and no interest shall accrue on amounts withheld pursuant to this Section during the foregoing time period. Invoices which are not sent via the Elevance Health Invoice online tool shall automatically be deemed to be in dispute until the invoice is resubmitted via such online tool; provided that access to such online tool is available to Vendor.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div><p style="margin-left:7.8%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:5.067%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:2.05pt;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:1.267%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:3.4pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:0.133%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1.6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  	 </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.52in;min-height:0.89in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.95pt;margin-right:4.315%;text-align:center;margin-left:0;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">3</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:0.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Certain confidential information contained in this document, marked by [**], has been omitted because American Well Corporation has determined that the information (i) is not material and (ii) is the type that American Well Corporation customarily and actually treats as private or confidential.</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font><font style="color:#0c0c0c;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:1.24%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.4in;z-index:2;min-height:0.98in;position:relative;box-sizing:border-box;"><p style="margin-left:1.267%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:1.267%;text-indent:-0.099%;padding-left:0.093%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.2pt;margin-right:4.806%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This SOW shall be considered executed and fully agreed to by the authorized representatives of both Parties upon</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:1.267%;text-indent:-0.099%;padding-left:0.093%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:3.5pt;margin-right:4.806%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Elevance Health&#x2019;s issuance of the purchase order associated with this contract through Elevance Health&#x2019;s Procurement Process Technology (Ariba) or upon signatures indicated below.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">   </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:1.267%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:4.55pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></p>
   <table style="margin-left:5.167%;border-spacing:0;table-layout:auto;width:88.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:47.48%;box-sizing:content-box;"></td>
     <td style="width:6.18%;box-sizing:content-box;"></td>
     <td style="width:46.34%;box-sizing:content-box;"></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;text-align:right;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">American Well Corporation</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.075in;text-align:right;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Elevance Health, Inc.</font></p></td>
    </tr>
    <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Supplier</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Elevance Health</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;text-align:right;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;text-align:right;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By: /s/ Anna Nesterova</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By: Peter J. Tamulonis</font></p></td>
    </tr>
    <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Signature</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Signature</font></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Anna Nesterova</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.075in;text-align:left;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Peter J. Tamulonis</font></p></td>
    </tr>
    <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Printed Name</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Printed Name</font></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;text-align:left;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deputy General Counsel, Head of Legal</font><font style="color:#231f20;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.075in;text-align:left;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">VP, Corporate Services</font></p></td>
    </tr>
    <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Title</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Title</font></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;text-align:left;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;text-align:left;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12-23-2025</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.075in;text-align:left;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12/25/2025</font></p></td>
    </tr>
    <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date</font></p></td>
    </tr>
   </table><p style="margin-left:1.267%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:4.55pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	   	   	 </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:5.352%;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">   	   	 </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:3.24%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:1.267%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:2.2pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:1.267%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:2.2pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:1.267%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:2.2pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:1.267%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:2.05pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:1.267%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:2.2pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:1.267%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:2.2pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:1.267%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:2.2pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:1.267%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:2.05pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:1.267%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:2.2pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:1.267%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:2.2pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.52in;min-height:0.89in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.95pt;margin-right:4.315%;text-align:center;margin-left:0;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">4</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:0.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Certain confidential information contained in this document, marked by [**], has been omitted because American Well Corporation has determined that the information (i) is not material and (ii) is the type that American Well Corporation customarily and actually treats as private or confidential.</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font><font style="color:#0c0c0c;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:1.24%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.4in;z-index:2;min-height:0.98in;position:relative;box-sizing:border-box;"><p style="margin-left:1.267%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:1.267%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:2.2pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:-0.101%;padding-left:0.093%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:13.4pt;margin-right:7.194%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid #000000;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Schedule 1</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:-0.101%;padding-left:0.093%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:21.9pt;margin-right:7.194%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid #000000;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Supplier Clinical Program Offerings</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:1.8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Reseller Rates. The parties agree to the following reseller rates until December 31, 2028, provided that Vendor&#x2019;s third-party partners do not increase Vendor&#x2019;s rates for such programs in the interim period.  If a Vendor third party partner increases its rates by more than 5% for one or more of the programs listed below, Vendor shall notify Elevance, and the Parties shall negotiate in good faith an adjustment to the rate(s) for impacted program(s). Any adjustments must be agreed by the parties in writing. During Year 2028, the parties will renegotiate the rates in good faith and memorialize their understanding via an amendment to the Agreement. </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div><p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.75pt;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:1.8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Parties agree that rates quoted to a Company Client based on reseller rates listed below shall be valid for a period of 12 (twelve) months from the date a formal written proposal is presented to such Company Client. In addition, Vendor shall not change the pricing to Elevance Health with respect to a Company Client for the first year of the contract with such Company Client. </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div><p style="margin-left:1.293%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
   <table style="margin-left:4.889%;border-spacing:0;table-layout:auto;width:87.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:12.34%;box-sizing:content-box;"></td>
     <td style="width:14.26%;box-sizing:content-box;"></td>
     <td style="width:23.44%;box-sizing:content-box;"></td>
     <td style="width:27.54%;box-sizing:content-box;"></td>
     <td style="width:22.42%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:54pt;white-space:pre-wrap;word-break:break-word;">
     <td style="border-top:1pt solid #000000;padding-top:0.117in;border-right:1pt solid #000000;text-indent:5.5pt;border-left:1pt solid #000000;padding-left:0.007in;vertical-align:bottom;padding-bottom:0.038in;border-bottom:1pt solid #000000;padding-right:0in;"><p style="margin-left:1.013%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:1.065%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">Program </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">or Service</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="border-top:1pt solid #000000;padding-top:0.117in;border-right:1pt solid #000000;text-indent:5.3pt;padding-left:0.007in;vertical-align:top;padding-bottom:0.038in;border-bottom:1pt solid #000000;padding-right:0in;"><p style="margin-left:0.987%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">Description</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="border-top:1pt solid #000000;padding-top:0.117in;border-right:1pt solid #000000;text-indent:5.3pt;padding-left:0.007in;vertical-align:top;padding-bottom:0.038in;border-bottom:1pt solid #000000;padding-right:0in;"><p style="margin-left:0.987%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">Sub program</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="border-top:1pt solid #000000;padding-top:0.117in;border-right:1pt solid #000000;text-indent:5.3pt;padding-left:0.007in;vertical-align:top;padding-bottom:0.038in;border-bottom:1pt solid #000000;padding-right:0in;"><p style="margin-left:0.987%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">Pricing Method</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="border-top:1pt solid #000000;padding-top:0.117in;border-right:1pt solid #000000;text-indent:5.3pt;padding-left:0.007in;vertical-align:top;padding-bottom:0.038in;border-bottom:1pt solid #000000;padding-right:0in;"><p style="margin-left:0.987%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">Wholesale Price</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    </tr>
    <tr style="height:114.5pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.117in;border-right:1pt solid #000000;text-indent:5.5pt;border-left:1pt solid #000000;padding-left:0.007in;vertical-align:top;padding-bottom:0.038in;border-bottom:1pt solid #000000;padding-right:0in;"><p style="margin-left:1.013%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">Healthy</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:1.013%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.75pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">Impact</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:1.013%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">Offerings</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.117in;border-right:1pt solid #000000;text-indent:5.3pt;padding-left:0.007in;vertical-align:bottom;padding-bottom:0.038in;border-bottom:1pt solid #000000;padding-right:0in;"><p style="margin-left:0.987%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.454%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">Direct to employer programs for health and wellness</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.117in;border-right:1pt solid #000000;text-indent:18pt;padding-left:0.007in;vertical-align:bottom;padding-bottom:0.038in;border-bottom:1pt solid #000000;padding-right:0in;text-align:left;"><div class="item-list-element-wrapper" style="text-indent:0;display:flex;margin-top:0;justify-content:center;align-items:baseline;margin-bottom:0;margin-right:0.796%;min-width:3.333%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Healthy </font></div></div><p style="margin-left:1.533%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:11.15pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">Weight</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="text-indent:0;display:flex;margin-top:0;justify-content:center;align-items:baseline;margin-bottom:5.3pt;margin-right:0.796%;min-width:3.333%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Healthy BP </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div><div class="item-list-element-wrapper" style="text-indent:0;display:flex;margin-top:0;justify-content:center;align-items:baseline;margin-bottom:0;margin-right:0.796%;min-width:3.333%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tobacco </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div><p style="text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:4.45pt;margin-right:0.676%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">Free</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:1.15pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> 	</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">&#xf0b7;  </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">Diabetes</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:7.773%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">Prevention</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.117in;border-right:1pt solid #000000;text-indent:5.3pt;padding-left:0.007in;vertical-align:top;padding-bottom:0.038in;border-bottom:1pt solid #000000;padding-right:0in;text-align:right;"><p style="margin-left:0.987%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">Per participant per year admin fee</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.117in;border-right:1pt solid #000000;text-indent:5.3pt;padding-left:0.007in;vertical-align:top;padding-bottom:0.038in;border-bottom:1pt solid #000000;padding-right:0in;"><p style="margin-left:0.987%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.65pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">$[**] HW</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:0.987%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">$[**] HBP</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:0.987%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.7pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">$[**] Tobacco Free</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:0.987%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">$</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">[**]</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">/ milestone DPP</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    </tr>
    <tr style="height:174.25pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.117in;border-right:1pt solid #000000;text-indent:0.1pt;border-left:1pt solid #000000;padding-left:0.007in;vertical-align:top;padding-bottom:0.038in;border-bottom:1pt solid #000000;padding-right:0in;"><p style="margin-left:0.013%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.117in;border-right:1pt solid #000000;text-indent:5.3pt;padding-left:0.007in;vertical-align:top;padding-bottom:0.038in;border-bottom:1pt solid #000000;padding-right:0in;"><p style="margin-left:0.987%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">MSK</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:0.987%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1.1pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Coaching</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:0.987%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.4pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">and digital</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:0.987%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">PT</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.117in;border-right:1pt solid #000000;text-indent:5.3pt;padding-left:0.007in;vertical-align:top;padding-bottom:0.038in;border-bottom:1pt solid #000000;padding-right:0in;"><p style="margin-left:0.987%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1.25pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">MSK and Pelvic Health</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:0.987%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">PT</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.117in;border-right:1pt solid #000000;text-indent:5.3pt;padding-left:0.007in;vertical-align:top;padding-bottom:0.038in;border-bottom:1pt solid #000000;padding-right:0in;"><p style="margin-left:0.987%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1.05pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">MSK and Pelvic Health PT are  	priced  using milestones. The milestones may be billed as an admin fee per enrolled participant. (Also, based on client preference, the Milestones may be billed as claims using an agreed upon fee</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:0.987%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">schedule.)</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:0.987%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1.15pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Milestone definitions are included in Section 2</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:0.987%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">herein</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.117in;border-right:1pt solid #000000;text-indent:5.3pt;padding-left:0.007in;vertical-align:top;padding-bottom:0.038in;border-bottom:1pt solid #000000;padding-right:0in;"><p style="margin-left:0.987%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">See Section 2 below</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.52in;min-height:0.89in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.95pt;margin-right:4.315%;text-align:center;margin-left:0;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">5</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:0.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Certain confidential information contained in this document, marked by [**], has been omitted because American Well Corporation has determined that the information (i) is not material and (ii) is the type that American Well Corporation customarily and actually treats as private or confidential.</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font><font style="color:#0c0c0c;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:1.24%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.4in;z-index:2;min-height:0.98in;position:relative;box-sizing:border-box;"><p style="margin-left:1.267%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:5.507%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.2pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:5.507%;text-indent:-0.104%;padding-left:0.093%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1.8pt;margin-right:4.806%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pricing may be modified on any program for a particular client as mutually agreed to by both parties.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:0.16%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12.7pt;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:9.8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</font><div style="display:inline;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MSK and Pelvic Health PT </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div><p style="margin-left:0.16%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12.05pt;margin-right:0.093%;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The MSK and Pelvic Health PT programs are offered to Company Clients with their choice of either event-based or outcomebased pricing models:</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="margin-left:0.139%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12.9pt;min-width:4.13%;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.135748690680045%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">a.</font><div style="display:inline;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Definition of Event-Based Pricing Milestones 1-3 </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div><p style="margin-left:0.16%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.25pt;margin-right:0.093%;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Below are event-based Milestones, triggered by a Participant&#x2019;s utilization of the Thrive and Move MSK programs and/or Bloom Pelvic Health program via the Sword digital platform (the &#x201c;Digital Platform&#x201d;). Vendor agrees to bill Elevance Health only for Milestones completed by Participants. For the purposes of the Thrive MSK program and the Bloom Pelvic Health program, the Parties agree that all Milestones listed below must be completed within 12 months from the date of completion of Milestone 1. Vendor shall not bill Elevance Health for more than 3 Milestones per Participant per year for the Thrive MSK program or Bloom Pelvic Health program. The program fees will not exceed (i) </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">[**]</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">per Participant per year for the Move program specifically, and (ii) </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">[**]</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">per Participant per year for any program or combination of programs that a Participant is enrolled in.</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
   <table style="margin-left:0.222%;border-spacing:0;table-layout:auto;width:97.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:15.343%;box-sizing:content-box;"></td>
     <td style="width:16.863%;box-sizing:content-box;"></td>
     <td style="width:44.989%;box-sizing:content-box;"></td>
     <td style="width:22.805%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:39.6pt;white-space:pre-wrap;word-break:break-word;">
     <td style="border-top:0.5pt solid #000000;padding-top:0.072in;border-right:0.5pt solid #000000;text-indent:0.1pt;border-left:0.5pt solid #000000;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.011in;"><p style="margin-left:0.013%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">Event-Based </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">Pricing</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0.072in;border-right:0.5pt solid #000000;text-indent:0.1pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.011in;text-align:right;"><p style="margin-left:0.013%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">Wholesale Price per Participant</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0.072in;border-right:0.5pt solid #000000;text-indent:6.5pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.011in;"><p style="margin-left:1.2%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">Includes</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0.072in;border-right:0.5pt solid #000000;text-indent:6.35pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.011in;"><p style="margin-left:1.173%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">Billing Trigger</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    </tr>
    <tr style="height:144.7pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.072in;border-right:0.5pt solid #000000;text-indent:0.1pt;border-left:0.5pt solid #000000;padding-left:0.075in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.011in;"><p style="margin-left:0.013%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.5pt;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">Milestone 1 </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">(Thrive, Blom</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:0.013%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:11.9pt;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">&amp; Move)</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:0.013%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:12.4pt;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:0.013%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:12.5pt;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:0.013%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:12.5pt;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.072in;border-right:0.5pt solid #000000;text-indent:6.35pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.011in;"><p style="margin-left:1.173%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:11.75pt;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">[**]</font></p><p style="margin-left:1.107%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.072in;border-right:0.5pt solid #000000;text-indent:27.35pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.011in;"><div class="item-list-element-wrapper" style="margin-left:1.731%;text-indent:0;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:11.75pt;margin-right:0.13%;min-width:3.333%;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.3917105089092185%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A live coaching session with a PT; or </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div><div class="item-list-element-wrapper" style="margin-left:1.731%;text-indent:0;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:0.13%;min-width:3.333%;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.3917105089092185%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">An exercise module with the Digital </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Platform </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div></td>
     <td style="padding-top:0.072in;border-right:0.5pt solid #000000;text-indent:6.5pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.011in;"><p style="margin-left:1.2%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Participant completes live coaching session or</font><font style="color:#231f20;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:1.2%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:11.9pt;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">1 exercise with the Digital Platform</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:1.133%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    </tr>
    <tr style="height:76.3pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.072in;border-right:0.5pt solid #000000;text-indent:0.1pt;border-left:0.5pt solid #000000;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.011in;"><p style="margin-left:0.013%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.65pt;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">Milestone 2</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:0.013%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">(Thrive &amp; </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">Bloom)</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.072in;border-right:0.5pt solid #000000;text-indent:6.35pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.011in;"><p style="margin-left:1.173%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">[**]</font></p></td>
     <td style="padding-top:0.072in;border-right:0.5pt solid #000000;text-indent:36pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.011in;"><div class="item-list-element-wrapper" style="margin-left:3.333%;text-indent:0;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12.5pt;min-width:3.333%;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3 exercise modules with the Digital </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Platform </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;text-indent:0;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unlimited chat-based interactions with PT coach </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div></td>
     <td style="padding-top:0.072in;border-right:0.5pt solid #000000;text-indent:6.5pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.011in;"><p style="margin-left:1.2%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">Participant completes 3 exercises with the Digital Platform</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    </tr>
   </table></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.52in;min-height:0.89in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.95pt;margin-right:4.315%;text-align:center;margin-left:0;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">6</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:0.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Certain confidential information contained in this document, marked by [**], has been omitted because American Well Corporation has determined that the information (i) is not material and (ii) is the type that American Well Corporation customarily and actually treats as private or confidential.</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font><font style="color:#0c0c0c;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:1.24%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.4in;z-index:2;min-height:0.98in;position:relative;box-sizing:border-box;"><p style="margin-left:1.267%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;">
   <table style="margin-left:0.222%;border-spacing:0;table-layout:auto;width:97.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:15.343%;box-sizing:content-box;"></td>
     <td style="width:16.863%;box-sizing:content-box;"></td>
     <td style="width:44.989%;box-sizing:content-box;"></td>
     <td style="width:22.805%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:125.3pt;white-space:pre-wrap;word-break:break-word;">
     <td style="border-top:0.5pt solid #000000;padding-top:0.072in;border-right:0.5pt solid #000000;text-indent:0.1pt;border-left:0.5pt solid #000000;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.011in;"><p style="margin-left:0.013%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.75pt;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">Milestone 3</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:0.013%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">(Thrive &amp; </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">Bloom)</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0.072in;border-right:0.5pt solid #000000;text-indent:6.35pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.011in;"><p style="margin-left:1.173%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">[**]</font></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0.072in;border-right:0.5pt solid #000000;text-indent:36pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.011in;"><div class="item-list-element-wrapper" style="margin-left:3.333%;text-indent:0;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12.5pt;min-width:3.333%;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6 exercise modules with the Digital </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Platform </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;text-indent:0;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12.95pt;min-width:3.333%;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unlimited chat-based interactions with a PT </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;text-indent:0;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additional exercise modules may be completed by Participants at no additional cost to Elevance Health </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0.072in;border-right:0.5pt solid #000000;text-indent:6.5pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.011in;"><p style="margin-left:1.2%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">Participant completes 9 exercises with the Digital Platform</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    </tr>
   </table><p style="margin-left:0.16%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:14.25pt;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">   </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="margin-left:0.139%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12.9pt;min-width:4.13%;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.135748690680045%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">b.</font><div style="display:inline;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Definition of Outcomes Based Pricing Milestones 1-2. </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div><p style="margin-left:0.16%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.093%;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Below are outcomes-based Milestones, triggered by a Participant&#x2019;s utilization of the Thrive and Move MSK programs and/or Bloom Pelvic Health program. Vendor agrees to bill Elevance Health only for Milestones completed by Participants. For the purposes of the Thrive MSK and Bloom Pelvic Health programs, the Parties agree that Milestone 2 must be completed within 12 months from the date of completion of Milestone 1. Vendor shall not bill Elevance Health for more than 2 Milestones per</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:0.16%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.25pt;margin-right:0.093%;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Participant per year for the Thrive MSK or Bloom Pelvic Health programs. The program fees will not exceed (i) </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">[**] </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">per Participant per year for the Move program specifically, and (ii) </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">[**] </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">per Participant per year for any program or combination of programs that a Participant is enrolled in.</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
   <table style="margin-left:2.685%;border-spacing:0;table-layout:auto;width:97.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:16.96%;box-sizing:content-box;"></td>
     <td style="width:22.76%;box-sizing:content-box;"></td>
     <td style="width:29.12%;box-sizing:content-box;"></td>
     <td style="width:31.16%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:40.3pt;white-space:pre-wrap;word-break:break-word;">
     <td style="border-top:1pt solid #000000;padding-top:0.078in;border-right:1pt solid #000000;text-indent:0.6pt;border-left:1pt solid #000000;padding-left:0.005in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0in;"><p style="margin-left:0.107%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.9pt;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">Outcome-based</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:0.107%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">Pricing</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="border-top:1pt solid #000000;padding-top:0.078in;border-right:1pt solid #000000;text-indent:0.1pt;padding-left:0.005in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0in;"><p style="margin-left:0.013%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.95pt;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">Wholesale Price per</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:0.013%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">Participant</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="border-top:1pt solid #000000;padding-top:0.078in;border-right:1pt solid #000000;padding-left:0.005in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">Includes</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="border-top:1pt solid #000000;padding-top:0.078in;border-right:1pt solid #000000;text-indent:0.1pt;padding-left:0.005in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0in;"><p style="margin-left:0.013%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">Billing Trigger</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    </tr>
    <tr style="height:104.4pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.078in;border-right:1pt solid #000000;text-indent:0.6pt;border-left:1pt solid #000000;padding-left:0.005in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0in;"><p style="margin-left:0.107%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">Milestone 1</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:0.107%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1.2pt;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Thrive, Bloom, &amp;</font><font style="color:#231f20;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:0.107%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">Move)</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:0.107%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.078in;border-right:1pt solid #000000;text-indent:36pt;padding-left:0.005in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0in;"><p style="margin-left:6.667%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">[**]</font></p></td>
     <td style="padding-top:0.078in;border-right:1pt solid #000000;text-indent:26.65pt;padding-left:0.005in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0in;"><div class="item-list-element-wrapper" style="margin-left:1.602%;text-indent:0;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:13.35pt;margin-right:0.537%;min-width:3.333%;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.3872639687798536%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A live coaching session with a PT; or  </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div><div class="item-list-element-wrapper" style="margin-left:1.602%;text-indent:0;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:1.65pt;margin-right:0.537%;min-width:3.333%;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.3872639687798536%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">An exercise module with </font></div></div><p style="margin-left:6.653%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">the Digital Platform</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.078in;border-right:1pt solid #000000;text-indent:0.1pt;padding-left:0.005in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0in;"><p style="margin-left:0.013%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">Participant completes live coaching session or 1 exercise with the Digital </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">Platform</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    </tr>
    <tr style="height:151.9pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.078in;border-right:1pt solid #000000;text-indent:0.6pt;border-left:1pt solid #000000;padding-left:0.005in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0in;"><p style="margin-left:0.107%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">Milestone 2 (Thrive &amp; Bloom)</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.078in;border-right:1pt solid #000000;text-indent:36pt;padding-left:0.005in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0in;"><p style="margin-left:6.667%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">[**]</font></p></td>
     <td style="padding-top:0.078in;border-right:1pt solid #000000;text-indent:36pt;padding-left:0.005in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0in;text-align:right;"><div class="item-list-element-wrapper" style="margin-left:3.333%;text-indent:0;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:11.5pt;margin-right:2.269%;min-width:3.333%;text-align:justify;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unlimited chat-based interactions with PT coach  </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;text-indent:0;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:1.1pt;margin-right:2.269%;min-width:3.333%;text-align:justify;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additional exercise modules may be completed by </font></div></div><p style="text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">	</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">Participants 	at 	no</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.7pt;margin-right:0.315%;text-align:center;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">additional cost to</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:1.074%;text-align:center;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">Elevance Health</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.078in;border-right:1pt solid #000000;text-indent:0.1pt;padding-left:0.005in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0in;"><p style="margin-left:0.013%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">Participant has indicated to Vendor either (i) a &#x201c;positive outcome&#x201d; on the applicable clinically validated outcome measure* used to periodically assess the impact of the applicable services on such Participant&#x2019;s focus area, or (ii) achievement of the goals established for the applicable service for the treatment of the Participant&#x2019;s focus area, whichever occurs first</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-kerning:none;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    </tr>
   </table><p style="margin-left:0.16%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10.85pt;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.52in;min-height:0.89in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.95pt;margin-right:4.315%;text-align:center;margin-left:0;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">7</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:0.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Certain confidential information contained in this document, marked by [**], has been omitted because American Well Corporation has determined that the information (i) is not material and (ii) is the type that American Well Corporation customarily and actually treats as private or confidential.</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font><font style="color:#0c0c0c;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:1.24%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.4in;z-index:2;min-height:0.98in;position:relative;box-sizing:border-box;"><p style="margin-left:1.267%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:0.16%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.093%;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">*Outcome measure: Vendor currently employs the Patient Global Impression of Change or &#x201c;PGIC&#x201d; scale to consistently assess outcomes using a validated 7-point Likert scale, as widely used in clinical research. This scale measures the</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:0.16%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:13.15pt;margin-right:0.093%;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Participant's perception of change, where improvement is captured by responses indicating significant positive change (e.g., &#34;very much improved&#34;) down to no change or worsening (e.g., &#34;no improvement&#34; or &#34;worse&#34;). A positive outcome is indicated if a Participant selects one of the top three positive choices out of the seven available choices. Vendor reserves the right to alter or change the outcome measure for one or more Services from time to time to reflect clinical best practices, enhance treatment assessment accuracy, or align with advancements in medical standards.</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:-0.093%;padding-left:0.093%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10.35pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Aggregate Measurement Period Fee Cap for Outcome Based Pricing. For Outcome-Based Pricing, Sword guarantees that cumulative fees paid in each Measurement Period will not exceed [Period Fee Cap] x [# of Measurable Participants]. &#x201c;Measurable Participant&#x201d; for the Measurement Period Fee Cap means a Participant who has activated and has fees paid for Services in that Measurement Period. &#x201c;Measurement Period&#x201d; means the repeating period of twelve (12) months, where the initial Measurement Period shall commence on the later to occur of (i) the applicable launch date or (ii) the date the Solution and applicable Services are made available to Participants. </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid #000000;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Period Fee Cap&#x201d; during a given Measurement Period is:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:-0.093%;padding-left:0.093%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10.4pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">[**]if all Primary Services (Thrive, Bloom and Move) are continuously active and being marketed in accordance with the co-marketing plan; or</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:-0.093%;padding-left:0.093%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1.8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">[**]if at any time less than all Primary Services are active OR any Primary Services are not being marketed per the comarketing plan. 100% of any excess fees paid that exceed the Period Fee Cap (whether [**]or [**]) will be refunded.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:1.24%;text-indent:-0.099%;padding-left:0.093%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1.8pt;margin-right:4.806%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Supplier agrees to offer and is responsible to refund and pay to Company Clients Supplier&#x2019;s standard performance guarantees for the MSK and Pelvic Health PT programs as set forth in Appendix 1 to this SOW. For the avoidance of doubt, Company will not be responsible, nor required, to refund to Company Client or Supplier any amounts resulting from performance guarantees not being met, regardless of whether or not performance guarantees are met. Supplier shall be responsible to refund Elevance Health the full amount due to Company Client as a result of any failure to meet the performance guarantee through a mutually agreed upon process, and Elevance Health shall refund said amount to Company Client.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">   </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:1.24%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.05pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:1.24%;text-indent:-0.099%;padding-left:0.093%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1.8pt;margin-right:4.806%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Supplier and Elevance shall work in good faith to review performance standards for the third-party programs provided under this Schedule 1 and within 90 days from the date of the Effective Date put in place a corrective action framework, including penalties where deemed appropriate, for addressing any material or substantial deficiencies in the delivery of such third-party program services.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:0.16%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12.5pt;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:0.16%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:14.45pt;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><h1 style="margin-left:0.027%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9.85pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">[Remainder of page intentionally left blank.]</font><font style="color:#231f20;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></h1><p style="margin-left:0.16%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:13.75pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:0.133%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  	 </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> 	 </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.52in;min-height:0.89in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.95pt;margin-right:4.315%;text-align:center;margin-left:0;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">8</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:0.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Certain confidential information contained in this document, marked by [**], has been omitted because American Well Corporation has determined that the information (i) is not material and (ii) is the type that American Well Corporation customarily and actually treats as private or confidential.</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font><font style="color:#0c0c0c;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:1.24%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>amwl-ex10_3.htm
<DESCRIPTION>EX-10.3
<TEXT>
<!-- DFIN ActiveDisclosure (SM) HTML Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2026-01-02T17:14:59.4168+00:00 --><!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html>
 <head>
  <title>EX-10.3</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;-webkit-text-size-adjust:100%;position:relative;">
  <div style="padding-top:0.3in;z-index:2;min-height:1.24in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.333%;text-align:right;margin-left:0;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 10.3</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:37.32%;text-indent:8.676%;font-size:10pt;margin-top:3.6pt;font-family:Times New Roman;margin-bottom:0;margin-right:39.167%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">FIFTH AMENDMENT TO THE ANTHEM BLUE</font></p><p style="margin-left:39.133%;text-indent:-14.153%;padding-left:2.293%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:42.37%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">CROSS PROVIDER AGREEMENT</font></p><p style="margin-left:3.333%;font-size:10pt;margin-top:10.35pt;font-family:Times New Roman;margin-bottom:0;margin-right:5.463%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">This Amendment is to the Provider Agreement (&#34;Agreement&#34;) dated January 1, 2023, and entered into between Blue Cross of California doing business as Anthem Blue Cross (hereinafter referred to as &#34;Anthem&#34;) and Online Care Group,</font></p><p style="margin-left:3.333%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">P.C. (hereinafter &#34;Provider&#34;) and is incorporated into the Agreement as follows:</font></p><p style="margin-left:3.333%;font-size:10pt;margin-top:10.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">BASE PROVISIONS</font></p><p style="font-size:10pt;margin-top:10.25pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.296%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">ARTICLE VIII</font></p><p style="margin-left:0.04%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.296%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">TERM AND TERMINATION</font></p><p style="font-size:10pt;margin-top:0.2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0.05pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:6.8968727694042435%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Provision 8.1 is hereby deleted in its entirety and replaced with the following:</font></div></div><p style="margin-left:10%;font-size:10pt;margin-top:10.25pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">8.1   </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Term of Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">. This Agreement shall commence at 12:01 AM on January 1, 2026 for a term of</font></p><p style="margin-left:16.667%;font-size:10pt;margin-top:0.1pt;font-family:Times New Roman;margin-bottom:0;margin-right:6.593%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">3 (three) year(s), January 1, 2026 until January 1, 2029 (&#x201c;Initial Term&#x201d;), and shall continue automatically in effect thereafter for consecutive one (1) year terms unless otherwise terminated as provided herein.&#x201d;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:6.8968727694042435%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Provision 8.4.1.10 is hereby added to the Agreement as shown below:</font></div></div><p style="font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:16.667%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:6.593%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">The Master Services Agreement between Elevance Health and American Well dated January 1, 2023 (Vendor Agreement), or the Statement of Work between Elevance Health and American Well dated January 1, 2026 for the Converge Platform, terminates pursuant to Section 7 of the Vendor Agreement.</font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:10.3pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:6.8968727694042435%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Provision 8.4.2.4 is hereby added to the Agreement as shown below:</font></div></div><p style="margin-left:16.667%;font-size:10pt;margin-top:10.3pt;font-family:Times New Roman;margin-bottom:0;margin-right:6.593%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">The Master Services Agreement between Elevance Health and American Well dated January 1, 2023 (Vendor Agreement), or the Statement of Work between Elevance Health and American Well dated January 1, 2026 for the Converge Platform, terminates pursuant to Section 7 of the Vendor Agreement.</font></p><p style="font-size:10pt;margin-top:0.1pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:62.454%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">PLAN COMPENSATION SCHEDULE PCS ATTACHMENT</font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0.45pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:8%;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:6.8968727694042435%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">The existing PCS Attachment to the Agreement is hereby deleted in its entirety and replaced with the PCS Attachment attached hereto.</font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.6in;min-height:0.74in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:0.453%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Certain confidential information contained in this document, marked by [**], has been omitted because American Well Corporation has determined that the information (i) is not material and (ii) is the type that American Well Corporation customarily and actually treats as private or confidential.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:0.187%;font-size:10pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-right:0;"><font style="white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:0.94in;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:3.333%;font-size:10pt;margin-top:3.95pt;font-family:Times New Roman;margin-bottom:0;margin-right:6.546%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Except as expressly set forth herein, nothing contained herein shall be construed to modify the Agreement. To the extent this Amendment conflicts with any provision of the Agreement, this Amendment shall control.</font></p><p style="font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.657%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Each party to this Amendment warrants that it has full power and authority to enter into this Amendment and the person signing this Amendment on behalf of either party warrants that he/she has been duly authorized and empowered to enter into this Amendment.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><h2 style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">THE EFFECTIVE DATE OF THIS AMENDMENT IS: January 1, 2026</font></h2><p style="margin-left:3.333%;font-size:10pt;margin-top:10.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">PROVIDER LEGAL NAME: Online Care Group, P.C.</font></p><p style="margin-left:4%;text-indent:-8.762%;padding-left:7.227%;font-size:10pt;margin-top:9.25pt;font-family:Times New Roman;margin-bottom:0;margin-right:6.296%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">By: </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">  /s/ Anna Nesterova	</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">					</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">December 23, 2025	</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> 	Signature, Authorized Representative of Provider(s)		Date</font></p><p style="margin-left:4%;text-indent:-8.674%;padding-left:7.227%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:5.463%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">	</font></p><p style="margin-left:4%;text-indent:-8.762%;padding-left:7.227%;font-size:10pt;margin-top:9.25pt;font-family:Times New Roman;margin-bottom:0;margin-right:6.296%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Printed: </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> Anna Nesterova	</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">					</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Vice President	</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> 		Name							Title</font></p><p style="margin-left:4%;text-indent:-9.108%;padding-left:7.227%;font-size:10pt;margin-top:9.65pt;font-family:Times New Roman;margin-bottom:0;margin-right:9.426%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Address </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> 75 State Street, 27th FL	</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">				</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Boston	MA	02109 	</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">	Street							City	State Zip</font></p><p style="font-size:10pt;margin-top:4.7pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:4%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Tax Identification Number (TIN):	</font></p><p style="font-size:10pt;margin-top:0.4pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:4%;font-size:10pt;margin-top:10.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Phone Number:	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> 6172043500	</font></p><p style="font-size:10pt;margin-top:0.8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:4%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Email Address:	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> contracts@amwell.com</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">	</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><h2 style="margin-left:4%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Blue Cross of California doing business as Anthem Blue Cross</font></h2><p style="font-size:10pt;margin-top:2.6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:4%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;vertical-align:sub;font-size:8.040000000000001pt;font-family:Arial;font-kerning:none;min-width:fit-content;">By:</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">/s/ Salma Khaleq</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> 					</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">12-24-2025</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">	</font></p><p style="margin-left:11.227%;font-size:10pt;margin-top:1.6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Signature, Authorized Representative of Anthem	Date</font></p><p style="margin-left:4%;text-indent:-8.774%;padding-left:7.227%;font-size:10pt;margin-top:10.25pt;font-family:Times New Roman;margin-bottom:0;margin-right:6.407%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Printed: </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> Salma Khaleq	</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">				</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Vice President	</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> 			Name						Title</font></p><p style="margin-left:4%;text-indent:-8.762%;padding-left:7.227%;font-size:10pt;margin-top:9.55pt;font-family:Times New Roman;margin-bottom:0;margin-right:6.296%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Address </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> 2505 N. Hwy 360	</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">				</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Grand Prairie	TX	75050	</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> 	Street						City	State	Zip</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.65in;min-height:0.78in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:0.453%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Certain confidential information contained in this document, marked by [**], has been omitted because American Well Corporation has determined that the information (i) is not material and (ii) is the type that American Well Corporation customarily and actually treats as private or confidential.</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:0.49in;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><h1 style="margin-left:0.013%;font-size:10pt;margin-top:0.75pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.296%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:16pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">PCS Attachment</font></h1><p style="font-size:10pt;margin-top:4.35pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:16pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:3.333%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Urgent Care and Behavioral Health - Commercial</font></p><p style="font-size:10pt;margin-top:0.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:3.407%;border-spacing:0;table-layout:auto;width:94.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:80.8%;box-sizing:content-box;"></td>
     <td style="width:19.2%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:33.85pt;white-space:pre-wrap;word-break:break-word;">
     <td style="border-top:0.5pt solid #000000;padding-top:0in;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:8pt;margin-top:2.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:0.187%;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">CPT Code </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&amp; </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Description</font></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0in;border-right:0.5pt solid #000000;text-indent:17.6pt;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="margin-left:3.253%;text-indent:3.538%;font-size:8pt;margin-top:0.4pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.389%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Rates 1/1/26 - 1/1/29</font></p></td>
    </tr>
    <tr style="height:10.1pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:5.85pt;border-left:0.5pt solid #000000;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="margin-left:1.08%;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">99422 </font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">NON-FACE TO FACE NEW &amp; ESTABLISHED URGENT CARE/ACUTE VISIT (MD/DO, NP)</font></p></td>
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:1.8pt;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="margin-left:0.333%;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.056%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">[**]</font></p></td>
    </tr>
    <tr style="height:12.25pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:6.2pt;border-left:0.5pt solid #000000;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="margin-left:1.147%;text-indent:0;font-size:8pt;margin-top:0.4pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">99204 </font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">OFFICE/OUTPATIENT VISIT NEW - PSYCH</font></p></td>
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:1.8pt;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="margin-left:0.333%;text-indent:0;font-size:9pt;margin-top:1.6pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.028%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">[**]</font></p></td>
    </tr>
    <tr style="height:10.1pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:5.85pt;border-left:0.5pt solid #000000;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="margin-left:1.08%;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">99213-GT </font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">OFFICE/OUTPATIENT VISIT EST - PSYCH (follow-up, low complexity)</font></p></td>
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:1.8pt;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="margin-left:0.333%;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.056%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">[**]</font></p></td>
    </tr>
    <tr style="height:10.8pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:5.85pt;border-left:0.5pt solid #000000;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="margin-left:1.08%;text-indent:0;font-size:8pt;margin-top:0.65pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">99214-GT </font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">OFFICE/OUTPATIENT VISIT EST - PSYCH (follow-up, moderate complexity)</font></p></td>
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:1.8pt;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="margin-left:0.333%;text-indent:0;font-size:9pt;margin-top:0.75pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">[**]</font></p></td>
    </tr>
    <tr style="height:12.25pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:6.2pt;border-left:0.5pt solid #000000;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="margin-left:1.147%;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">90834 </font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">BH THERAPY - MIDLEVEL- LCSW, LPC, LMFT (And any other non-PhD/non-PsyD)</font></p></td>
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:1.8pt;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="margin-left:0.333%;text-indent:0;font-size:9pt;margin-top:1.35pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.009%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">[**]</font></p></td>
    </tr>
    <tr style="height:15.1pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:6.2pt;border-left:0.5pt solid #000000;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="margin-left:1.147%;text-indent:0;font-size:8pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">90834- </font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">BH THERAPY - PhD/ PsyD (Doctorate Level)</font></p></td>
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:1.8pt;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="margin-left:0.333%;text-indent:0;font-size:9pt;margin-top:3.5pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.074%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">[**]</font></p></td>
    </tr>
   </table><p style="margin-left:3.333%;font-size:10pt;margin-top:10.9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Urgent Care and Behavioral Health - Medicare Advantage</font></p><p style="font-size:10pt;margin-top:0.1pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:3.407%;border-spacing:0;table-layout:auto;width:94.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:80.8%;box-sizing:content-box;"></td>
     <td style="width:19.2%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:34.55pt;white-space:pre-wrap;word-break:break-word;">
     <td style="border-top:0.5pt solid #000000;padding-top:0in;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:8pt;margin-top:2.85pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:0.187%;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">CPT Code </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&amp; </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Description</font></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0in;border-right:0.5pt solid #000000;text-indent:17.6pt;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="margin-left:3.253%;text-indent:3.538%;font-size:8pt;margin-top:0.9pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.389%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Rates 1/1/26 - 1/1/29</font></p></td>
    </tr>
    <tr style="height:9.35pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:5.85pt;border-left:0.5pt solid #000000;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="margin-left:1.08%;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">99422 </font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">NON-FACE TO FACE NEW &amp; ESTABLISHED URGENT CARE/ACUTE VISIT (MD/DO, NP)</font></p></td>
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:1.8pt;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="margin-left:0.333%;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.056%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">[**]</font></p></td>
    </tr>
    <tr style="height:12.25pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:6.2pt;border-left:0.5pt solid #000000;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="margin-left:1.147%;text-indent:0;font-size:8pt;margin-top:0.85pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">99204 </font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">OFFICE/OUTPATIENT VISIT NEW - PSYCH</font></p></td>
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:1.8pt;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="margin-left:0.333%;text-indent:0;font-size:9pt;margin-top:2.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.028%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">[**]</font></p></td>
    </tr>
    <tr style="height:9.35pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:5.85pt;border-left:0.5pt solid #000000;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="margin-left:1.08%;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">99213-GT </font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">OFFICE/OUTPATIENT VISIT EST - PSYCH (follow-up, low complexity)</font></p></td>
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:1.8pt;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="margin-left:0.333%;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.056%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">[**]</font></p></td>
    </tr>
    <tr style="height:10.8pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:5.85pt;border-left:0.5pt solid #000000;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="margin-left:1.08%;text-indent:0;font-size:8pt;margin-top:0.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">99214-GT </font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">OFFICE/OUTPATIENT VISIT EST - PSYCH (follow-up, moderate complexity)</font></p></td>
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:1.8pt;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="margin-left:0.333%;text-indent:0;font-size:9pt;margin-top:0.75pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">[**]</font></p></td>
    </tr>
    <tr style="height:11.5pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:6.2pt;border-left:0.5pt solid #000000;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="margin-left:1.147%;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">90834 </font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">BH THERAPY - MIDLEVEL- LCSW, LPC, LMFT (And any other non-PhD/non-PsyD)</font></p></td>
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:1.8pt;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="margin-left:0.333%;text-indent:0;font-size:9pt;margin-top:1.35pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.009%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">[**]</font></p></td>
    </tr>
    <tr style="height:15.85pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:6.2pt;border-left:0.5pt solid #000000;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="margin-left:1.147%;text-indent:0;font-size:8pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">90834- </font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">BH THERAPY - PhD/ PsyD (Doctorate Level)</font></p></td>
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:1.8pt;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="margin-left:0.333%;text-indent:0;font-size:9pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.074%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">[**]</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:3.4%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:5.463%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;">National Accounts, Local, Large/Small Group Employers, etc.- Commercial Buy-Up/Benefit Programs</font></p><p style="margin-left:3.333%;font-size:10pt;margin-top:1.3pt;font-family:Times New Roman;margin-bottom:0;margin-right:5.463%;text-align:left;"><font style="white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:0.602%;border-spacing:0;table-layout:auto;width:94.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:88.18%;box-sizing:content-box;"></td>
     <td style="width:11.82%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:28.8pt;white-space:pre-wrap;word-break:break-word;">
     <td style="border-top:0.5pt solid #000000;padding-top:0in;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:8pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:0.173%;font-size:8pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">CPT Code </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&amp; </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Description</font></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0in;border-right:0.5pt solid #000000;text-indent:13.4pt;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="margin-left:2.48%;text-indent:0.856%;font-size:8pt;margin-top:0.65pt;font-family:Times New Roman;margin-bottom:0;margin-right:2.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Rates 1/1/26-</font></p><p style="margin-left:3.08%;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">1/1/29</font></p></td>
    </tr>
    <tr style="height:58.3pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:5.85pt;border-left:0.5pt solid #000000;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="margin-left:1.08%;text-indent:0;font-size:8pt;margin-top:0.75pt;font-family:Times New Roman;margin-bottom:0;margin-right:23.269%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Diabetes Prevention Program (as aligned with Healthy Impact Offerings) 0488T-32</font></p><p style="margin-left:1.107%;text-indent:0;font-size:8pt;margin-top:0.2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">-Milestone 1, 5% weight loss</font></p><p style="margin-left:1.107%;text-indent:0;font-size:8pt;margin-top:0.4pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">-Milestone 2, after 1st visit with Provider</font></p><p style="margin-left:1.107%;text-indent:0;font-size:8pt;margin-top:0.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">-Milestone 3, after 4th visit with Provider</font></p><p style="margin-left:1.107%;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">-Milestone 4, after 8th visit with Provider</font></p></td>
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:2.55pt;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="margin-left:0.467%;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.046%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">[**]</font></p></td>
    </tr>
    <tr style="height:19.45pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:5.85pt;border-left:0.5pt solid #000000;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="margin-left:1.08%;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:32.093%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Dermatology (as aligned with Healthy Impact Offerings) 99423-GQ </font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Asynchronous new and established dermatoloqy visit</font></p></td>
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:2.55pt;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="margin-left:0.467%;text-indent:0;font-size:9pt;margin-top:5.65pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.093%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">[**]</font></p></td>
    </tr>
    <tr style="height:68.4pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:5.85pt;border-left:0.5pt solid #000000;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="margin-left:1.08%;text-indent:0;font-size:8pt;margin-top:0.85pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Musculoskeletal Services*</font></p><p style="margin-left:1.147%;text-indent:0;font-size:8pt;margin-top:0.4pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">98975-32 Milestone 1 - Thrive </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&amp; </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Bloom</font></p><p style="margin-left:1.147%;text-indent:0;font-size:8pt;margin-top:0.65pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">(One-time per program)</font></p><p style="margin-left:1.133%;text-indent:0;font-size:8pt;margin-top:0.4pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Live coaching session with a physical therapist</font></p><p style="margin-left:1.147%;text-indent:0;font-size:8pt;margin-top:0.65pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">98975-32 Milestone 1 - Move</font></p><p style="margin-left:1.147%;text-indent:0;font-size:8pt;margin-top:0.4pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">(One-time per program)</font></p><p style="margin-left:1.133%;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Live coachinq session with an exercise module with the Diqital Platform</font></p></td>
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:2.55pt;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="margin-left:0.467%;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">[**]</font></p></td>
    </tr>
    <tr style="height:39.6pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:5.85pt;border-left:0.5pt solid #000000;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="margin-left:1.08%;text-indent:0;font-size:8pt;margin-top:0.65pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Musculoskeletal Services*</font></p><p style="margin-left:1.147%;text-indent:0;font-size:8pt;margin-top:0.6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">97161-32 Milestone 2 -Thrive </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&amp; </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Bloom</font></p><p style="margin-left:1.067%;text-indent:0;font-size:8pt;margin-top:0.4pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Three exercise modules with Digital Platform and unlimited chat with physical therapist coach</font></p><p style="margin-left:1.133%;text-indent:0;font-size:8pt;margin-top:0.8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Platform</font></p></td>
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:2.55pt;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="margin-left:0.467%;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">[**]</font></p></td>
    </tr>
    <tr style="height:22.3pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:5.95pt;border-left:0.5pt solid #000000;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="margin-left:1.107%;text-indent:0;font-size:8pt;margin-top:0.4pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Virtual Primary Care</font></p><p style="margin-left:1.08%;text-indent:0;font-size:8pt;margin-top:0.4pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">99213 </font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">OFFICE/OUTPATIENT VISIT NEW - PRIMARY CARE ALL LEVELS (MD/DO, NP)</font></p></td>
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:2.55pt;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="margin-left:0.467%;text-indent:0;font-size:9pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.287%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">[**]</font></p></td>
    </tr>
    <tr style="height:19.45pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:6.35pt;border-left:0.5pt solid #000000;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="margin-left:1.147%;text-indent:-0.028%;padding-left:0.027%;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:1.898%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">99385 </font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">OFFICE/OUTPATIENT VISIT ANNUAL WELLNESS 18-39 YEARS (Initial exam/new patient) (MD/DO, NP)</font></p></td>
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:2.55pt;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="margin-left:0.467%;text-indent:0;font-size:9pt;margin-top:0.65pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.019%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">[**]</font></p></td>
    </tr>
    <tr style="height:9.35pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:6.2pt;border-left:0.5pt solid #000000;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="margin-left:1.147%;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">99395 </font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">OFFICE/OUTPATIENT VISIT ANNUAL WELLNESS 18-39 YEARS (Established patient) (MD/DO, NP)</font></p></td>
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:2.55pt;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="margin-left:0.467%;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.019%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">[**]</font></p></td>
    </tr>
    <tr style="height:20.15pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:6.35pt;border-left:0.5pt solid #000000;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="margin-left:1.147%;text-indent:-0.028%;padding-left:0.027%;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:1.898%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">99386 </font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">OFFICE/OUTPATIENT VISIT ANNUAL WELLNESS 40-64 YEARS (Initial exam/new patient) (MD/DO, NP)</font></p></td>
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:2.55pt;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="margin-left:0.467%;text-indent:0;font-size:9pt;margin-top:0.85pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.019%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">[**]</font></p></td>
    </tr>
    <tr style="height:3.6pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:6.2pt;border-left:0.5pt solid #000000;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="margin-left:1.147%;text-indent:0;font-size:8pt;margin-top:0.4pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">99396 </font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">OFFICE/OUTPATIENT VISIT ANNUAL WELLNESS 40-64 YEARS (Established patient) (MD/DO, NP)</font></p></td>
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:2.55pt;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="margin-left:0.467%;text-indent:0;font-size:9pt;margin-top:0.4pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.019%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">[**]</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.63in;min-height:0.76in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:0.453%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Certain confidential information contained in this document, marked by [**], has been omitted because American Well Corporation has determined that the information (i) is not material and (ii) is the type that American Well Corporation customarily and actually treats as private or confidential.</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:0.49in;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:3.333%;font-size:10pt;margin-top:1.3pt;font-family:Times New Roman;margin-bottom:0;margin-right:5.463%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Programs listed below are also referenced in the Healthy Impact Statement of Work dated January 1, 2026, between Elevance Health, Inc. and American Well Corporation.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.63in;min-height:0.76in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:0.453%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Certain confidential information contained in this document, marked by [**], has been omitted because American Well Corporation has determined that the information (i) is not material and (ii) is the type that American Well Corporation customarily and actually treats as private or confidential.</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:0.96in;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:3.333%;font-size:10pt;margin-top:3.1pt;font-family:Times New Roman;margin-bottom:0;margin-right:6.583%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">*</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">The Anthem Rate for Musculoskeletal Services (currently defined as 98975-32, Milestone 1 - 1st visit with Provider-Tech Kit &amp; Marketing Engagement services and 97161-32, Milestone 2 - 3 exercises modules with digital platform &amp; unlimited chat with PT coach Platform, Milestone 3 &#x2013; 6 exercise modules with the digital platform &amp; unlimited chat with PT coach) will be limited to total Eligible Charges of [**] for Option #1: a bundle of one (1) Visit of 98975-32 and two (2) Visits of 97161-32, or Option 2: outcomes based pricing for Milestone 1 = [**] and Milestone 2 = [**]. Outcomes Based Pricing:</font></p><div class="item-list-element-wrapper" style="margin-left:5.87%;display:flex;margin-top:0.1pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.13%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Calibri;font-kerning:none;min-width:4.3875491341761395%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">i.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">98975-32. Milestone 1 &#x2013; Participant completes live coaching session or 1 exercise session with digital platform</font></div></div><div class="item-list-element-wrapper" style="margin-left:5.463%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:6.537%;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Calibri;font-kerning:none;min-width:4.799179157366956%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">ii.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">97161-32. Milestone 2 - Participant has indicated to Vendor either (i) a &#x201c;positive outcome&#x201d; on the applicable clinically-validated outcome measure* used to periodically assess the impact of the applicable services on such Participant&#x2019;s focus area, or (ii) achievement of the goals established for the applicable service for the treatment of the Participant&#x2019;s focus area, whichever occurs first</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:1.85pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Visit Wait Time SLAs, Monthly Data and Reporting Requirements</font></p><p style="margin-left:5.867%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">i.	</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Urgent Care/Acute Care</font></p><div class="item-list-element-wrapper" style="margin-left:13.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:6.667%;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Calibri;font-kerning:none;min-width:3.8457544394060026%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">a.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">[**] percent ([**]%) of urgent care visits will have a wait time under [**] ([**]) minutes (not including requested Providers), for Commercial and Medicare Advantage, calculated separately. For purposes of calculating performance under this SLA, (i) any market with fewer than [**] ([**]) visits per month shall be excluded to avoid statistical distortion from low-volume outliers, and (ii) data from the period of November through January shall be excluded to account for seasonal flu&#x2013;related volatility.</font></div></div><div class="item-list-element-wrapper" style="margin-left:13.333%;display:flex;margin-top:10.75pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:6.667%;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Calibri;font-kerning:none;min-width:3.8457544394060026%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">b.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Member drop off percentages (abandonment): no more than [**] percent ([**]%) of total connections for Commercial and Medicare Advantage after [**] ([**]) minutes of wait time</font></div></div><p style="margin-left:5.493%;font-size:10pt;margin-top:10.9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">ii.	</font><img src="img83049861_0.jpg" alt="img83049861_0.jpg" style="width:115px;height:10px;"></p><div class="item-list-element-wrapper" style="margin-left:13.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:6.796%;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Calibri;font-kerning:none;min-width:3.8457544394060026%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">a.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Psychology: Members will be offered an appointment time that occurs within [**] days, [**]% of the time, excluding markets with annual visits less than [**] visits per month</font></div></div><div class="item-list-element-wrapper" style="margin-left:13.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:6.667%;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Calibri;font-kerning:none;min-width:3.8457544394060026%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">b.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Psychiatry: Members will be offered an appointment time that occurs within [**] ([**]) days from the date of request, [**]% of the time, excluding markets with less than [**] visits per month .</font></div></div><div class="item-list-element-wrapper" style="margin-left:13.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:6.667%;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Calibri;font-kerning:none;min-width:3.8457544394060026%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">c.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Provider satisfaction measure: Provider will maintain a patient rated score of their satisfaction with the therapist, or Psychologist for therapy, and Psychiatrist for medical visits at an average score of [**], out of a [**] ([**]) point scale.</font></div></div><p style="margin-left:3.333%;font-size:10pt;margin-top:10.75pt;font-family:Times New Roman;margin-bottom:0;margin-right:6.657%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">With respect to Urgent Care/Acute Care Visit Wait Time SLAs, and Behavioral Health measures, Monthly Data and Requirements, the parties agree that any performance impacts as a result of system performance shall be based on the system performance SLAs captured in Schedule III of the Statement of Work between Elevance health, Inc. and American Well Corporation effective January 1, 2026.</font></p><p style="font-size:10pt;margin-top:0.15pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.62%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">For clarity, Members seeking on demand urgent care, who choose to wait for a provider with a specific attribute, are not counted in the SLA.</font></p><p style="font-size:10pt;margin-top:0.1pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img83049861_1.jpg" alt="img83049861_1.jpg" style="width:290px;height:14px;"></p><p style="margin-left:3.333%;font-size:10pt;margin-top:0.2pt;font-family:Times New Roman;margin-bottom:0;margin-right:6.778%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">The parties will work towards finalizing new reporting requirements and appropriate additional SLAs for all lines of business consistent with industry standards for urgent care and behavioral health to be finalized by amendment no later than 3/31/26. Topics to be discussed will include the following for urgent care:</font></p><div class="item-list-element-wrapper" style="margin-left:5.87%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.13%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Calibri;font-kerning:none;min-width:4.3875491341761395%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">i.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">patient issues resolved via the first virtual care visit</font></div></div><div class="item-list-element-wrapper" style="margin-left:5.463%;display:flex;margin-top:0.3pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Calibri;font-kerning:none;min-width:4.799179157366956%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">ii.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">appropriateness of follow up visits within [**] hours</font></div></div><div class="item-list-element-wrapper" style="margin-left:5.065%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.935%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Calibri;font-kerning:none;min-width:5.198293569284246%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">iii.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">percent of incoming patients navigated to an ER by the treating doctor</font></div></div><div class="item-list-element-wrapper" style="margin-left:5.065%;display:flex;margin-top:0.1pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.935%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Calibri;font-kerning:none;min-width:5.198293569284246%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">iv.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">repeat visit rate within [**] hours</font></div></div><div class="item-list-element-wrapper" style="margin-left:5.463%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Calibri;font-kerning:none;min-width:4.799179157366956%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">v.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">usage of the ER by patient&#x2019;s after [**] minute wait time for LiveHealth Online </font></div></div><p style="font-size:10pt;margin-top:0.15pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img83049861_2.jpg" alt="img83049861_2.jpg" style="width:203px;height:14px;"></p><p style="margin-left:3.333%;font-size:10pt;margin-top:0.3pt;font-family:Times New Roman;margin-bottom:0;margin-right:6.602%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Provider agrees to provide monthly and quarterly supporting reporting for all provider access requirements, subject to audit by Anthem.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.63in;min-height:0.76in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:0.453%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Certain confidential information contained in this document, marked by [**], has been omitted because American Well Corporation has determined that the information (i) is not material and (ii) is the type that American Well Corporation customarily and actually treats as private or confidential.</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>5
<FILENAME>amwl-ex10_4.htm
<DESCRIPTION>EX-10.4
<TEXT>
<!-- DFIN ActiveDisclosure (SM) HTML Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2026-01-02T17:14:59.9141+00:00 --><!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html>
 <head>
  <title>EX-10.4</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;-webkit-text-size-adjust:100%;position:relative;">
  <div style="padding-top:0.3in;z-index:2;min-height:1.24in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.333%;text-align:right;margin-left:0;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 10.4</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:29.587%;text-indent:14.332%;font-size:10pt;margin-top:3.6pt;font-family:Times New Roman;margin-bottom:0;margin-right:31.62%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">FIFTH AMENDMENT TO THE ANTHEM BLUE CROSS AND BLUE SHIELD</font></p><p style="margin-left:36.76%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">PROVIDER AGREEMENT</font></p><p style="margin-left:3.333%;font-size:10pt;margin-top:10.3pt;font-family:Times New Roman;margin-bottom:0;margin-right:6.704%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">This Amendment is to the Provider Agreement (&#34;Agreement&#34;) dated January 1, 2023, and entered into between Anthem (hereinafter referred to as &#34;Anthem&#34;) and Online Care Group, PC (hereinafter &#34;Provider&#34;) and is incorporated into the Agreement as follows:</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">BASE PROVISIONS</font></p><p style="font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.324%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">ARTICLE VIII</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.287%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">TERM AND TERMINATION</font></p><p style="font-size:10pt;margin-top:0.1pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:6.8968727694042435%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Provision 8.1 is hereby deleted in its entirety and replaced with the following:</font></div></div><p style="margin-left:10%;font-size:10pt;margin-top:10.3pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">8.1   </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Term of Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">. This Agreement shall commence at 12:01 AM on January 1, 2026 for a term of</font></p><p style="margin-left:16.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.602%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">3 (three) year(s), January 1, 2026 until January 1, 2029 (&#x201c;Initial Term&#x201d;), and shall continue automatically in effect thereafter for consecutive one (1) year terms unless otherwise terminated as provided herein</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:6.8968727694042435%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Provision 8.4.1.10 is hereby added to the Agreement as shown below:</font></div></div><p style="font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:16.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.63%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">The Master Services Agreement between Elevance Health and American Well dated January 1, 2023 (Vendor Agreement), or the Statement of Work between Elevance Health and American Well dated January 1, 2026 for the Converge Platform, terminates pursuant to Section 7 of the Vendor Agreement</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:6.8968727694042435%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Provision 8.4.2.4 is hereby added to the Agreement as shown below:</font></div></div><p style="font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:16.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.63%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">The Master Services Agreement between Elevance Health and American Well dated January 1, 2023 (Vendor Agreement), or the Statement of Work between Elevance Health and American Well dated January 1, 2026 for the Converge Platform, terminates pursuant to Section 7 of the Vendor Agreement.</font></p><p style="margin-left:3.333%;font-size:10pt;margin-top:10.35pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">PLAN COMPENSATION SCHEDULE</font></p><p style="font-size:10pt;margin-top:10.25pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.306%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">PLAN COMPENSATION SCHEDULE (&#34;PCS&#34;)</font></p><p style="font-size:10pt;margin-top:0.1pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">IV.	SPECIFIC REIMBURSEMENT TERMS</font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:10.3pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:6.8968727694042435%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Provider Access Fee is replaced with the following effective January 1, 2026:</font></div></div><p style="font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:10%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.296%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Provider Access Fee</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">. Anthem will pay Provider a one-time provider access fee of $</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">[**]</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> by December 15, 2026.</font></p><p style="margin-left:3.333%;font-size:10pt;margin-top:10.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">PCS ATTACHMENT</font></p><p style="font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:6.667%;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:6.8968727694042435%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">The existing PCS Attachment to the Agreement is hereby deleted in its entirety and replaced with the PCS Attachment attached hereto.</font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.6in;min-height:0.72in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="margin-left:0.453%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-right:0;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:0.187%;font-size:10pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Certain confidential information contained in this document, marked by [**], has been omitted because American Well Corporation has determined that the information (i) is not material and (ii) is the type that American Well Corporation customarily and actually treats as private or confidential.</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:0.453%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-right:0;"><font style="white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:0.94in;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:3.333%;font-size:10pt;margin-top:3.95pt;font-family:Times New Roman;margin-bottom:0;margin-right:6.611%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Except as expressly set forth herein, nothing contained herein shall be construed to modify the Agreement. To the extent this Amendment conflicts with any provision of the Agreement, this Amendment shall control.</font></p><p style="font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.722%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Each party to this Amendment warrants that it has full power and authority to enter into this Amendment and the person signing this Amendment on behalf of either party warrants that he/she has been duly authorized and empowered to enter into this Amendment.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">THE EFFECTIVE DATE OF THIS AMENDMENT IS: January 1, 2026</font></p><p style="font-size:10pt;margin-top:0.4pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:4.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:3.333%;font-size:10pt;margin-top:4.7pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">PROVIDER LEGAL NAME: Online Care Group, PC</font></p><p style="font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:4%;text-indent:-8.762%;padding-left:7.227%;font-size:10pt;margin-top:9.25pt;font-family:Times New Roman;margin-bottom:0;margin-right:6.296%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Printed: </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">  /s/ Anna Nesterova	</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">				</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">December 23, 2025	</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> 		Signature, Authorized Representative of Provider(s)	Date</font></p><p style="margin-left:4%;text-indent:-8.674%;padding-left:7.227%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:5.463%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">	</font></p><p style="margin-left:4%;text-indent:-8.762%;padding-left:7.227%;font-size:10pt;margin-top:9.25pt;font-family:Times New Roman;margin-bottom:0;margin-right:6.296%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Printed: </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> Anna Nesterova	</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">				</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Vice President	</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> 			Name						Title</font></p><p style="margin-left:4%;text-indent:-9.108%;padding-left:7.227%;font-size:10pt;margin-top:9.65pt;font-family:Times New Roman;margin-bottom:0;margin-right:9.426%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Address </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> 75 State Street, 27th FL	</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">			</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Boston	MA	02109 	</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">		Street						City	State Zip</font></p><p style="font-size:10pt;margin-top:5.6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:4%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Tax Identification Number (TIN):	</font></p><p style="font-size:10pt;margin-top:0.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:4%;font-size:10pt;margin-top:10.25pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Phone Number:	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> 6172043500	</font></p><p style="font-size:10pt;margin-top:0.8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:4%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Email Address:	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> contracts@amwell.com</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">	</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:4%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Anthem</font></p><p style="font-size:10pt;margin-top:1.35pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:4%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;vertical-align:sub;font-size:8.040000000000001pt;font-family:Arial;font-kerning:none;min-width:fit-content;">By:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">/s/ Salma Khaleq</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> 					</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">12-24-2025</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font></p><p style="margin-left:11.227%;font-size:10pt;margin-top:1.6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Signature, Authorized Representative of Anthem</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Date</font></p><p style="margin-left:4%;text-indent:-8.774%;padding-left:7.227%;font-size:10pt;margin-top:10.25pt;font-family:Times New Roman;margin-bottom:0;margin-right:6.407%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Printed: </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> Salma Khaleq</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">				</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Vice President</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> 			Name</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">						</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Title</font></p><p style="margin-left:4%;text-indent:-8.762%;padding-left:7.227%;font-size:10pt;margin-top:9.55pt;font-family:Times New Roman;margin-bottom:0;margin-right:6.296%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Address </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> 2505 N. Hwy 360</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">				</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Grand Prairie</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">TX</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">75050</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> 	Street</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">						</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">City</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">State</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Zip</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.65in;min-height:0.78in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="margin-left:0.453%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Certain confidential information contained in this document, marked by [**], has been omitted because American Well Corporation has determined that the information (i) is not material and (ii) is the type that American Well Corporation customarily and actually treats as private or confidential.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:0.44in;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><h1 style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.296%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:16pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">PCS Attachment</font></h1><p style="font-size:10pt;margin-top:11.2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10.5pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:3.347%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Urgent Care and Behavioral Health - Commercial</font></p><p style="font-size:10pt;margin-top:0.2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:3.398%;border-spacing:0;table-layout:auto;width:94.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:80.8%;box-sizing:content-box;"></td>
     <td style="width:19.2%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:33.85pt;white-space:pre-wrap;word-break:break-word;">
     <td style="border-top:0.5pt solid #000000;padding-top:0in;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:8pt;margin-top:2.5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:0.107%;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">CPT Code </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&amp; </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Description</font></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0in;border-right:0.5pt solid #000000;text-indent:17.35pt;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="margin-left:3.213%;text-indent:3.607%;font-size:8pt;margin-top:0.4pt;font-family:Times New Roman;margin-bottom:0;margin-right:2.907%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Rates 1/1/26 - 1/1/29</font></p></td>
    </tr>
    <tr style="height:10.1pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:5.7pt;border-left:0.5pt solid #000000;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="margin-left:1.053%;text-indent:0;font-size:8pt;margin-top:0.65pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">99422 </font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">NON-FACE TO FACE NEW &amp; ESTABLISHED URGENT CARE/ACUTE VISIT (MD/DO, NP)</font></p></td>
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:1.45pt;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="margin-left:0.267%;text-indent:0;font-size:9pt;margin-top:0.65pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.056%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">[**]</font></p></td>
    </tr>
    <tr style="height:12.25pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:5.95pt;border-left:0.5pt solid #000000;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="margin-left:1.107%;text-indent:0;font-size:8pt;margin-top:0.4pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">99204 </font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">OFFICE/OUTPATIENT VISIT NEW - PSYCH</font></p></td>
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:1.45pt;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="margin-left:0.267%;text-indent:0;font-size:9pt;margin-top:1.6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">[**]</font></p></td>
    </tr>
    <tr style="height:10.1pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:5.7pt;border-left:0.5pt solid #000000;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="margin-left:1.053%;text-indent:0;font-size:8pt;margin-top:0.65pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">99213-GT </font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">OFFICE/OUTPATIENT VISIT EST - PSYCH (follow-up, low complexity)</font></p></td>
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:1.45pt;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="margin-left:0.267%;text-indent:0;font-size:9pt;margin-top:0.65pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.056%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">[**]</font></p></td>
    </tr>
    <tr style="height:10.8pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:5.7pt;border-left:0.5pt solid #000000;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="margin-left:1.053%;text-indent:0;font-size:8pt;margin-top:0.65pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">99214-GT </font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">OFFICE/OUTPATIENT VISIT EST - PSYCH (follow-up, moderate complexity)</font></p></td>
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:1.45pt;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="margin-left:0.267%;text-indent:0;font-size:9pt;margin-top:0.9pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.037%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">[**]</font></p></td>
    </tr>
    <tr style="height:12.25pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:5.95pt;border-left:0.5pt solid #000000;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="margin-left:1.107%;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">90834 </font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">BH THERAPY - MIDLEVEL- LCSW, LPC, LMFT (And any other non-PhD/non-PsyD)</font></p></td>
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:1.45pt;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="margin-left:0.267%;text-indent:0;font-size:9pt;margin-top:1.35pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.028%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">[**]</font></p></td>
    </tr>
    <tr style="height:15.1pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:5.95pt;border-left:0.5pt solid #000000;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="margin-left:1.107%;text-indent:0;font-size:8pt;margin-top:0.4pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">90834- </font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">BH THERAPY - PhD/ PsyD (Doctorate Level)</font></p></td>
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:1.45pt;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="margin-left:0.267%;text-indent:0;font-size:9pt;margin-top:3.5pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.028%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">[**]</font></p></td>
    </tr>
   </table><p style="margin-left:3.347%;font-size:10pt;margin-top:10.95pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Urgent Care and Behavioral Health - Medicare Advantage</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:3.398%;border-spacing:0;table-layout:auto;width:94.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:80.8%;box-sizing:content-box;"></td>
     <td style="width:19.2%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:34.55pt;white-space:pre-wrap;word-break:break-word;">
     <td style="border-top:0.5pt solid #000000;padding-top:0in;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:8pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:0.107%;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">CPT Code </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&amp; </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Description</font></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0in;border-right:0.5pt solid #000000;text-indent:17.35pt;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="margin-left:3.213%;text-indent:3.607%;font-size:8pt;margin-top:0.9pt;font-family:Times New Roman;margin-bottom:0;margin-right:2.907%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Rates 1/1/26 - 1/1/29</font></p></td>
    </tr>
    <tr style="height:9.35pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:5.7pt;border-left:0.5pt solid #000000;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="margin-left:1.053%;text-indent:0;font-size:8pt;margin-top:0.4pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">99422 </font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">NON-FACE TO FACE NEW &amp; ESTABLISHED URGENT CARE/ACUTE VISIT (MD/DO, NP)</font></p></td>
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:1.45pt;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="margin-left:0.267%;text-indent:0;font-size:9pt;margin-top:0.65pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.056%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">[**]</font></p></td>
    </tr>
    <tr style="height:12.25pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:5.95pt;border-left:0.5pt solid #000000;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="margin-left:1.107%;text-indent:0;font-size:8pt;margin-top:0.9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">99204 </font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">OFFICE/OUTPATIENT VISIT NEW - PSYCH</font></p></td>
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:1.45pt;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="margin-left:0.267%;text-indent:0;font-size:9pt;margin-top:2.1pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">[**]</font></p></td>
    </tr>
    <tr style="height:9.35pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:5.7pt;border-left:0.5pt solid #000000;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="margin-left:1.053%;text-indent:0;font-size:8pt;margin-top:0.4pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">99213-GT </font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">OFFICE/OUTPATIENT VISIT EST - PSYCH (follow-up, low complexity)</font></p></td>
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:1.45pt;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="margin-left:0.267%;text-indent:0;font-size:9pt;margin-top:0.65pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.056%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">[**]</font></p></td>
    </tr>
    <tr style="height:10.8pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:5.7pt;border-left:0.5pt solid #000000;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="margin-left:1.053%;text-indent:0;font-size:8pt;margin-top:0.9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">99214-GT </font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">OFFICE/OUTPATIENT VISIT EST - PSYCH (follow-up, moderate complexity)</font></p></td>
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:1.45pt;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="margin-left:0.267%;text-indent:0;font-size:9pt;margin-top:0.9pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.037%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">[**]</font></p></td>
    </tr>
    <tr style="height:12.25pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:5.95pt;border-left:0.5pt solid #000000;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="margin-left:1.107%;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">90834 </font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">BH THERAPY - MIDLEVEL- LCSW, LPC, LMFT (And any other non-PhD/non-PsyD)</font></p></td>
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:1.45pt;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="margin-left:0.267%;text-indent:0;font-size:9pt;margin-top:1.35pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.028%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">[**]</font></p></td>
    </tr>
    <tr style="height:15.85pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:5.95pt;border-left:0.5pt solid #000000;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="margin-left:1.107%;text-indent:0;font-size:8pt;margin-top:0.9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">90834- </font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">BH THERAPY - PhD/ PsyD (Doctorate Level)</font></p></td>
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:1.45pt;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="margin-left:0.267%;text-indent:0;font-size:9pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.028%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">[**]</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0.6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:3.387%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.296%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;">National Accounts, Local, Large/Small Group Employers, etc.- Commercial Buy-Up/Benefit Programs</font></p><p style="margin-left:3.333%;font-size:10pt;margin-top:1.3pt;font-family:Times New Roman;margin-bottom:0;margin-right:6.296%;text-align:left;"><font style="white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:0.602%;border-spacing:0;table-layout:auto;width:94.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:88.18%;box-sizing:content-box;"></td>
     <td style="width:11.82%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:29.5pt;white-space:pre-wrap;word-break:break-word;">
     <td style="border-top:0.5pt solid #000000;padding-top:0in;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:8pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:0.107%;font-size:8pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">CPT Code </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&amp; </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Description</font></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0in;border-right:0.5pt solid #000000;text-indent:13.25pt;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="margin-left:2.453%;text-indent:0.839%;font-size:8pt;margin-top:0.65pt;font-family:Times New Roman;margin-bottom:0;margin-right:2.194%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Rates 1/1/26-</font></p><p style="margin-left:3.04%;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">1/1/29</font></p></td>
    </tr>
    <tr style="height:58.3pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:5.65pt;border-left:0.5pt solid #000000;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="margin-left:1.04%;text-indent:-0.017%;padding-left:0.013%;font-size:8pt;margin-top:0.65pt;font-family:Times New Roman;margin-bottom:0;margin-right:22.75%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Diabetes Prevention Program (as aligned with Healthy Impact Offerings) 0488T-32</font></p><p style="margin-left:1.067%;text-indent:0;font-size:8pt;margin-top:0.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">-Milestone 1, 5% weight loss</font></p><p style="margin-left:1.067%;text-indent:0;font-size:8pt;margin-top:0.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">-Milestone 2, after 1st visit with Provider</font></p><p style="margin-left:1.067%;text-indent:0;font-size:8pt;margin-top:0.65pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">-Milestone 3, after 4th visit with Provider</font></p><p style="margin-left:1.067%;text-indent:0;font-size:8pt;margin-top:0.4pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">-Milestone 4, after 8th visit with Provider</font></p></td>
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:2.15pt;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="margin-left:0.4%;text-indent:0;font-size:9pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.028%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">[**]</font></p></td>
    </tr>
    <tr style="height:19.45pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:5.7pt;border-left:0.5pt solid #000000;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="margin-left:1.04%;text-indent:-0.02%;padding-left:0.013%;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:30.722%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Dermatology (as aligned with Healthy Impact Offerings) 99423-GQ </font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Asynchronous new and established dermatoloqy visit</font></p></td>
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:2.15pt;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="margin-left:0.4%;text-indent:0;font-size:9pt;margin-top:5.7pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.056%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">[**]</font></p></td>
    </tr>
    <tr style="height:68.4pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:5.65pt;border-left:0.5pt solid #000000;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="margin-left:1.04%;text-indent:0;font-size:8pt;margin-top:0.9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Musculoskeletal Services*</font></p><p style="margin-left:1.107%;text-indent:0;font-size:8pt;margin-top:0.4pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">98975-32 Milestone 1 - Thrive </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&amp; </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Bloom</font></p><p style="margin-left:1.107%;text-indent:0;font-size:8pt;margin-top:0.65pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">(One-time per program)</font></p><p style="margin-left:1.08%;text-indent:0;font-size:8pt;margin-top:0.4pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Live coaching session with a physical therapist</font></p><p style="margin-left:1.107%;text-indent:0;font-size:8pt;margin-top:0.65pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">98975-32 Milestone 1 - Move</font></p><p style="margin-left:1.107%;text-indent:0;font-size:8pt;margin-top:0.4pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">(One-time per program)</font></p><p style="margin-left:1.08%;text-indent:0;font-size:8pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Live coachinq session with an exercise module with the Diqital Platform</font></p></td>
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:2.15pt;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="margin-left:0.4%;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">[**]</font></p></td>
    </tr>
    <tr style="height:38.9pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:5.65pt;border-left:0.5pt solid #000000;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="margin-left:1.04%;text-indent:0;font-size:8pt;margin-top:0.65pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Musculoskeletal Services*</font></p><p style="margin-left:1.107%;text-indent:0;font-size:8pt;margin-top:0.65pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">97161-32 Milestone 2 -Thrive </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&amp; </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Bloom</font></p><p style="margin-left:1.027%;text-indent:-0.055%;padding-left:0.053%;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:2.481%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Three exercise modules with Digital Platform and unlimited chat with physical therapist coach Platform</font></p></td>
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:2.15pt;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="margin-left:0.4%;text-indent:0;font-size:9pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">[**]</font></p></td>
    </tr>
    <tr style="height:22.3pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:5.75pt;border-left:0.5pt solid #000000;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="margin-left:1.067%;text-indent:0;font-size:8pt;margin-top:0.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Virtual Primary Care</font></p><p style="margin-left:1.053%;text-indent:0;font-size:8pt;margin-top:0.4pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">99213 </font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">OFFICE/OUTPATIENT VISIT NEW - PRIMARY CARE ALL LEVELS (MD/DO, NP)</font></p></td>
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:2.15pt;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="margin-left:0.4%;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.287%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">[**]</font></p></td>
    </tr>
    <tr style="height:19.45pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:6.1pt;border-left:0.5pt solid #000000;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="margin-left:1.107%;text-indent:-0.028%;padding-left:0.027%;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:2.481%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">99385 </font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">OFFICE/OUTPATIENT VISIT ANNUAL WELLNESS 18-39 YEARS (Initial exam/new patient) (MD/DO, NP)</font></p></td>
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:2.15pt;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="margin-left:0.4%;text-indent:0;font-size:9pt;margin-top:0.65pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.056%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">[**]</font></p></td>
    </tr>
    <tr style="height:9.35pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:5.95pt;border-left:0.5pt solid #000000;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="margin-left:1.107%;text-indent:0;font-size:8pt;margin-top:0.65pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">99395 </font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">OFFICE/OUTPATIENT VISIT ANNUAL WELLNESS 18-39 YEARS (Established patient) (MD/DO, NP)</font></p></td>
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:2.15pt;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="margin-left:0.4%;text-indent:0;font-size:9pt;margin-top:0.65pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.056%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">[**]</font></p></td>
    </tr>
    <tr style="height:20.15pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:6.1pt;border-left:0.5pt solid #000000;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="margin-left:1.107%;text-indent:-0.028%;padding-left:0.027%;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:2.481%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">99386 </font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">OFFICE/OUTPATIENT VISIT ANNUAL WELLNESS 40-64 YEARS (Initial exam/new patient) (MD/DO, NP)</font></p></td>
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:2.15pt;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="margin-left:0.4%;text-indent:0;font-size:9pt;margin-top:0.9pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.056%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">[**]</font></p></td>
    </tr>
    <tr style="height:10.8pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:5.95pt;border-left:0.5pt solid #000000;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="margin-left:1.107%;text-indent:0;font-size:8pt;margin-top:0.4pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">99396 </font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">OFFICE/OUTPATIENT VISIT ANNUAL WELLNESS 40-64 YEARS (Established patient) (MD/DO, NP)</font></p></td>
     <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:2.15pt;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="margin-left:0.4%;text-indent:0;font-size:9pt;margin-top:0.4pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.056%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">[**]</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.63in;min-height:0.76in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="margin-left:0.453%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Certain confidential information contained in this document, marked by [**], has been omitted because American Well Corporation has determined that the information (i) is not material and (ii) is the type that American Well Corporation customarily and actually treats as private or confidential.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:0.44in;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:3.333%;font-size:10pt;margin-top:1.3pt;font-family:Times New Roman;margin-bottom:0;margin-right:6.296%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Programs listed below are also referenced in the Healthy Impact Statement of Work dated January 1, 2026, between Elevance Health, Inc. and American Well Corporation.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.63in;min-height:0.76in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="margin-left:0.453%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Certain confidential information contained in this document, marked by [**], has been omitted because American Well Corporation has determined that the information (i) is not material and (ii) is the type that American Well Corporation customarily and actually treats as private or confidential.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:0.96in;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:3.333%;font-size:10pt;margin-top:3.1pt;font-family:Times New Roman;margin-bottom:0;margin-right:6.639%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">*</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">The Anthem Rate for Musculoskeletal Services (currently defined as 98975-32, Milestone 1 - 1st visit with Provider-Tech Kit &amp; Marketing Engagement services and 97161-32, Milestone 2 - 3 exercises modules with digital platform &amp; unlimited chat with PT coach Platform, Milestone 3 &#x2013; 6 exercise modules with the digital platform &amp; unlimited chat with PT coach) will be limited to total Eligible Charges of $[**] for Option #1: a bundle of one (1) Visit of 98975-32 and two (2) Visits of 97161-32, or Option 2: outcomes based pricing for Milestone 1 = $[**] and Milestone 2 = $[**]. Outcomes Based Pricing:</font></p><div class="item-list-element-wrapper" style="margin-left:5.87%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.13%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Calibri;font-kerning:none;min-width:4.3875491341761395%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">i.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">98975-32. Milestone 1 &#x2013; Participant completes live coaching session or 1 exercise session with digital platform</font></div></div><div class="item-list-element-wrapper" style="margin-left:5.463%;display:flex;margin-top:0.05pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:6.667%;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Calibri;font-kerning:none;min-width:4.799179157366956%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">ii.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">97161-32. Milestone 2 - Participant has indicated to Vendor either (i) a &#x201c;positive outcome&#x201d; on the applicable clinically-validated outcome measure* used to periodically assess the impact of the applicable services on such Participant&#x2019;s focus area, or (ii) achievement of the goals established for the applicable service for the treatment of the Participant&#x2019;s focus area, whichever occurs first</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:1.85pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Visit Wait Time SLAs, Monthly Data and Reporting Requirements</font></p><p style="margin-left:5.867%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">i. 	</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Urgent Care/Acute Care</font></p><div class="item-list-element-wrapper" style="margin-left:13.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:6.667%;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Calibri;font-kerning:none;min-width:3.8457544394060026%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">a.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">[**] percent ([**]%) of urgent care visits will have a wait time under [**] ([**]) minutes (not including requested Providers), for Commercial and Medicare Advantage, calculated separately. For purposes of calculating performance under this SLA, (i) any market with fewer than [**] ([**]) visits per month shall be excluded to avoid statistical distortion from low-volume outliers, and (ii) data from the period of November through January shall be excluded to account for seasonal flu&#x2013;related volatility.</font></div></div><div class="item-list-element-wrapper" style="margin-left:13.333%;display:flex;margin-top:10.85pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:6.667%;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Calibri;font-kerning:none;min-width:3.8457544394060026%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">b.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Member drop off percentages (abandonment): no more than [**] percent ([**]%) of total connections for Commercial and Medicare Advantage after [**] ([**]) minutes of wait time</font></div></div><p style="margin-left:5.493%;font-size:10pt;margin-top:10.8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">ii.	</font><img src="img83973382_0.jpg" alt="img83973382_0.jpg" style="width:124px;height:14px;"></p><div class="item-list-element-wrapper" style="margin-left:13.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:6.667%;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Calibri;font-kerning:none;min-width:3.8457544394060026%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">a.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Psychology: Members will be offered an appointment time that occurs within [**] days, [**]% of the time, excluding markets with annual visits less than [**] visits per month</font></div></div><div class="item-list-element-wrapper" style="margin-left:13.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:6.667%;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Calibri;font-kerning:none;min-width:3.8457544394060026%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">b.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Psychiatry: Members will be offered an appointment time that occurs within [**] ([**]) days from the date of request, [**]% of the time, excluding markets with less than [**] visits per month .</font></div></div><div class="item-list-element-wrapper" style="margin-left:13.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:6.667%;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Calibri;font-kerning:none;min-width:3.8457544394060026%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">c.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Provider satisfaction measure: Provider will maintain a patient rated score of their satisfaction with the therapist, or Psychologist for therapy, and Psychiatrist for medical visits at an average score of [**], out of a [**] ([**]) point scale.</font></div></div><p style="margin-left:3.333%;font-size:10pt;margin-top:10.9pt;font-family:Times New Roman;margin-bottom:0;margin-right:6.704%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">With respect to Urgent Care/Acute Care Visit Wait Time SLAs, and Behavioral Health measures, Monthly Data and Requirements, the parties agree that any performance impacts as a result of system performance shall be based on the system performance SLAs captured in Schedule III of the Statement of Work between Elevance health, Inc. and American Well Corporation effective January 1, 2026.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.639%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">For clarity, Members seeking on demand urgent care, who choose to wait for a provider with a specific attribute, are not counted in the SLA.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img83973382_1.jpg" alt="img83973382_1.jpg" style="width:300px;height:16px;"></p><p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.722%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">The parties will work towards finalizing new reporting requirements and appropriate additional SLAs for all lines of business consistent with industry standards for urgent care and behavioral health to be finalized by amendment no later than 3/31/26. Topics to be discussed will include the following for urgent care:</font></p><div class="item-list-element-wrapper" style="margin-left:5.87%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.13%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Calibri;font-kerning:none;min-width:4.3875491341761395%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">i.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">patient issues resolved via the first virtual care visit</font></div></div><div class="item-list-element-wrapper" style="margin-left:5.463%;display:flex;margin-top:0.05pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Calibri;font-kerning:none;min-width:4.799179157366956%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">ii.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">appropriateness of follow up visits within [**] hours</font></div></div><div class="item-list-element-wrapper" style="margin-left:5.065%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.935%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Calibri;font-kerning:none;min-width:5.198293569284246%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">iii.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">percent of incoming patients navigated to an ER by the treating doctor</font></div></div><div class="item-list-element-wrapper" style="margin-left:5.065%;display:flex;margin-top:0.05pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.935%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Calibri;font-kerning:none;min-width:5.198293569284246%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">iv.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">repeat visit rate within [**] hours</font></div></div><div class="item-list-element-wrapper" style="margin-left:5.463%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Calibri;font-kerning:none;min-width:4.799179157366956%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">v.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">usage of the ER by patient&#x2019;s after [**] minute wait time for LiveHealth Online</font></div></div><p style="font-size:10pt;margin-top:0.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img83973382_2.jpg" alt="img83973382_2.jpg" style="width:212px;height:16px;"></p><p style="margin-left:3.333%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:6.63%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Provider agrees to provide monthly and quarterly supporting reporting for all provider access requirements, subject to audit by Anthem.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.63in;min-height:0.81in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="margin-left:0.453%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Certain confidential information contained in this document, marked by [**], has been omitted because American Well Corporation has determined that the information (i) is not material and (ii) is the type that American Well Corporation customarily and actually treats as private or confidential.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>img83049861_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img83049861_0.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  4 .X# 2(  A$! Q$!_\0
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MK>+/C1\//BW\$/ /B/5@SZQJEAI/A76/B'\;/$TEQ(F;NV\6^-M3\$V!O(F
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MXBZ3J/CA?"6N>'--\%:UKC^&O%;:9X2N-+O?B'XQD\'27EWHOB"-]8>WDTX
M^9/CM_P;&?L%?$[XW_&3XE:_\6_VN[37?B'\5?B'XYUJTTCQ[\&K?2;75O%G
MB[5]?U&WTN"]^ 6H7D&G07FH3164-W?WMS';+$D]W<RJ\S_L=_P2,_X(!?\
M!/W_ ()\Z_HW[4'PNTKXI?$KXZW6D^)-%\/>/?C=XNT#Q1<^ +"_U#5="U<^
M!]%\(^#/ ?AO2]2UG2(AIE[KU]H^JZ_#IT^H:=IFJ:?8:MJUM?%% 'Y8_P#!
M?3_@@Q^P9K7C^S_:Z\+V'Q.^%/Q*^.WQ&U=_BCH/PS\2^%M*^'GB3Q+>:5>:
MWK/CE?#&O^!O$LVD>+?$6IQ-?^(KC1=5T_2-8U*ZU#6;O1GUO4;_ %*X_7S_
M ((S?\$L_P!G/]B#]@GQ3H_PB\2_&G6/^&M? $7BGXIW?Q ^(%OKT5IJ5[X4
MUC0%/@KPUI7A_P />!O#$MOINIS0R:M%X4NO$6LQVNDVWB76M<LM#T:UL"B@
M#+_X(>?\$J?V>O\ @FAI_P"U-:? GQE\9O%D?QN'P?\ ^$K;XM>(?!&NOI__
M  K^#XK1:-_PCQ\'?#OP&MI]I7QSJQU/^TEU;SC;Z=]E^Q"&Y%WRG_!$?_@D
M+^S+_P $X?$7[25]\&?%?QE\=)\:?"?@/PWXQTWXS:[X \3:6-*\.7WBZ:V@
MTZT\*?#3P+M%\/$-_!JD>IR:I;W-NL,4<$&)FF** /Q$_:I_X-KO^"=%M_P4
MV^&_PD\)7GQ]^'WPI^,^OZ3XBUCX>^$/'_A)=!\*1:U<:A<WWASP/=^(OAQX
MB\1Z7X<+V?EVMKJNNZY?Z?;W$UO8:E;0Q626G[ ?\$9?^"+7[*O_  3>_:M^
M*_QF^ _C7X\Z_P"(?%WP8\4_#"\T7XG^*_ 6O^&M/\-ZI\2/AYXJ=]+@\-_#
M+P?K2ZG;7W@_2[2UNM0UW48OL$MZES;7-W+#>6Y10!SW_!9W_@AK^QW_ ,%!
MOVH?"W[0/Q;\2_''P-\0#\)- \#ZL_P@\3?#[0-)\26/AKQ!XGGT?5M>M/%W
MPO\ '5U=>(+6TU8Z-_:%M?V<<FC:;I%D]J38)*WZ_?L??L8_!W]EW_@G3X&_
M8X^%A\36_P +-%^#'C#PN-4U>^T>Z\;:FWQ#A\1ZUXM\1ZMJMAH.F:+<^)-4
MUCQ1JVI-=1>';?3XIY88HM,6S@CM@44 ?GO_ ,$8O^"0_P"RO^P3X#_:\^'?
MP\U'XF_%?P3^TOI_PZ\/_%/PS\>]2\ ^,M&U3P_H&D?%#17T&'3O#/PY\#V<
MVD:]I?CO7+'Q%8ZS!K$.H6WV6&(6L:W2W7\YG[='_!N%_P $_P#X:?MR^$?A
M7\.?$7[1G@OX>?$_5_">HW'A?3/B!X*U*V\(6_B_Q$UE>:-X/U#Q-\,->UN/
M2M.MVV:3_P )/JGB?4H=J_;=1OP,444 ?U]:/_P2\_9,_9W_ .":'QL_X)[?
M!/PSX@^'GP-^(/P:^+'@OQEK.DZS:WWQ-\1WOQ(\'W_A_P 7^/M8\6:]I.KV
M>I>.]1M)D:"_OM"N-#TM+/3=)TOP]9^'=,L-%M_,?^")O_!.[X*_\$W/V>?B
ME\)?@=XH^*/BKPYXV^,][\1=5O?BOK?A/7-;M];N? _@SPT]KI]SX0\$^!;"
M+2A8>';*5(+G3;N[%W+=2&^:%X8("B@#XL_X.'/^"07['?[9/PT@_:Q^(FE^
M.?"'Q[^&MGX=\$0>//AEX@TC0KGQAX.N=8N!8^'?'.G>(/#7BK2=9MM N-4U
M"ZT+4K.RTK7[1KI[*;6+K28X-.B_'_X=_P#!KU_P3VU;X8_LT_$G_A97[6NG
M^)O%/@30_'7B!['XB?"EK+4==G\3ZI*A:TU#X'WXM;.U@L[6QM[>P>U+6L(>
MZDN;YY;R0HH _7S_ (..O^"4G[*_[9GPI\(?M0?$Q?B#X:^-'PA_L/X::+XJ
M^'?B'1-(_P"$A\">(_$ES?KX<\76'B'POXJL]1M= U34=8U3P[<Z=%I&HV=W
MK6J)=7E]931VD/[K?L7>![+X9?L@?LM_#?3-6UG7=+^'_P"SW\'O!.E:OXB?
M2Y->U#2_"O@#0-"TVYUB71-*T/29=1>QL+?[7+I^CZ;;2S!Y([2$-L!10!^(
MO[-?_!'']F3X.?\ !8_X@_\ !0OPQXZ^.]]\:/%?Q4_:1\<:CX8U[Q/\/[KX
M7PZM\8-+\<6/B:WLM%T_X8:7XKCTZQB\37[:%#/XUN;FVDAM#J%WJ:QS)<?1
M_P#P6^_X)H_ G_@I7\,O@7X+^.OBSXM>%-+^&/COQ/XGT&X^$VN^#M"O[N_U
MKP_:Z5=0ZO+XP\!^.[>XLX[>!'MX[*UT^9)BS27$J$1@HH ]T\0_\$M/V2?V
MD/\ @F?\#O\ @GO\;O#7B#X@?!'X;_!WX2>$? NOZIJNGVGQ2\*ZC\-O!5EX
M9\)_$'0O%ND:)IUAI7CZSTP7,-WJ-AX?M]%U2UU/6-'U+0+KP]JVH:-<?QY_
ML0?\&\'[$'B__@H#/\,-?^(7[4EQX6^%_BCQ?X@T0Z;\3?!OAG7;Z\^''B2V
M.@)?^)O"WPOT37].+R0Q3W6H^$=0\,:[;W,<=SHVK:3<1QR*44 ?UD_\%FO^
M"77[*'_!13]EFXM_V@-$\60>*?@!H?B+Q7\)?B7X(\1Q:5\0_"DT]A8#7=&_
MMGQ#I?BG3]<T#Q5'HNDKXBT_Q'I&KR74^G6>IVES8ZQ;QZBO\J7[-W_!LO\
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M:Z)XGMK:QU%C#H2:AXPU.6ULL1ZA-JD_^DT44 )\ _\ @D;^S?\ "S_@LO\
M$O\ X*(^'_&WQNO/C5XR\5?&77-4\+ZSXD\!W'PN@N_B'X6U+1-:CL-$LOAK
MIWBR*WM;2\EDTM+CQM=2P7"QO=S7L8:)OS^_95_X-^/V!8O^"GG[=,&H2?&_
M6_#VEV,NKZ'X3U'XBZ9;:+H=Q\4O$7AOQUJT5E>:)X0T?Q/<VVB7OF:/X=36
4/$6J21:)*ZZU+KFKK%J\110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>img83049861_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img83049861_1.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  < F # 2(  A$! Q$!_\0
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M>$]8\221B2]N4\?^%K3P)XXUV[FBB47'B+6(&N&CL9KYOXQ_^"(__!&G5/\
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M'_P3^,GA;2KV32M5TW7KGP'K1L-1-E;602Z\->*_#9TCQKX7BO=%]X_X.T=
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M9]1::(6:S&1 WE__  3Y_P"3"/V(?^S0OV:O_5,^"Z_S?/\ @Y<\)>)/'_\
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M>(+#3O 'C"_\6:%=:!>$17.HQV]NVFW!"32PR'%?RY?\'!'_  4B_:"\<?\
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MK];[6?@[%XQU_4DC\^*R^$GB'Q%K&HE;6\FU2X<G]^?VE?\ @JG8_P#!6_\
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M&GPZ\7>+]#\0WUB);G[?I/@]V1(+)YX?R3U3_@V]_P""[?\ P3Y_:2\=7?\
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MTZ;PU)J6KW&K+'IVD0ZQX8GU?PW9^*]6_;C_ ((1?LH_\%R/@A\2?C]\6/\
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MFI1>,-(^+/QE\7WMO;Z;J,,DUQ8KHOC;0I([Y&$4EQ+<VX&^V<G[>_X.8O\
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MVT6^\!+J'B:_M-!UBPTW3]1U'5;36AXFL=2\/:7:W']#-% '^99XN_X(N_\
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?Z#8Z1XL\;^)=<M/%4%@MW>6UIKEXFG^5_H344 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>img83049861_2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img83049861_2.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  < :D# 2(  A$! Q$!_\0
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M1\0?V /^#BG]L#]K7X6_#"R^,OCOX4_M]_\ !0]=#^&^HR:W%9^(AX[\7_M
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M+?!CPUXYL=7DF-M'I=YX3UGQI9:]:ZB]P# MC/81W+3 Q"(O\M?A7_P<H_\
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M+^QN(KNROK*[_9]^*,]K>6=U \D%S:W,$D<UO<0R/%-$Z21NR,K'\M?V_O\
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M[0'AO]H;3/AS<2>$(81J$5]=W7Q'\,+JE@S^;I237;SEA9R9_MPHHH _B/\
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M]C/JFMRP:AK@MH_Z;/\ @J)_P;_7W_!1_P#X)Y?L7_#JQ\3>%?A9^VU^QU\
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M$'_!"_4/C3_P0 ^"G_!+#]L:;2OAY\:_ANGQ!\5^'/'?@V[L/'EK\*OBS/\
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GE-J"K::E:6$<^G/_ ',_\.[/V:?^@'XE_P#"NUS_ .2Z^Z:* /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>img83973382_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img83973382_0.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !: P<# 2(  A$! Q$!_\0
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M:-_PL6S\)W'@2;Q'J?\ PC-OXBE\066H:;: 'W_1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%> ?'3]K']EC]E_\ X1;_ (:7_:6_9_\ V=_^
M$X_MO_A"O^%Z?&3X=?"3_A,/^$9_LC_A)/\ A%O^$_\ $?A__A(/^$?_ .$@
MT'^V_P"R?M?]E?VWI'V_[/\ VE9^< >_T5\ ?\/8O^"67_22S]@#_P 3(_9U
M_P#GC5]O^$_%GA7Q[X5\,^.O OB;P_XT\$^-/#^C>+/!WC'PGK.G>(_"OBSP
MKXCTZVUCP]XF\,^(='N;S2->\/Z[I%Y9ZIHVLZ7>76G:IIUU;7UC<SVT\4K
M'04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MBW7=!\7_  +\?Z3I'[/OB/PIXQ\ Z)X]O_#DFIWEGH7A< _K]HHHH **\_\
MBE\6/A9\#O FN_%+XU_$OX?_  ?^&7A?^S/^$F^(OQ2\9>'/A_X$\._VWK&G
M^'=&_MWQ=XLU+2/#^D?VOX@U?2M"TS^T-0M_M^L:GI^F6OFWM[;02_,'A/\
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MMX3\"^(=0\,WVL?M*Z]I%GX@L](UV\N-&NM4T/6=.M]1CMIK[2M1MDELYO\
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MZ_K\ ?\ @Z._Y04?MS?]VS?^MA_L^T ? '_$:M_P2R_Z('^W_P#^&L_9U_\
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M&_MWPCXL\:Z1X@TC^U_#^KZ5KNF?VAI]O]OT?4]/U.U\VRO;:>7Z_H ****
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M^(WPU^-M_P#M >#M,M=2TOXBP:WXIT+P)X<UCQ9XB\ +\.O$6I^ ]&^*NO\
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M?D"O[O/A;_P8Z?%/5_ FA:A\:_\ @HE\/_A_\3;C^T_^$F\(_"W]G'Q'\8/
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M]VS?^L>?L^U\ ?\ !)W_ )2F_P#!-/\ [/\ _P!C?_UHKX<T ?[?-?R!?\'
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MSW,\LK 'K_[2_P"U5^T=^V1\4]6^-?[4?QH^('QQ^)NK_;X/^$F\?Z_=:O\
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MJ/\ PBOP_P#"O]HV*:AJ"6.HZQK.L:CH7@OP7H7BKX@>*O"?A/7?ZO?VE_\
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M_P"*?B?X*?\ !-[XM?$#]G+]D7POYGAW_A;'@H77P_\ CM^T/K&F>(]%UO\
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MY_P5B_Y19?\ !2S_ +, _;(_]9U^(U?X@U?[O/[6/P+_ .&H/V6/VEOV:/\
MA*?^$'_X:(_9_P#C)\"_^$U_L3_A)O\ A#_^%M_#KQ'X _X2G_A'/[7\/_\
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MXIZ3\:_V7/C1\0/@=\3=(^P0?\)-X U^ZTC^W='L/$>@^+/^$1\:Z-F7P_\
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M%7QT_P"$U_X:(_X5)_9?_"3?#KX5> /^$6_X1S_A1GQ-^V_8O^%9?VM_;?\
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M\H5?N]_P;1_ '3OV@_\ @M)^QII?B7X>^(/'_@GX5^(/''Q^\52Z-#XJ33O
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M'_B"+5? WQ%\.:?XAU?_ (13QWX=\1>&;J]EO=(N<?B!_P '4_['7CO]KO\
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MW_\ 8?B.PUG2KOX-77V72/%+_P (= 'W_P#\$G?^4IO_  33_P"S_P#]C?\
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M;[_@K%_RBR_X*6?]F ?MD?\ K.OQ&H _Q!J_O\_X,8_^<HO_ '9-_P"_<5_
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M[55?Y@E?[_%% '^ /17^_P 44 ?XLW['G_!$#_@J-^V]XJ\":/\ "/\ 8_\
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M>?!3QS_JMT44 ?Y O_!T=_RG7_;F_P"[9O\ UCS]GVO@#_@D[_RE-_X)I_\
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M@&SU?0?$&A:O9V>J:-K.EWEKJ.EZC:VU]8W,%S!%*H!_CB^-O^"=7[7'PO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
)HHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>img83973382_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img83973382_1.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !C!U,# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M="_9\O/#]Y'H5\OA/Q99_$^?PKX]GGT:U\"ZSXCN?$?AZ'5 #^[S_@S_ /\
M@H%XJ_:E_8,\=?LI?$:?Q!KGC;]@OQ!X0\)^&O&.JR:CJ4&K_ +XO)XRUCX0
M>&;KQ#KOC/Q#J^H>(/AIJ_@;XE> M/T:P\.>#O!?@WX-:+\%/"WA>VU.YTW7
MY;3^MVOQA_X(<?\ !(KPK_P2#_9'F^%%]XB\/_$?]H/XL^(+/XC_ +1?Q3T/
M0-.T_3K_ ,51:)9Z3H?PQ\#:U-H>D^-M9^#_ ,*[9-4C\$MXZN)=1U/Q5XK^
M)/Q$L_#_ ,/H_B/<?#[PU^SU !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !7\ ?\ P?.?\XNO^[V?_?1Z_O\ *_@#_P"#YS_G%U_W>S_[
MZ/0!_ '7^GW_ ,&5/_*++X^?]G__ !3_ /6=?V5:_P P2O\ 3[_X,J?^467Q
M\_[/_P#BG_ZSK^RK0!_7[1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\0>+/^"FW_!-O
MP%XJ\3>!?'7_  4&_8@\%^-O!?B#6?"?C'P=XL_:O^ WASQ5X3\5>'-1N='\
M0^&?$WA[6/'UGJ^@^(-"U>SO-+UG1M4L[74=+U&UN;&^MH+F"6)?M^O\0;_@
MK%_RE-_X*6?]G_\ [9'_ *T5\1J /]?K_A[%_P $LO\ I)9^P!_XF1^SK_\
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M>$M&\,_$_5]1EUR#_.CHH _W6?V0_P!M#]F#]O3X-67Q_P#V1_B_X?\ C/\
M"F\\0:]X3E\0Z-9>(-"U'1?%7AJ>*+6/#/BSP=XQT?PYXV\%^((+:ZTS6[;1
MO%WAS1-1U+PKKOAGQ?IEM>>%O$_A[6-3^GZ_S9/^#-+]@3XR^./VH/'O_!1B
M7Q1X@\$_L^?!7P_X_P#@#8V?A;X@P:-/\;/C+XO\/^#-4U3X>^/_  +9Z=JE
MSXJ^#_P\\$^)]'^)FJ0^(;WPA ?C*/@1KW@ZX\82>"?'5CX:_P!)N@#^ /\
MXCG/^L77_F[/_P"2/7T!^R=_P>4_\-0?M3_LT_LT?\.X_P#A!_\ AHC]H#X-
M_ O_ (37_AK[_A)O^$/_ .%M_$7PYX _X2G_ (1S_AE[P_\ \)!_PC__  D'
M]K?V)_;VB?VK]D^P?VOIOVC[9#_G!U]__P#!)W_E*;_P33_[/_\ V-__ %HK
MX<T ?[?-%%% !1110 445^8'_!9/]NG1_P#@G;_P3C_::_:-_P"$S_X0SXFQ
M?#_6OAU^SI<V<7@34_$=]^T=\2-+O_#/PBG\.>$_B)?6WA_QM_PA/B"Y_P"%
MJ^-?#OV#Q+=0_"SX?^/_ !)_PB/BBR\/WVC78!_/#^VM_P 'D'A7]E3]KC]H
MW]F/P=_P3\\0?%;2/V>OC!XX^"EY\0_$W[3&G?"W4?%/BKX8:W=>#/'6H6W@
M?2_@5\5+;2?#Z>-M&\0VGA.ZE\;7^HZ_X5MM&\1:QI7A35]6OO"6A_,'_$<Y
M_P!8NO\ S=G_ /)'K^ .B@#_ %NO^"(7_!Q!X$_X+&?%/XX?!34/V>?^&9/B
M;\+/A_X=^*7A'PS_ ,+9UCXT?\+*\"-XCD\)_$77?[9@^"?PP\/^#?\ A7?B
M#7OA;I_]F:GJNHZQXN_X6+]JT+3Q9>$?$5S#_1]7^)-_P2%_:\T[]A#_ (*7
M?L<?M2^(;WP_I/@GX>?&#3=&^*.N^)M!\5>)].\,_!KXJ:3JWP@^-'BRVT#P
M3*OBG5/$'A/X4^/?&/B3PG;:/:ZS.?%6EZ,\OAGQ5;)/X:U7_;9H **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBOR@_P""W'[>6H_\$X_^":/[27[2
M/@[6O#^D_&1/#^F_#'X 1:SXA\*Z-J,_QE^*FK6O@[PYX@\)Z/XOT'Q7I'Q!
M\0?";2-0\0_':Y^'$OAG68/%WA7X5^)K+6%TGPVFM^(=' /\P3_@O]^WEJ/_
M  4%_P""HW[1?Q,L]:\/ZW\*?A%X@U#]F;]GR\\)^(?"OC3PK?\ P:^#'B;Q
M)I>G>,?#/CKPIH.AVWC'P_\ %[QMJ7CKXWZ-J-]<>)Y](T[XF6WA#2_&'B+P
MMX:\/7Q_('PGX3\5>/?%7AGP+X%\,^(/&GC;QIX@T;PGX.\'>$]&U'Q'XJ\6
M>*O$>HVVC^'O#/AGP]H]M>:OKWB#7=7O+/2]&T;2[.ZU'5-1NK:QL;:>YGBB
M;GZ_I>_X-3_V#=._;'_X*C>$OB9XZT7Q!>?"G]B7P_;_ +3.HWEMX>\53>%=
M3^,NA>)M%TO]GSP=K/CKP]KWARV\%^((/&UU>?&_PSIVJ7&O0?$#3O@+XL\(
M7W@_6_"UYXKOM$ /Q _;6_9?\5?L5_M<?M&_LH>,7\07FK_ /XP>./AQ9^(?
M$W@O4?AYJ/CKPKH6MW47@7XG6W@[5+[5KG1O#_Q4\$OX>^(_A-8M9UW3KWPK
MXIT;4M'\0:]I%Y8ZQ>\!^SU\:_%7[-?Q]^!_[1G@73_#^K>-O@#\8/AI\:_!
MVE^++74;[PKJ7BKX5^--%\=>'M/\36.CZKH.KWGA^\U?0K.WUFUTO7-&U&XT
MZ2YAL=5TZY>*\A_K]_X//OV#=.^%?[4'P0_;]\"Z+X@&D?M4^'[SX8_'*\MO
M#WBJ_P#"ND_&7X*^'_#.E_#[Q!K/CJ^U[5O#>C>(/BI\&WL_#'AGX<:7HG@^
M!]._9Q\6>-;%?%6KZSXUOM&_BBH _P!YC]GKXU^%?VE/@%\#_P!HSP+I_B#2
M?!/Q^^#_ ,-/C7X.TOQ9:Z=8^*M-\*_%3P7HOCKP]I_B:QT?5=>TBS\06>D:
M[9V^LVNEZYK.G6^HQW,-CJNHVR17DWL%?QQ?\&8/[7FH_%[]@SXW_LC^([WQ
M!J6K_L=?&"SUGP=+<Z#X5TWPKH?P:_:43Q-XQ\/>$]&UC1Y8/$GB/Q!:_&3P
M7\?_ !=XFN?%^F33Z;IWC?PGIFB>)M5TBWB\/>#O[': "OQA_P""NO\ P7'_
M &1_^"0?A7P[8_%>+Q!\6?V@_B/X?U_7/A9^SG\.+S1(O%5_IVGZ=KD.B^.?
MB=KFK7B6WPK^#^L^-M)M_ J^-I-+\5^*M3U&7Q!>?#OX;?$>/X??$&W\-?H_
M^U5^TO\ "S]C?]G'XT?M1_&O5O[(^&7P.^'^O^/_ !-Y%_X<L-8UW^R+4_V-
MX*\(_P#"6:]X7\/ZG\0/B!X@ETKP-\.O#FH>(=(_X2OQWXB\.^&;6]BO=7ML
M_P"(+^U5^TO\4_VR/VCOC1^U'\:]6_M?XF_''X@:_P"/_$WD7_B._P!'T+^U
M[H_V-X*\(_\ "6:]XH\0:9\/_A_X?BTKP-\.O#FH>(=7_P"$4\">'?#OAFUO
M9;+2+; !_0]^U!_P=]_\%:?C/XJ2\^ ^N?!_]CSP3I/B#QI<Z)X>^''PN\(_
M%3Q5K?A77-1L9?"&C?$[QC\?]'^)>D>(?$'@;2-/-BOB;X;>!?@WIWB74=9\
M0:IJWA-+:3PYH_ACP#PG_P '4_\ P7&\.>*O#/B'6/VN?#_CW2-!\0:-K.J>
M!?%G[-W[,MGX5\::=I>HVU]?>$_$UYX%^$7@OQM:^'_$=M!+H^LW/@[QCX3\
M50:=>7,OA[Q-H6KK9ZI:_P \-=!<^$_%5GX5T;QU>>&?$%KX)\1^(/$WA/P]
MXQN=&U&#PKKOBKP7IWA/6/&/AG1O$,MLND:IX@\)Z1X]\"ZIXFT:QO)]1T'3
MO&GA.^U2VM;;Q'H\MX ?U^_\%C_^"X_P:_X*]?\ !$WX$:7JD7A_X5_MH?"O
M]M_X077QX^ ]K>3IIVJZ<G[/G[3VDGXU_!0:M>7FKZ]\']>U>\L;/5=*O+[5
MO%7P:\5:MI_@7QUJ&LZ=K/PV^)/Q4_CBHHH _P!/O_@RI_Y19?'S_L__ .*?
M_K.O[*M?U^U_(%_P94_\HLOCY_V?_P#%/_UG7]E6OO\ _P"#D7_@I=_P[D_X
M)Q^/?^$ \6?\(_\ M-?M0?VE\ OV?_[(UW^RO&/A?_A(-+E_X6M\:M$_L7QY
MX'^(&B?\*D^']Q>_\(M\1_!7_"0?\(%\=O&'P+_X2/1IM%\02[@#Y _X+ ?\
M'4O[./\ P3\\=_$G]E_]F;P#_P -4?M6^!/M7AKQ9K,^NVNC?LX_!SQW-H_B
MRVN?#_B[Q-HUU>^+?B;\0/AEXMLO!Z?$7X2>#K'PIHZVNL>(O!>H_'7P)\4O
M!OB;PGI'\@7Q2_X.P/\ @MK\0/'>N^+O"?[1OP_^!WA_5_[,_L_X6_"W]G?X
M'ZOX$\+_ &#1]/TRZ_L+4/C7X(^,'Q-N/[;O;*Y\1:G_ ,)-\1?$7E:QJ^H0
M:-_9'A^+2M"TS^<&B@#^GW]FC_@[B_X*]?!_XIZ3XL^.GQ(^'_[6_P ,F^P:
M?XI^$GC_ .$WPG^%OVC1SXCT'4M;U/P5X]^!?@'X?^(/"_Q E\/Z9J_AGPYK
MOBFV^(W@31/^$DO=9UOX6^+[W3](CLN _P"#FW]NG]G'_@HO^U_^RA^U!^R_
MXS_X2KX?^*OV /AAIFLZ-J<5KIWCOX8^.]._: _:<N?$WPM^*7AFVOM1_P"$
M5^('A7^T;%]0T]+[4='UG1]1T+QIX+UWQ5\/_%7A/Q9KO\\/B;PGXJ\%ZC;:
M/XQ\,^(/">KWGA_PGXLL]+\3:-J.@ZC=>%?'OA71O'7@7Q-;6.J6UK<S^'_&
MG@GQ'X>\8^$]9BB;3O$?A77=&\0Z/<WFD:I8WD_/T %?[?/_  2=_P"467_!
M-/\ [, _8W_]9U^'-?X@U?[?/_!)W_E%E_P33_[, _8W_P#6=?AS0!_/#_P<
M+?\ !PM^VA_P29_;0^&/[.?[.?PQ_9@\:>"?&G[,'@OXUZIJGQK\%_%;Q'XJ
MM_%7B/XK?&KP+?:?I]]X%^-7PXTB+P_%I'PXT.XM;6XT.ZU%-1NM5FFU6>VG
ML[.Q_"'_ (C5O^"IO_1 _P!@#_PUG[17_P!%51_P>K?\I3?@'_V8!\+/_6BO
MVJJ_D"H _P!KG_@C/^VM\4_^"B7_  38_9P_;%^->@?#_P +_$WXP?\ "X/^
M$FT+X6Z5XCT3P)8_\*_^/7Q1^%NC?V%IGBSQ7XV\06WVGP_X)TJ\U/\ M#Q/
MJ?G:Q<:A<6OV*REMM/M/X0_^(U;_ (*F_P#1 _V /_#6?M%?_155_7[_ ,&N
M/_*"C]AG_NYG_P!;#_:"K_(%H *]@_9Z^-?BK]FOX^_ _P#:,\"Z?X?U;QM\
M ?C!\-/C7X.TOQ9:ZC?>%=2\5?"OQIHOCKP]I_B:QT?5=!U>\\/WFKZ%9V^L
MVNEZYHVHW&G27,-CJNG7+Q7D/C]% ']?O_$:M_P5-_Z('^P!_P"&L_:*_P#H
MJJ_N\_X(S_MK?%/_ (*)?\$V/V</VQ?C7H'P_P#"_P 3?C!_PN#_ (2;0OA;
MI7B/1/ EC_PK_P"/7Q1^%NC?V%IGBSQ7XV\06WVGP_X)TJ\U/^T/$^I^=K%Q
MJ%Q:_8K*6VT^T_Q1J_U^O^#7'_E!1^PS_P!W,_\ K8?[05 '@'_!R%_P6K_:
MG_X(^?\ #&G_  S1X!_9_P#''_#1'_#1'_":_P#"]/"OQ%\3?V7_ ,*D_P"%
M&?\ "-_\(M_P@'Q5^&7V+[;_ ,+-U[^V_P"UO[;^T_9-(^P?V;]GO/M_\P/_
M !&K?\%3?^B!_L ?^&L_:*_^BJK[_P#^#YS_ )Q=?]WL_P#OH]?P!T ?[#7_
M  ;T_P#!4#X^_P#!6;]B_P")W[1G[1GA#X/^"_&W@O\ :?\ &GP4TO2_@IH'
MC3PYX5N/"OASX4_!7QU8ZAJ%CXZ^('Q'U>7Q!+J_Q'URWNKJWURUTY].M=*A
MATJ"Y@O+R^_=ZOY O^#*G_E%E\?/^S__ (I_^LZ_LJU^SW_!:7_@IAIW_!*/
M]@SX@?M/6>B>'_%_Q6U3Q!X=^$G[/G@7Q8OBI?"OB_XR^-DU.^TZ/Q->>%--
MNKF#P_X+\$^'/'7Q2UG3;[6/!,'C/3O 5S\/=+\>^$_%/B_P]JD0!P'_  5U
M_P""X_[(_P#P2#\*^';'XKQ>(/BS^T'\1_#^OZY\+/V<_AQ>:)%XJO\ 3M/T
M[7(=%\<_$[7-6O$MOA7\']9\;:3;^!5\;2:7XK\5:GJ,OB"\^'?PV^(\?P^^
M(-OX:_A"_:@_X.^_^"M/QG\5)>? ?7/@_P#L>>"=)\0>-+G1/#WPX^%WA'XJ
M>*M;\*ZYJ-C+X0T;XG>,?C_H_P 2](\0^(/ VD:>;%?$WPV\"_!O3O$NHZSX
M@U35O":6TGAS1_#'\P7BSQ9XJ\>^*O$WCKQUXF\0>-/&WC3Q!K/BSQCXQ\6:
MSJ/B/Q5XL\5>(]1N=8\0^)O$WB'6+F\U?7O$&NZO>7FJ:SK.J7EUJ.J:C=7-
M]?7,]S/+*W/T ?O]_P 11W_!=?\ Z/F_\UF_8\_^A]K^A[_@G[_P>GZ=XC\5
M0^!_^"E_[/OA_P !:1KWB".WTOX]_LK:=XJO/"O@O3M4U'P9I%C#\1?@CXZ\
M6>-/&UUX?\.6T_CSQGXN^(7P]^(?BSQ5/IUGX=\)>$_@#KNKM>:Y=?P!^)O"
M?BKP7J-MH_C'PSX@\)ZO>>'_  GXLL]+\3:-J.@ZC=>%?'OA71O'7@7Q-;6.
MJ6UK<S^'_&G@GQ'X>\8^$]9BB;3O$?A77=&\0Z/<WFD:I8WD_/T ?[['A/Q9
MX5\>^%?#/CKP+XF\/^-/!/C3P_HWBSP=XQ\)ZSIWB/PKXL\*^(].MM8\/>)O
M#/B'1[F\TC7O#^NZ1>6>J:-K.EWEUIVJ:==6U]8W,]M/%*W05_ER?\&I_P#P
M6"\5?L>_M0>$O^">WQ*/A^Z_9<_;+^,%O;:#JESI.HCQ5\+/VG_&GA_1? O@
M+6=&OO"_AW6]7\3^'_C/J_AKX<_!WQ-X9\3I!X?\)ZC<^$_B;8>+/ >A^'/B
M;9_$+_4;H _SH_VW?^#NO_@I)^S7^VA^UW^SGX%^"7[$&K>"?@#^T_\ 'WX*
M>#M4\6?#;X\WWBK4O"OPK^*WBSP+X>U#Q-?:/^TKH.D7GB"\TC0K.XUFZTO0
M]&TZXU&2YFL=*TZV>*SA^8/^(U;_ (*F_P#1 _V /_#6?M%?_155^ /_  5B
M_P"4IO\ P4L_[/\ _P!LC_UHKXC5\ 4 ?W^?\%KO^#M7QWX-^*?B?]F;_@DY
MXE^'\OA_P9YFA>/_ -M"_P##>C_$C^WO'>F>(]%O;S3_ -FC1_$9U?X9:O\
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M_;Q_X)4?#+Q9\7O&?Q ^)7QM^!'Q ^('[-_Q;^)/Q%BT>36/'6L>#I-'\<^
M]8@US3;ZZU/QC]@^"7Q*^%?AGQ%XW\9VUAX[\5^.] \7:SXKD\1ZG=2>-O%
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M_@RI_P"467Q\_P"S_P#XI_\ K.O[*M?Y@E?Z??\ P94_\HLOCY_V?_\ %/\
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M$?BS2%\/^/=(TNZUWP-XL\-^)?$?A77H+77- 368/&W@OQ[X5\*_XDU?;_\
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MP5K&J:=I_BKX>:SXQL= ^'?@[Q[X)\"Z+T'_  ='?\H*/VYO^[9O_6P_V?:
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M6O'7B'3_  S8ZQJNO:O9^'[/5]=O+?1K75-<UG4;?3H[:&^U74;E);R;Z?\
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MZ=;>-_$/[1GA7Q[!!X/UC7/#/ARVA\0^"=4_&'_B*._X+K_]'S?^:S?L>?\
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M>(/AQXIE\7RZ=;>-_$/[1GA7Q[!!X/UC7/#/ARVA\0^"=4_&'_B*._X+K_\
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MM&>%?'L$'@_6-<\,^'+:'Q#X)U3\8?\ B*._X+K_ /1\W_FLW['G_P!#[7X
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M0M/[O*_R!?\ @UQ_Y3K_ +#/_=S/_K'G[05?Z_5 '^8)_P 1JW_!4W_H@?[
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M]/>^T[1]&T?3M=\:>--=\*_#_P *^+/%FA?3_BSQ9X5\!>%?$WCKQUXF\/\
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M8N;/2-!\/Z%I%G>:IK.LZI>6NG:7IUK<WU]<P6T$LJ_XHW_!6?\ X*!>*O\
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M5?B;]M^Q?\*RT'^Q/[)_L3[-]KU?[?\ VE]HL_L'Z??\%F?VUOBG_P $[?\
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M^'O#/AGP]H]M>:OKWB#7=7O+/2]&T;2[.ZU'5-1NK:QL;:>YGBB;GZ /M_\
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MI?\ !%+_ ()'_&#P)KOPZ\6?\$Y?V0-(\/\ B+^S/[0U#X6_ _P1\#O'=O\
MV1K&GZ[:_P!A?%+X*:7\/_B;X7\V]TRV@U/_ (1GQ=I']MZ/+J'AW6?M_A_5
M]5TR]_FB_;R_X,L/@UXLT[6O&/\ P3E_:"\0?"?QM=>(/$.LQ?!?]IG49_&G
MP:?3O$'BK09]'\)^#OBCX.\)R_%;X<>'_AQX6E\7Q:=<^-_#W[1GBKQ[/!X/
MT?7/$WARYA\0^-M4_"#]C/\ X.U?^"J_[,G_  COAGXP>)?A_P#MG_#+2/\
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M*O!&J:QXU\$>$_#WP^^(?BK4-.TO0+[QCHW@+P=\1/ OC;6OX@_C7_P=L_\
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MXS_X0?X)?%O^W/V;_COK,\7@2WT>V\"?%N.TMO"VL>+O$WC^^T?3/ GP_P#
MGQMT?X2?$[XB^-]-\0:)K&A>!/ _B)HY-;TRXU3PGXA_V.J_P!Z_VF?^"(_[
M>6H_\%'/^":/[-O[2/C'6O#^K?&1_#^I?#'X_P 6C>(?"NLZC!\9?A7JUUX.
M\1^(/%FC^$-!\*:1\/O$'Q9TC3_#WQVMOAQ%X9T:#PCX5^*GAFRT==6\-OHG
MB'6 #\H?^#R3XI>._A__ ,$C_#?A/PCKO]D>'_CC^U_\&OA;\4M/_LS1[_\
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M .-O[)OP_P##O[-_QG^&WA&+6-+UCX?:/\-9-8\#? 36/$6A^([Z_P!3NO\
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M31-,M]+\)^'@#\0:_P!OG_@D[_RBR_X)I_\ 9@'[&_\ ZSK\.:_Q!J_V^?\
M@D[_ ,HLO^":?_9@'[&__K.OPYH _@#_ .#U;_E*;\ _^S /A9_ZT5^U57\@
M5?U^_P#!ZM_RE-^ ?_9@'PL_]:*_:JK^0*@#_7Z_X-<?^4%'[#/_ '<S_P"M
MA_M!5^_U?@#_ ,&N/_*"C]AG_NYG_P!;#_:"K]_J /\  'K[_P#^"3O_ "E-
M_P"":?\ V?\ _L;_ /K17PYKX K[_P#^"3O_ "E-_P"":?\ V?\ _L;_ /K1
M7PYH _V^:*** /X _P#@^<_YQ=?]WL_^^CU_ '7]_G_!\Y_SBZ_[O9_]]'K^
M .@#_3[_ .#*G_E%E\?/^S__ (I_^LZ_LJU^,/\ P>X?&OQ5KO[:'[''[.=Y
MI_A^/P3\*_V8->^-?A[5+:UU%/%5YXJ^/WQ6\2^!?&.GZS?2ZK-I%QX?TW2/
MV:_ MQX9M;'0].U&SU'5O%DVJ:KK-M?:/9Z%^SW_  94_P#*++X^?]G_ /Q3
M_P#6=?V5:_ '_@]&^%NL>%?^"FOP6^)RZ%\0$\)?%?\ 9 \$P6WBSQ%J?CO7
M/ FH^._ /Q/^+&C>+/"/PZN?$VH:CX2\*_\ "*^$M1^&/B#Q=\.OAPNAZ/IV
ML>/H/B/X@\.Q^+?BOK/B;Q4 ?R!5_IM_\&H?_!'?X-? S]E_X7?\%-?BOX/\
M0:]^UC^T'X?\6ZA\+(OB/X/G\.P?L]?!J\\0>)?!VBZK\,='U;S+G4?$'Q^\
M$6-OX\;XUR0V<^L?!KQYX?\ !GP[M=(\':[\0?$/Q@_S)*_U^O\ @VG_ &Z?
M G[97_!*C]G'PG;>,_A_?_&W]DWX?^'?V;_C/\-O",6L:7K'P^T?X:R:QX&^
M FL>(M#\1WU_J=U_PLKX)>#O"?B:?QOHUS=>!/$_CN'XBZ-X9DT?4_!WB?P3
MX/ /V>^/WP!^#7[4OP:^(7[/G[0?P]\/_%3X-_%3P_-X9\=>!?$T,[Z=J^G/
M/;WUG<VUY8W%GJ^A>(-"U>ST[Q%X3\6>'M1TGQ5X-\5:3HWBOPIK.C>)-&TO
M5+3_ !9O^"IW[%/_  [M_P""@G[4/['5MK__  E'A_X/_$"#_A ]=GU7^V]8
MOOA9\0/#&@?%+X2_\)=J<?A3P397/Q MOAEXV\)V?Q%_L;PQIGAR'QW;^(K?
MPS]M\/Q:;J%W_M\U_CB_\'$?[=.C_M]_\%5_V@OB/X#\9_\ "<?!+X2?V'^S
M?\"-9@B\"7&CW/@3X21W=MXIUCPCXF\ 7VL:9X[^'_COXVZQ\6_B=\.O&^I>
M(-;UC7? GCCPZTDFB:9;Z7X3\/ 'X@U_NL_L1?&OQ5^TI^Q?^R)^T9XZT_P_
MI/C;X_?LP? +XU^,=+\)VNHV/A73?%7Q4^%/A/QUXAT_PS8ZQJNO:O9^'[/5
M]=O+?1K75-<UG4;?3H[:&^U74;E);R;_  IJ_P!QG_@F3X3\5> O^";?_!/G
MP+XZ\,^(/!?C;P7^Q!^RAX3\8^#O%FC:CX<\5>$_%7ASX#> ='\0^&?$WA[6
M+:SU?0?$&A:O9WFEZSHVJ6=KJ.EZC:W-C?6T%S!+$H!_CR_\%8O^4IO_  4L
M_P"S_P#]LC_UHKXC5\ 5]_\ _!6+_E*;_P %+/\ L_\ _;(_]:*^(U? % '^
MYS^PM^PM^SC_ ,$Z/V<?!G[+_P"R_P"#/^$5^'_A7S=3UG6=3EM=1\=_$[QW
MJ-K8VWB;XI?%+Q-;6.G?\)5\0/%7]G6*:AJ"6.G:/HVCZ=H7@OP7H7A7X?\
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MQMXT\'>#K;6=8EL].G\5>+/#/AZ*Y;5]>TNSNO[W/^#H[_E!1^W-_P!VS?\
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MF7T"B@ K_$&_X*Q?\I3?^"EG_9__ .V1_P"M%?$:O]OFO\0;_@K%_P I3?\
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M:>6)O\R3_@RI_P"4IOQ\_P"S /BG_P"M%?LJU_I]T ?XDW_!7K]D/3OV$/\
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M.C^(?#/B;P]K%M9ZOH/B#0M7L[S2]9T;5+.UU'2]1M;FQOK:"Y@EB4 ^G_V
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M>L](T'P_H6D6=YJFLZSJEY:Z=I>G6MS?7US!;02RKT'_ !!4_P#!4W_HOG[
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M%KFEVNLV]G)IUQJ.C:K8PW+W.G7D4/C] '^_Q17\T/\ P:Y_\%0_%7_!0_\
M8,U'X>?&_P ;>(/'W[4?['GB#2_AQ\3_ !CXLOM1USQ5\1OAGXQ36]8^!/Q.
M\3>(6\(:#I%YX@O-(T+Q?\*=96X\2>//B%K^H_!NY^*GQ,\02:Y\4+66[_I>
MH **** "BBB@ HHHH _E"_X.]_VZ=8_9A_X)Q^'OV<OA[XS_ .$7^)O[<'Q
MNOAUJ]M9Q>.]/\1W?[./P_TN'Q-\=)_#GBSPM?:1X?TC^U_$&K_!WX5>-?#O
MC"_U.U\>?"SXL>/_  W:^$=:LI=;UGPM_EB5_7[_ ,',7P&_X*)?MX_\%5_B
M;XL^$/[ W[7_ ,2O@E\"/A_\/_V;_A)\2?AU^QE^U%)H_CK1_!T>L>.?'FL3
MZYJ7@:ZTSQC]@^-OQ*^*GAGP[XW\&6UAX$\5^!- \(ZSX4D\1Z9=1^-O%'X
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MP]XWN=.B\7SP> O"O[.?B;7-'\'S6WB/QMXATO\ EB_X=._\%3?^D:?[?_\
MXAO^T5_\[FOI_P#8I_8]_P""N_[%?[7'[.7[5_@[_@FA_P %'[S5_@'\8/ _
MQ'O/#WAG]FO]IOX>:CXZ\*Z%K=K+XZ^&-SXQTOX5:M<Z-X?^*G@E_$/PX\6-
M+HVNZ=>^%?%.LZ;K'A_7M(O+[1[T _U6_P#@J=^Q3_P\2_X)]_M0_L=6VO\
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MB'XF?%S2?$?PQ^'NM>$/A_=7,'A_P7X)\.?#Z.%O&MQ#XT\4SZA<?$2^\/\
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M\4OAMX3A\1Z+\-4\6:U_D"_"WX3_ !3^./CO0OA;\%/AI\0/C!\3?%']I_\
M",_#KX6^#?$?Q \=^(O[$T?4/$6L_P!A>$?">FZOX@U?^R/#^D:KKNI_V?I]
MQ]@T?3-0U.Z\JRLKF>+^_P _X-?/^",G_!5?]C#X[6_[6WQT\5_\,I?LY?$C
MX?ZCI_Q!_9/\27L?B#XI_M VM[X.T[6/@[J?C_X=VJ7GA_X*_P#"!>(/'.K^
M(;+7?%.NZ5^T=X%\1^#/&OP<UOX6^&O!GQ:\8:M< 'G_ /P?.?\ .+K_ +O9
M_P#?1Z_@#K_1\_X/*?V3OVI_VH/^'<?_  S1^S3^T!^T1_P@_P#PU]_PFO\
MPHOX-_$7XM_\(?\ \)-_PR]_PC?_  E/_" >'/$'_"/_ /"0?\(_KW]B?VM]
MD_M7^Q-7^P?:/[-O/)_B"_X=._\ !4W_ *1I_M__ /B&_P"T5_\ .YH _O\
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MW@71=>U>S\/V>KZ[H>EW6LW%G'IUOJ.LZ58S7*7.HV<4P!_E25_?Y_P8Q_\
M.47_ +LF_P#?N*_D"_X=._\ !4W_ *1I_M__ /B&_P"T5_\ .YK^WW_@S6_9
M._:G_9?_ .'CG_#2_P"S3^T!^SO_ ,)Q_P ,@_\ "%?\+T^#?Q%^$G_"8?\
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MH*/VYO\ NV;_ -;#_9]K_(%K_8Z_X.//A/\ %/XX_P#!&/\ ;)^%OP4^&GQ
M^,'Q-\4?\,\_\(S\.OA;X-\1_$#QWXB_L3]JOX&^(M9_L+PCX3TW5_$&K_V1
MX?TC5==U/^S]/N/L&CZ9J&IW7E65E<SQ?Y8G_#IW_@J;_P!(T_V__P#Q#?\
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M>'/^%B_!WP#]E\.:=>VOB[_A%?%KZ?X6OP#^8*BO[_/%O_!M7^QM_P $G/\
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M;X[\?_VE\#?B!^T!^SEX:_X3KQ'X9_:C^"7@G5/&?@2^^%G@31])\3:SX_\
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MZ\JRLKF>( _QQ:_K]_X,J?\ E*;\?/\ LP#XI_\ K17[*M?@#_PZ=_X*F_\
M2-/]O_\ \0W_ &BO_G<U_4[_ ,&BG[$7[:'[-?\ P4D^-OCK]HS]D3]I_P"
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M-0\)?%/PIX<\6^-=,\!>/_"7_"6Z[/>_O]_Q&K?\%3?^B!_L ?\ AK/VBO\
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MO)80#_0<^+/PM\"?''X6?$OX*?%+0O\ A*/AE\8/A_XR^%OQ%\,_VGK&B?\
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M\[FOZG?^#13]B+]M#]FO_@I)\;?'7[1G[(G[3_P!\$ZM^Q!\2?">E^,?C7\
MOBM\*_"NI>*K[X\_LU:Q8^&=/\0^.O">@Z1>>(+S2-"US5+71K>\DU&XT[1M
M5OH;9[;3KR6$ _T7*_R!?^#H[_E.O^W-_P!VS?\ K'G[/M?Z_5?Y8G_!QY_P
M3V_;Z^./_!9S]LGXI?!3]A[]K_XP?#+Q1_PSS_PC/Q%^%O[-/QH^('@3Q%_8
MG[*GP-\.ZS_87B[PGX*U?P_J_P#9'B#2-5T+4_[/U"X^P:QIFH:9=>5>V5S!
M$ ?RA5_M\_\ !)W_ )19?\$T_P#LP#]C?_UG7X<U_D"_\.G?^"IO_2-/]O\
M_P#$-_VBO_G<U_L-?\$R?"?BKP%_P3;_ ."?/@7QUX9\0>"_&W@O]B#]E#PG
MXQ\'>+-&U'PYXJ\)^*O#GP&\ Z/XA\,^)O#VL6UGJ^@^(-"U>SO-+UG1M4L[
M74=+U&UN;&^MH+F"6)0#^ /_ (/'/^"?OBKX-?MM>%?V_P#P]!X@UOX4_MB^
M'_#OA/QUJEQ'J.I:=X ^/OP8\#Z!X%L_#,U]8^#-+\-^%?#_ ,0_@WX8\'>(
M/A[HVL>,_$_C3Q;XJ\$?'[5HK;2O"WAK2[.W_CBK_=9_;0_9#^#7[>G[+_Q?
M_9'^/]EX@O/A3\9_#]EHWB&7PGKT_AKQ5HNHZ%X@T?QCX.\6>&=8BBNK:#Q!
MX+\;>'/#GB[1K;6],UWPKJ6HZ);:9XO\,^)_"UYK'A[4_P#+D_X*3_\ !L+_
M ,%'/V%_':_\*4^&WQ _;R^ NK_\(O9^&?B[^SW\+M4U?QVGB/6M'UJ^UGPY
MX\_9T\)Z_P#$CXF^#/\ A'[WPUJN[QKI_P#PEWPLN]'U?P)]J\?Z1XZ\5W/P
M[T  _.#]B'_@KG_P45_X)Q^%?''@7]C7]ICQ!\(?!/Q%\0:=XL\5>#KGP7\+
M_B9X5G\5:;IS:./$VC>'OB[X'\>Z1X3\0:II"V&E^)M9\)6>AZCXNT[0/"=C
MXIN=8MO!WA6+1S]M[_@KG_P45_X*.>%? _@7]LK]ICQ!\7O!/PZ\0:CXL\*^
M#K;P7\+_ (9^%8/%6I:<NCGQ-K/A[X1>!_ 6D>+/$&EZ0U_I?AG6?%MGKFH^
M$=.U_P 66/A:YT>V\8^*HM8_."OV>_X)>?\ !"7]O/\ X*C>*O!.L?#SX9^(
M/A7^RYK/B"QMO&/[7'Q'T)])^&>C^%4U'Q?IGB'6?ACIFL:CX=U?]H/Q!I&K
M^ _$G@YO#/PIEU;3M"^(3^'_  ]\5/%GPKT/69?%VF@'XPU]_P#_  2=_P"4
MIO\ P33_ .S_ /\ 8W_]:*^'->__ +6/_!%_]OKX4?M3_M+?"WX%_L$?M_\
MQ*^"7PU_: ^,G@#X._$7_AEKXT>,?^$^^%G@[XB^(_#OP^\:_P#"7>#_ (6:
M=X2\5?\ "5>$M.TC7?\ A(_"VGV'AS7/M_\ :>B65KIEU:P)[!_P3)_X)D_\
M%)/ 7_!23_@GSXZ\=?\ !/G]M_P7X)\%_MO_ +*'BSQCXQ\6?LH?'GPYX5\)
M^%?#GQY\ ZQXA\3>)O$.L> ;/2-!\/Z%I%G>:IK.LZI>6NG:7IUK<WU]<P6T
M$LJ@'^PU1110 5_F"?\ !WO_ ,%+O^&F?VR?#W[#'PM\6?VC\$OV+OM7_"Q?
M[!UW[9X<\:_M3^*K&'_A+OM__".^/-?\)>(_^%$>$I-/^%VD_P!N^$?"OQ%^
M&'Q3UK]I?P3J?VC3-1@S_I]U_"'_ ,%@/^#0_6/BWX[^)/[4'_!-[XG_ /%6
M^+?M7C3QM^S'^T)X[\=^+=8\<>._['\6:YXY\5^ _P!I_P")/BCQQXMUOX@?
M%OQ;;^%W7PM\?+[^Q[CQWXM\=^-/$/[0_A+PE_8?@O1 #^ /X6_%CXI_ [QW
MH7Q2^"GQ+^('P?\ B;X7_M/_ (1GXB_"WQEXC^'_ ([\._VWH^H>'=9_L+Q=
MX3U+2/$&D?VOX?U?5="U/^S]0M_M^CZGJ&F77FV5[<P2_K]\+?\ @Y#_ ."V
MOP?\":%\.O"?[>_Q U?P_P"'?[3_ +/U#XI?#[X'_''QW<?VOK&H:[=?V[\4
MOC7\+_B!\3?%'E7NIW,&F?\ "3>+M7_L31XM/\.Z-]@\/Z1I6F67P!^TO_P3
M\_;B_8W_ +6N?VH_V3/V@/@=X?TCX@7_ ,+?^$]\?_"[Q;I'PLUWQW8?V])_
M87@KXM_V9+\,OB!_:=EX7\0ZSX<U/P-XL\1:/XK\.:1>^)O#.H:OX?B_M(_(
M% 'Z?_MB_P#!9_\ X*?_ +?/@2S^%O[5/[7WQ ^('PRM_M']H?#KP[HG@#X/
M^!/%OFZQX8\16O\ PL7PC\%/"'P[\/\ Q/\ [!\0>#?#NN^$?^%BZ?XH_P"$
M*UBRGU/PC_8E[J>JSWWY@5Z!\+?A/\4_CCX[T+X6_!3X:?$#XP?$WQ1_:?\
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M(='N;/5]!\0:%J]G9ZIHVLZ7>6NHZ7J-K;7UC<P7,$4J_;__  Z=_P""IO\
MTC3_ &__ /Q#?]HK_P"=S1_PZ=_X*F_](T_V_P#_ ,0W_:*_^=S0 ?\ #V+_
M (*F_P#22S]O_P#\3(_:*_\ GC4?\/8O^"IO_22S]O\ _P#$R/VBO_GC4?\
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M9L9=*ATBW\/ZEI'[2G@6W\,W5CKFHZC>:CI/BR'5-*T:VL='O-=_N<KQ_P"
M/P!^#7[+7P:^'O[/G[/GP]\/_"OX-_"OP_#X9\"^!?#,,Z:=I&G)/<7UY<W-
MY?7%YJ^N^(-=U>\U'Q%XL\6>(=1U;Q5XR\5:MK/BOQ7K.L^)-9U35+OV"@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** /X _P#@^<_YQ=?]WL_^^CU_ '7]_G_!\Y_SBZ_[
MO9_]]'K^ .@#_3[_ .#*G_E%E\?/^S__ (I_^LZ_LJU_7[7\@7_!E3_RBR^/
MG_9__P 4_P#UG7]E6OZ_: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\,^&/"UGH_A[3/I^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"O\  'K_ '^*_P  >@#]_O\ @UQ_Y3K_ +#/_=S/_K'G[05?Z_5?Y O_  :X
M_P#*=?\ 89_[N9_]8\_:"K_7ZH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MFG6VC^'O#/AGP]H]M9Z1H/A_0M(L[/2]&T;2[.UT[2].M;:QL;:"V@BB4HH
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/ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>img83973382_2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img83973382_2.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !C!2\# 2(  A$! Q$!_\0
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/X)\9:CJ?BI?#/AV72M+TC6M4\6^&OY8O^(YS_K%U_YNS_\ DCU^8'_!WO\
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MQ6O/V@_#=M;>%+K3I]&\*^!?#*>(O#-E<WUCXE\8 '];M%%% !1110 4444
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MW'A7P%K/PVU_3_%G@GXH>*M+A_L=K\8?^"X__!(KPK_P5\_9'A^%%CXB\/\
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M0+_P='?\IU_VYO\ NV;_ -8\_9]H _T^_P#A[%_P2R_Z26?L ?\ B9'[.O\
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MKX%\3/X=\365S?7WAKQA_ER4 ?[#7_!OS_P5U\5?\%>?V1_'?Q-^+_AWX/\
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MZ8^J^*-8L?\ A#-(NK[3_#5EJ>E7/B;^<'_B-6_X*F_]$#_8 _\ #6?M%?\
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MQ!>:1H5G<:S=:7H>C:=<:C)<S6.E:=;/%9P_XLW_  5B_P"4IO\ P4L_[/\
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MO_"]_&_@7_A76O\ ASS_ !7X5TS3O[.^-OA7X6_\)KJNI_\ "1_8_A9-X_\
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M9X9_X*'?!;X?_%'X):=\/Y?#OB;XC_LW^";KPK^T=J/CO2='L5T;XBZQX?\
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M 'P!7^WS_P .G?\ @EE_TC3_ & /_$-_V=?_ )W-?X@U?Z_7_$4=_P $*/\
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MB!>?M+^+M=\ 6'VC_A#_ /AG?0M2^*7PZU;QKJ<^@^(-,\/_  _\0?&WP_\
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MG^>'7[_?\&N/_*=?]AG_ +N9_P#6//V@J /]?JO\P3_B-6_X*F_]$#_8 _\
M#6?M%?\ T55?Z?=?X ] '^AY_P $9_\ @Z!_;Z_X*)?\%)_V</V.OC7\(OV0
M/"_PR^,'_"X/^$FUWX6^ ?C1HGCNQ_X5_P# 7XH_%+1O["U/Q9\?_&WA^V^T
M^(/!.E6>I_VAX8U/SM'N-0M[7[%>RVVH6G]WE?Y O_!KC_RG7_89_P"[F?\
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MXU>+Q!%J_P .-#M[6ZN-<NM.33KK589M*GN9[.\L?S@_X,J?^467Q\_[/_\
MBG_ZSK^RK1_P>K?\HLO@'_V?_P#"S_UG7]JJ@#\ ?^(U;_@J;_T0/]@#_P -
M9^T5_P#155_3]_P;>_\ !:O]J?\ X+!_\-E_\-+^ ?V?_ __  SO_P ,[_\
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MO&-MHVL17FG0>*O"?AGQ#%;+J^@Z7>6O/T ?W>?\&_\ _P %^?\ @LE^V?\
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M+K_]'S?^:S?L>?\ T/M?T??\$V/^#S7PY\0/';?#K_@J'\*?A_\  [P_J_\
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M72-4\0>$](\>^!=4\3:-8WD^HZ#IWC3PG?:I;6MMXCT>6\Y^@#_8Z_X(R?\
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M"C]N;_NV;_UL/]GVO\@6O]?K_@Z._P"4%'[<W_=LW_K8?[/M?Y M !17Z/\
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M+OM)N=9\/_"OP2GB'XC^+%EUG0M.LO"OA;6=2UCQ!H.D6=]K%EX!XL\)^*O
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MC2[_ ,,_"*?PYX3^(E];>'_&W_"$^(+G_A:OC7P[]@\2W4/PL^'_ (_\2?\
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M!SXT?VK_ ,*Z^W:AXO\ !5GH6D>%/$>A?%/2O 'CW3/&MC_PAL^A>(?Z_?\
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MMF_]8\_9]H _ &O]AK_@W,_8-^#7[%?_  2Y_9H\4>!=%\/W_P 5OVM/@_\
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M ,6=7T_Q#\=KGX<2^&=&G\(^*OBIXFLM875O$CZWXAUC_3[_ ."_W[>6G?\
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M].MM8\/>)O#/B'1[F\TC7O#^NZ1>6>J:-K.EWEUIVJ:==6U]8W,]M/%*W04
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MPL7[#I_B_P :V>NZ1XK\1Z[\4]5\?^/=3\:WW_"90:%X>_?[_B"I_P""IO\
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M/$/@[PSXT^#=UX?\.>&Y]3\(6WAGPC\ /!&HZE!#X9UO4_%EQJ^E>(9?&/\
M6[_P31_X.1?^"<?_  4;_P"$3\ ?\)[_ ,,O_M->(/["TC_AG_X^ZEI?A_\
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MO[&?_!VK_P %5_V9/^$=\,_&#Q+\/_VS_AEI'_"LM"GTKXZ>&X](^*>G>!/
MOFZ?XBT_PM\:_AT?"_B#4_B!\0/#\L-MK?Q2^/6C?M ZPOB/2-(\67>F:O>W
M'BZU\7?8'[=/_!F5^V3\+=8\9^+OV#?BM\/_ -J+X96_E:EX3^%OQ%UJQ^#_
M .T<O]L^.[[3+;P;!J&LP6WP%\;?\(3X%N=!\1>(OB7K7Q%^"G_"7W5EXN@\
M/?"?1+VU\,Z%XD_F!_:7_P""?G[<7[&_]K7/[4?[)G[0'P.\/Z1\0+_X6_\
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MF>')M6^)WA?X/_#'Q_??0'_!R'\4O'?P?_X(E?M[^+/AUKO_  COB#5_A_\
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M[17_ -"K7]?O_!!7_@DS\;/^"9O[ OQS_9"_:C\;_#_Q1X@^,'[0'Q-^(O\
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M_P#X6?\ K.O[55'_  94_P#*++X^?]G_ /Q3_P#6=?V5:/\ @]6_Y19? /\
M[/\ _A9_ZSK^U50!_F"5_?Y_P8Q_\Y1?^[)O_?N*_@#K^_S_ (,8_P#G*+_W
M9-_[]Q0!^_W_  ='?\H*/VYO^[9O_6P_V?:_R!:_U^O^#H[_ )04?MS?]VS?
M^MA_L^U_D"T ?T/?\&PG[!OP:_;X_P""HWA[PO\ '_1?#_C;X4_L^?!_QO\
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M &?_ /"S_P!9U_:JH _S!*_T//\ @QT^*7CO5_A9_P %$_@IJ&N_:/AE\/\
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M7U?Q!^SYJ_B*7XK>&5\'>&T^(6NZ=I/BSX5^'O$&C:'\5/%T6I '^RU1110
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M9RS '\,=?Z_7_!KC_P H*/V&?^[F?_6P_P!H*O\ ,$_X=._\%3?^D:?[?_\
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M  1Z*_3_ .+/_!%__@J;\*/BG\2_A;_PP1^U_P#$K_A6OQ \9> /^%B_"?\
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MK:^L;F>VGBE8 _"&O]_BO\0;_AT[_P %3?\ I&G^W_\ ^(;_ +17_P [FO\
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M&/B_Q7<>)[;X>?&#Q5XVU1O"+>!M>U/PA\ M3T[6?#^IVVN?!6/P3XAN/B0
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MM6\8ZO>>*=>\/Z[\*;R^^&DUS9^(])\5>'?"MQ;_ /""^)O"6N:-X>UK2/\
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MX,\J\N?VB_AUHFJ?$C]G&^\.:GX[OOAWX3\1S_%WPS87/A_P3_PFWB"VL/\
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M\+/@Q\%OV?\ ]EKX@>%?^%4?$"Q^*%G^T/\ '1?AUH?Q3TG^T?#GC[PIX_\
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M6Z\17/A/PWJ.E^%3XJUGQ-XK31D\2>*O$NJ:K\__ +;W_!2']MK_ (*/>*O
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M/B_Q7<>)[;X>?&#Q5XVU1O"+>!M>U/PA\ M3T[6?#^IVVN?!6/P3XAN/B1_
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MQC_YRB_]V3?^_<5_9[^WY^QUX$_X* ?L;?M"?L>?$6\_LCP_\<?A_>>'=/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 ?X ]?O]_P:X_\IU_V&?\
MNYG_ -8\_:"K\ :_?[_@UQ_Y3K_L,_\ =S/_ *QY^T%0!_K]4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 ? '_#IW_@EE_P!(T_V /_$-_P!G7_YW->@?"W_@GM^P+\#O'>A?%+X*
M?L/?L@?!_P")OA?^T_\ A&?B+\+?V:?@O\/_ !WX=_MO1]0\.ZS_ &%XN\)^
M"M(\0:1_:_A_5]5T+4_[/U"W^WZ/J>H:9=>;97MS!*44 ?7]%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
7!1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>12
<FILENAME>amwl-20251224.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2026-01-02T17:15:00.3208+00:00 -->
<!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://business.amwell.com/20251224" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:amwl="http://business.amwell.com/20251224" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" namespace="http://fasb.org/us-gaap/2025"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" namespace="http://xbrl.sec.gov/dei/2025"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://business.amwell.com/20251224/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbase id="lnk">
        <link:roleRef roleURI="http://business.amwell.com/20251224/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="amwl-20251224.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
        <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Issuer Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl"/>
        </link:labelLink>
        <link:presentationLink xlink:role="http://business.amwell.com/20251224/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10010.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10130.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10020.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10000.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10090.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="10091.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10100.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10120.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10110.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10040.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10050.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10060.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10070.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10030.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10080.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10140.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="10190.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="10180.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10210.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="10340.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="10170.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10220.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="10160.0" priority="2" use="optional"/>
        </link:presentationLink>
      </link:linkbase>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Dec. 24, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 24,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">American Well Corporation<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001393584<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39515<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">20-5009396<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">75 State Street<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">26th Floor<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">	 Boston<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02109<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">617<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">204-3500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">	 Class A Common Stock, $0.01 Par Value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AMWL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="amwl-20251224.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://business.amwell.com/20251224/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="amwl-20251224.htm">amwl-20251224.htm</File>
    <File>amwl-20251224.xsd</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>20
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "amwl-20251224.htm": {
   "nsprefix": "amwl",
   "nsuri": "http://business.amwell.com/20251224",
   "dts": {
    "inline": {
     "local": [
      "amwl-20251224.htm"
     ]
    },
    "schema": {
     "local": [
      "amwl-20251224.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 23
   },
   "report": {
    "R1": {
     "role": "http://business.amwell.com/20251224/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document And Entity Information",
     "shortName": "Document And Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "h2",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "amwl-20251224.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "h2",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "amwl-20251224.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://business.amwell.com/20251224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://business.amwell.com/20251224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://business.amwell.com/20251224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://business.amwell.com/20251224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://business.amwell.com/20251224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://business.amwell.com/20251224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://business.amwell.com/20251224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://business.amwell.com/20251224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://business.amwell.com/20251224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://business.amwell.com/20251224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://business.amwell.com/20251224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://business.amwell.com/20251224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://business.amwell.com/20251224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://business.amwell.com/20251224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://business.amwell.com/20251224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://business.amwell.com/20251224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://business.amwell.com/20251224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://business.amwell.com/20251224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://business.amwell.com/20251224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://business.amwell.com/20251224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://business.amwell.com/20251224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://business.amwell.com/20251224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://business.amwell.com/20251224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>21
<FILENAME>0001193125-26-001087-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-26-001087-xbrl.zip
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MWQ"L!7VGJ4@2,2(?XY2E8<P2<MKTN@-@ABVRER3D!*L5Y$04(K\0O*4:[9>
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M8 JZ_<O/NJ/MOFUC[X#:X10R;AZKW7+M6R#XSH!#Z%GD\T,.LR3+.PV>;T;
MI:*/($OX-$:\I6'D'X>]L_T/Y/1L[VS_]&V0M]^?[G?_<=([Z^V?DKW##V3_
M]^[GO<-/^Z1[='#0.SWM'1W*8@T2ES@J8VFC^KIW^KEW^.GLZ'"'?&AU6V!G
MVI:_<-[KJ4.Z[%B@!9=%\S5S-<^2A@C8TC$?LU==15K#LN\5YI.^<3NCW K
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M3\E/>P=?OVR89<,L3\8L06@[AN_02/,]('SF4I][0/V:$VF&9@O#\I>E?YJ
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M.NJFL:O8WPUR]1=%) ODZ9Q.@;YGV%K<'Y"Q*FN*3FU;18LBR^=5(Q@3._.
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MXB?ASY;<^2K1'5C+A8B0J8C<:],J3,T<%+@)&2PF!:A0<M<']GEV:BRT+2S
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MZY!.X^""[[!$9<LP1&^6 ?B* E?%04081%8\#.D9 F.P]D:J,%9J$%"%LVT
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M12>PN^K*W^03UIR@\IQ !KIK3H#+&=:'$ZRG)!'C_A#0EQ$9&J(H2@@/EAL
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MZY5DY4'8=S_]-@]GQAPGP*8C8<=7M9Y%)'F*G%V9O]$"JR[(%7/WXZUDO#.
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M'E9EY=L4CW%,].2LW2;<(3^,Q/0"TBI.#@,W[]8E!QJIO5JS-YLA0$:.YL8
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MZ2QH XV^XK(SVH+95 C$6;^/(?5BPF*\*<KC,4PINSV].F+^2A3@*?;RU1G
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MD*4WXAE+P>T#^\=D.S$30C+%QANV.=.#DEUZ=-^J3.CS $6>*\$SZ3/W;C.
MHI1[!+[I<H0P-'NYAW4%<N\PO( W /3#76&/"^+X=M2'._<)O,</N- 9$82%
M?=*C@G08\XC?YR'6<'2832/!2*,/\V13CWQGKDN._&" 6Q=B\_B(PP#'^K*/
M$(L^L*@S/81=OD>@7\\/H4>X%8>(M2*[7%W ^\/1@*FG'^[+!MF!^0F 3O)Y
M:F-.%#Z$8(&%@L!0!@$?XIZ*?C!!$6VFK/>"*=[AG@MO40!U&<1[=DU> #E5
M7P_H-5/67T$N,ZY3]X:.A++_9F/(!!04:P %]R7^A65;\FN6PFU,[PJZ_#Z
M$T!LNU0(G!UX/-F++.'GX-TTC4M/4#3]XINQL=U<2)&A_DOV_R-@%"HQQR,T
MY+G$KO!)P+HL8)Z=8 :;7LC:"D'&$$*(WR7?_> '<2BV\T_J15B=8.P34S?+
M^]!P>(-XTG39D$*#<4/[Y,2S-2G##TK[;)'-U7.NGG/UG*OGEU7/M7*NGC=;
M/5MS'W,_0<FR5JI.JN<8^-<*%K\N$U!Z"3AO@^0W/)#_/L%-^0A@!GEHY079
MM:, K(80!-YA70DW(/')\L']J?6##VST5&@SNT?^!5^K=0!G"($AKMQL>M<@
MU=+H$$F7B#+) H=T!R9T8(VKUL5DV;H3EZT/DK)UU=.LPO7+MBI4'Y>XISNQ
MR"\_WYJZ81V2\@,5\HB<"W2W!Q\!6SN,)/>$/OR'K32!63GN1'S4 WZ&?L
M0^4@I^9"[J9)?C;JA)).Y#EP'US'P>X:>^2;)#=\,5[2B?0+;WRR:\9797MW
M%+UKTZP3/PIM'V6L0P4&$D$+X+Q(GDA-[3_4>+#I](2HKS5RD;3R2;9RJ5JI
MIS$F!2WP\OT"&JD%X#:<>\GP@Q2ZI%&CI&&!WX3=-Q&_0\B8:>!)C7(H@:"
M78HZOB/JE/LP,A:5HF:\/(3$\ONHS!8UJUHI%6N&530J9<.JE=ZGTQ,_&!O
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M6I))ON,4!DP,P.U ?WMVI([,#MGB='YB/3KD?@ 3J&H6$PZ;'=*]"^3NJ[@
M9A*P0N$:]\^3T(Q1C'2D0R5&9%D4Q:%&KN0!,1* 5Q-WCB,(*O,>9VIFW(C#
M)S8=A%&@"LI:=H_)S79/3DX2<+]?O'FO2K/W["I-PD CV3*A-%7\J<V9'8A7
M*;_&E,A<\KG$RF&03'/3!1/C@& (!#P$W$S,&\'8#[0S@)\<UI?;2-X%-3'K
MYA- 7E\P%&7I_2/ 4MQS.\%ZN9T[BCOO<AO %G"X V*^+ZN:,;PIXVUW%<T@
M*@MPZ/(,.M,=-QYPQXT9[KA9TU/N>/'.'5^0W>8^3W':MZY4-YWGVBE EE;!
M#:)>Z-_0P,$4K@>M8QVW/ PI&*?G@A2JJX+6 3#<(.!H.V,].0(@5L AZDJ&
MA*;16I)!JDXD\$^!P2^!9?9>'+WFG@,DPL!P"(VJ(<##Z3 ^=M:Y4T *CI'W
M00?$PU5UP10&YT@L]WR"$>,X+&X=6'AZKD;:_H#;(GX4;#H[$D*>3N6Z<<!?
M6CDP M?U;Y)ZKM185E*9]9)569G'YO*2K.=+7F)S<R' S40KQW>'F-;@5+$=
MED_ )[6YY5T*:Z5%57*E3Y8<F.6AVGD%U9(LF )M"<< S0KL2#2XRY?>A4MZ
M?A2(C/E/+Y=6A7XUJ[1^WBMI1JUJPE#*-;-:-(O9\=Z6,5^2$0.F VWK]V6V
M6V&B(![H]^ND9@^4=O,*5?JX, WO=7P[](.5<F/F5=*OFR.'V\608-T":\4K
M+S 2]N+8]](%S6]%[VX9HT4"PYQQR$DA6PQ\=Y6UJ22_RNZGBI70#<'SI.+@
MVX5\0;)HI6TFL:69KKOY@.MNSG+==2M;UWVI)>IEK:QO?+AH',V7@53IR,9!
M'Y5MBI>:_AF!D+  /HEH<.>_)W\ESODX7D1M&VW!8")N*Z+.'W&XF$;@W2//
MJM5O^5KT?"UZOA8]7XN>]5KT#P<=WQE]_.G#02_LNQ__'U!+ P04    " !&
MBB)<Y&16/QX?  !H8P$ #P   &%M=VPM97@Q,%\T+FAT;>U=_W?:2)+_.?-7
M]&8VN_:<)4OB.\[F';'QA%U_.T.2G;MW[UXC-483(3%J"<S\]5?5+6' &!L0
M(&SES20V2-VM[JI/?:JZNO3Q+XI"SLX;5Z1F!O: G=G<=#P>^HP<-"\/R9?6
MY04Y\\RPQ]R **0;!/WJ\?%P.%2MCNURSPD#VW.Y:GJ]8Z(HGSYB@Z<^H_@Q
M.:,!(U5#,XJ*IBN:T=)+53U?+534BI[7_T/3JIKV<)?7'_GV73<@!^8AP9N@
M9]=ECL-&Y-QVJ6O:U"'-N,\CTG!-E=0<A]SB;9S<,L[\ ;-4;/.GC]V@YWSZ
MB7SL,FK!O^1C8 <.^U3_MZ)K:O[CL?P5+CB.KOC8]JP1X<'(8?]XWZ>69;MW
MU7+__J1'_3O;K=(P\/YB]_J>'U W./E3L5V+W5>U$V7(VC_L0 G8?:!P^T^F
M4.OWD =57=,^G/0];N.(JSYS*,[RR7LQ',L>S'2F!%Z_JJDYVQTW;IST;%?I
M,GS"JJX:>?CN<8-M[Q[[Q?&V/=]BO@*?0#<?^W$/'<^50X,Q]8/HB61_)^*[
M#NW9SJC:LGN,DRLV)+=>C[KQA6TO"+P>7!O]+A:JFE-SN=R'$_'8U+'O8$3X
M>7R1PSH!W +#P![BD9B>X_G5GS7QYV38M0.F\#XU6;7O,V7HT[X<T% ^<]MS
MK).)T>LP^D4#%M_]8+Z+D^%Z+A,3.+2MH%OMP!J9\#T(,XRJ?M^UVW9 I#3@
M?9\^'O?A?UB8\0*9#N7\'^][%!J);A7_PN_,?Q\_4[Q:A;F+_; *DQ-C5-1"
MN13-'M[NP@+G84:-#R=/KU9.+3XS 8M73%>+QM2*X5B27:+*S !K/NCM$NMR
MWCAO?2&UR_K5&?S?(JUKTOI2)[4K^/N2?+[X6B>GM]?-)GQR)G]M?FG4+\XF
MUW#NC.>*:JFX:'(U52LL.;NIGLF;V^MOC;/Z+:G]>ENOXV0^/T=2I9^>(]"6
MW#H2"&N@Y:<D$)'2[HQ6G;I$9JK5M3FI@96SA*6#7P*/!%U&;GQO8 .@DMJ=
MSYCX\N!O/^?R)^/?Q6^'Q );9Y%_4C>D_HCH1VC!<D>$NA:!BY@/7]HN--IF
MP9 QE]1<:+Y'#KKP%1BW#EQ"?-9A/EX)UU%.9#_BNJ@3;.W:=0![R"D%(_VK
M[X7](W)S.MV.N#H>^<2M\%BV:WH^6# Q6C$@?,J'AX-N.Y[C>$->G2LK2=F1
M9_1FP\O]MY_UHG:ROC(D^LR[Q8K/M6:=",!H-JZOFLLN?N+(N3L)V!15,J9A
MSQ2PD"XAJ-VV&J<7=?*MT6AL<VZ,,1%*[]RTZK>7@G+@#XVK6@O49&DM>8Z]
MIEU))B@Q]-Q3')L'"G.$[1"]]R=8\1PHM6S>=^BHVG'8_;3T1"P@[EU<H?"
M^L&)>'X%^^/5-N4,[=]CB1H_0U$M%DN)<=P5)[*HEBO%<LDH%2MY+6_D<X4/
M)T-PS90V.,<_JC\8Z\/@G/&$V,*J*V)>%DS%^T^Z&J_'A/\XW<I.F92@'1R]
M_[*J(^- 8M(>$0ND1'(.8H.O#A?;/@M&@I?X#$9OPI=#.^@*0B(Y"'8VEC[T
MRJ*_YQIK74N8MJ:,HN)T@E,:3<>2PQ#/8C$3B1]ZIR'XF[[@D=QS[$1ADOD]
MXG4>*.6*(TYN1"J1['[,<7D7-(^87@]^,QFA =&-JJ:#RTE ;*<I?!%$T2>4
M!/*QGJ6,>H0^&S&4T+9FI,YWRI&#H MS>TA&C/H'_/#HT1R&H.W.S*<5=*3N
M#4TW3QJN'6!L#V5'?F:='$K?*5XK:, -8:U"F!8081,^'2&6L$Z'F0%B!N"J
M<'YPO>!ZSLP0XR^PI(P<Z')P8ADY#,=AG!,/[QK:G(F/P7E"? ('J"\])XM(
MG^I-^4&9@=^U@3?VR,#G55W5M0DK3RU+AB\>115XUQNZI,W K"^VZ6_#R=RF
MS<BESF2T0#HN*4>X;C)_8)MLTC['(;*ZPP84+?071AT@AF@/:CWF _J[Y#L#
MNS WZ$8.OC'7\B9"=F!+X%<4R68 =XA.@*)\]_P?:W8FZ0&V?.JY ^;?,7+C
MT  ^[!T]6!4P*:'/0PK=@FHTP6"A^I1P#'CK[' S@Y,9G"T:G-Q>&1Q#S6?V
M)K,WF;U)SMZHR>P*OJZMTXO:%3F]OKRI7S5%J)<T3[_4S[Y>U)>TSC SQK(S
M,[MSH!53'QU_>KZB_=*;TZ;<B7QS,?,WO[78^*:^:][43QOGC5-R6V]<?OYZ
MVZS+W([Z[65S&W0PBO]FG/!EG#"_#YQ0I&68)H;RSAE#5KA@(R&*%&)$<,:D
M9O1PF8V4M:BA42DFH3+;V\V8(V<IV,^(<H>&-K#$/AT])"E1C'8K 2Q*',2&
MS^3(.Z AP/_^FOCP_WX*:]GV[;\?<>IRA0.%[2SQ-/_SRR__N_,I)>!*GC&3
M]=HP87I!XD)"M/A5L>+3)JFU6K73+T\F$[YJO$QQL&K&!T=N\E;(2B'E9 6C
M#^P>1 5IB%"A(*!F5X0%'H6N5LV8F&F7BA^C/<S 4^=QG*E$]YE,=N-$3+$%
M78KH015F+.RYTQ(<'UN(I5 MVN[D>05-+1GPR=S%8ZZUTD&&J;,%:KZP02=J
M2J<>G6-X1FC$4!;UGCAO T^YO#BJIY;6Q-_%,[)5I3IE/A["P*W^CHV')S"!
MP'8Q$B8/'\6G-(0"!9@!8D4'F8X(/,</^ *4#.G'$>E23MH8E?-Z=H ZUV8F
M#3F;B<B=1JG3V#S>8C$9<L,0=)>*+(2I(1S8AZC/KA= CW I#A&U]\"67^#U
MP:C/Y-U/]V6" L'Z^#!/XGYJ!J%(@ CPI!67.0OV $];R>2'\8RHNZ=6+Y#;
M]&KQ'J09/_&\T>&K1)]^3:K_>#+&%JCKSTA&9/R%B1<'[TZFOP#S(3_NTSLF
M&80B\G^JU!G2$7]\QF[NB3I-K<P_4;>)LW//G)-;S]S,1DG7E]0MG8-[UHG*
MJ96U NA ?G4]=5M2]7N3]<5.);N'YCD'..<LP/T=8'0R\^P(34<76>.#,9/?
M1'EQ;292W0(_E+N@/<^"YYIFE"II28X)SR\8Y_11)[06CFV"%1%4DKHC&3H0
M&Z[1AM&XK:/9NQ_2\WS/F>\POVJ'<!NQ_=GC<T;Z4D#KX&N0/D#U2#HT4S(R
MI+Y/W8!+EF,'@CIU0HQ=>4,,4"&C"8.NY]OR?K&]%1].FVH*+T6!!#>;@WAR
M>'[4CIFK/-SW!\'LH/PR&[,\H\%-#Z7+CCDT-B9_5HC\2H[D3TP%Q;-[/3%(
MJ5Y/#FQIR<^$?FO)]QLZ#?2E3NKGY_735N-;G9S56G5R?4Y:7QK-B9/+C69U
M=K-A:8C,;Q4A\^HL(N]*7/)K.ZNIDI?Q4>R+^J^U"W(%0E*=?Y0W,Z)"0/+3
ME1&4LEK"R@5QR$E<4U(-8V'$H[)F[D5B.U8)"I(/]H=9U?2?!"+DF!^3FNM2
MF&[,O?(&]-W.XQ'OX$_JIVZ\%X4E!,!L%'8_;^3=NR8H  U"GQV1V@-+NF7H
MOL!%5!ZWZ8RW(P_XX3LL ;2"KA=+^65U?0U275#S,TF+.U?S=QE OGZ S+!Q
MA4%^LTTLR\*XB''O?M( &-]=T1Y[)_ZTL*C8TKI;476MO+SN%M?2W8J:-U*F
MNS7+PE#8'JANJ2!SN^%OG[$ K'0IZ)+SB]W+XS[H\&>/!Y[[[K+V3C-TK4+2
M,&MR(:46G]K!Z)U<W_^V^TMZ9(6E2[3MBT.V@>#.SB&G1>])0^R6=FQ3;K=>
MA8)['[0:5X?5^41L8<1FN_[X]A,-%DK"*N<=TB0/-UTL&"!%H)I^)"5%O61H
M^5Q!TY:7U'*&4WLCE_4>M1T2$:1]$$RQ*4C-@/\G[0V9XV"-X-V;^;>Y4;,(
M!$JO-7R<,A384,4^<11@V3.)B1_67):CO(55'S!?%"J*6N%A>V)P957+:Q-_
MUDW?^3RJK@VN"3+)]-LGW)MH4J='R;^ZU&%_;'S *9C=B<$8"42]MA!H2,&D
M;4\D=4,Q\@IN]^SEO#Y]H%!_+I2I)QTRV2JI?.F^V+2MWF>83F[N5MP?+"V_
M/[AV(8:BFM=V?HAJ;_>ZWK"M37 P^Q#<G]Z@>UMKG=1F8MJ$;F6Q2VYJ5MM9
M73$KHO#:LB+V9V?5*&@%<J62+\,1R16UMX4?;\U6_.ICDOV-3VW?7A7T]FJI
MMUB(_=_9?"8YGR7 I3>&1NNS&9E4D3983 &;P0R35$W+SF=$I-MD4S(Y@N5S
MC[:Y7_GHR''BQ\/3]L";S+390#&6PJ-J+.576XTEJSV2WMHC6=F+])6]R&=E
M+[96]J*K/S^EN>7S<*8F+O<HY+1>E6@YR-E=N34U8;I&V7C2N_K+LE9T=7;7
M>M/V_M%IZ,U1G)G#T?D$S[IM-(%ISB0MJX-?_3LLVR".0:.)^<RZ=&"# 7+B
MXO@*F*0>F"@3&EXZP6W;0I,T(OV$K_T+:-MA3\A*I?SA).)G."SL 9X";U"
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MWV+KFQG>ETK:G@E:R#&V&06:)+1%R/>02CNQLR^W]"<RE- 1P=<M12&W:_&
MJV;6)E'N?:[;;CSAMAMSW'9#-Q)UV]=\JS7&B=+NNH\#^")X*AS9*-@C-YBB
MH[9_A* BS(??>-A_\-_CGV+G?!PGHJ:)5-"?BM7RL/U[%"*F(7CW*+'RP-O6
MCY^7]>SX>7;\/#M^ONO8_8:/GW\\;GO6Z--/'X^[0<_Y]/]02P$"% ,4
M" !&BB)<%OF@J6L9  !LU0  $0              @ $     86UW;"TR,#(U
M,3(R-"YH=&U02P$"% ,4    " !&BB)<"05_AXD(   L80  $0
M    @ &:&0  86UW;"TR,#(U,3(R-"YX<V102P$"% ,4    " !&BB)<P5SK
M"[P;   9+ $ #P              @ %2(@  86UW;"UE>#$P7S$N:'1M4$L!
M A0#%     @ 1HHB7*602Z2]+P  C\ "  \              ( !.SX  &%M
M=VPM97@Q,%\R+FAT;5!+ 0(4 Q0    ( $:*(ES?['"]<!X  -9, 0 /
M          "  25N  !A;7=L+65X,3!?,RYH=&U02P$"% ,4    " !&BB)<
MY&16/QX?  !H8P$ #P              @ '"C   86UW;"UE>#$P7S0N:'1M
64$L%!@     &  8 <@$   VL      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>amwl-20251224_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="amwl-20251224.xsd" xlink:type="simple"/>
    <context id="C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001393584</identifier>
        </entity>
        <period>
            <startDate>2025-12-24</startDate>
            <endDate>2025-12-24</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658"
      id="F_8f326e7c-a74c-4211-9351-37ca84db312d">0001393584</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658"
      id="F_f5e02698-a278-42c3-a64a-75d7aa9c6295">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658"
      id="F_62bf9aa3-d82f-4ee0-9113-066293c4457c">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658"
      id="F_dfa433db-1595-4366-bcb5-6184b09c8d4c">2025-12-24</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658"
      id="F_40c8a37a-2588-4d60-b970-d0cd9b6efeac">American Well Corporation</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658"
      id="F_f3d1998b-da92-45a5-bd26-2c83a0578925">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658"
      id="F_e4288165-f1d2-4705-8ef4-1b2dd8d20cd7">001-39515</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658"
      id="F_e4ddeece-befa-4963-aadc-c12ca58ed113">20-5009396</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658"
      id="F_cc742520-5292-436a-8d47-ca0f7cabd245">75 State Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658"
      id="F_7600ce43-cd3d-4740-a4b8-e267c071aae0">26th Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658"
      id="F_dffd31a5-f1fb-46aa-9ac8-9b703d50471e">  Boston</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658"
      id="F_f1ac7087-fe16-4072-afca-3daf97a7057b">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658"
      id="F_272a0fe7-42f5-4268-898f-5838f5ea5817">02109</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658"
      id="F_76cd6f8a-2737-4944-80b3-fbeeed973f87">617</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658"
      id="F_920a4465-4212-4fb2-b198-5b2b605b3bc1">204-3500</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658"
      id="F_33ef86bd-2c19-4174-82cb-2263a5f04306">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658"
      id="F_7f65d22b-904c-4769-b62a-e729c1fa63db">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658"
      id="F_35184c92-0639-4b08-a848-5d4be7475d63">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658"
      id="F_e683ec61-d1d3-4d2e-9859-3c9d27a4e5da">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658"
      id="F_e9e073c0-53f1-4ef2-a2fd-f61625a3439f">  Class A Common Stock, $0.01 Par Value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658"
      id="F_9d3615b3-def2-4882-909b-beb59e2a6e2e">AMWL</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658"
      id="F_9bc56296-f098-44a7-9d8a-806f0205e249">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_4debc7c8-03b1-44da-8cdf-a67ae3dd6658"
      id="F_67c7ac61-1378-4fc7-af6e-a8f5b19ab237">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
